Antibodies Against the Shikimate Pathway Enzymes by Likidlilid, Atip
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
ANTIBODIES AGAINST THE SHIKIMATE PATHWAY ENZYMES
ATIP LIKIDLILID
is thesis is submitted for the degree of Master of Science
Department of Biochemistry 
University of Glasgow
December, 1989
ProQuest Number: 10970987
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10970987
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
This thesis is dedicated 
to
my parents
ACKNOWLEDGEMENTS
I wish to express my sincere thanks to the late Professor 
R.M.S. Smellie and Professor M.D. Houslay for making available the 
facilities of the Biochemistry Department; Professor J.R. Coggins 
and Dr. I.D. Hamilton for their constant guidance and encouragement, 
and also for making available the resources to carry out this 
research; Professor C.A. Fewson, Drs. H.G. Nimmo and L.M. Fixter 
for their helpful discussion and criticism; Mr. J.J. Greene for his 
generous gift of the purified enzymes from the overproducing 
strains; Mr. J. Jardine for his expert technical advice and 
everyone in C24 and D-floor for their help.
My sincere thanks also to Siriraj Foundation, Faculty of 
Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand, 
for three years of financial support and to Glasgow University 
Bursary Fund for support during the last three months. Thanks also 
to the staff of the Medical Illustration Unit for their efforts in 
preparing most of the prints herein and Mrs. J. Greenwood for her 
skill and patience in typing this thesis.
And last of all, my gratitude is also due to my parents and 
other members of my family for their perpetual support, morally, 
financially and for encouragement throughout the course of this 
study.
CONTENTS Page
Dedication i
Acknowledgements ii
Contents iii
List of Figures 1X
List of tables x ii
Abbreviations X1V
Abstract xv
CHAPTER ONE
1 Introduction 1
1
1.1 Introduction to the shikimate pathway 1
1.1.1 The shikimate or aromatic biosynthetic pathway 1
1.1.2 The organisation of the genes and enzymes in the ^
shikimate pathway
1.2 The individual enzymes of the shikimate pathway
1.2.1 DAHP synthase 5
1.2.2 Dehydroquinate synthase (DHQ synthase) ®
1.2.3 Dehydroquinase ^
1.2.4 Shikimate dehydrogenase
1.2.5 Shikimate kinase
1.2.6 5-enolpyruvyl-shikimate-3-phosphate (EPSP) 11
synthase
1.2.7 Chorismate synthase xe
1.2.8 The multifunctional enzyme c o m p l y  ^2
1.2.8.1 The arom complex \2
1.2.8 .2 The bifunctional dehydroquinase/shikimate ^
dehydrogenase polypeptide
1.3 Introduction to the quinate pathway
1.3.1 The quinate catabolic pathway 14
1.3.2 The organisation and regulation of the genes and 17
enzymes of the quinate pathway
1.3.2.1 Organisation and regulation in fungi ^7
1.3.2.2 Organisation and regulation in bacteria
1.3.2.3 Organisation and regulation in plants ^
1.4 Evolution of shikimate pathway 22
1.4.1 Evolution of individual enzymes in bacteria 22
1.4.2 Evolution of the arom complex in fungi 24
1.5 Aims of this project 24
iv
CHAPTER TWO Page
2 Materials & Methods 27
2.1 Materials 27
2.1.1 Fine chemicals 27
2.1.2 Chromatographic media 28
2.2 Organisms 28
2.3 Sterilisation 28
2.3.1 Moist heat 28
2.3.2 Dry heat 30
2.3.3 Ethylene oxide 30
2.4 Media 30
2.4.1 Nutrient broth 30
2.4.2 Nutrient agar plates 31
2.4.3 Soy broth 31
2.4.4 Complex medium 31
2.4.5 Minimal medium I 31
2.4.6 Minimal medium II 33
2.5 General methods 33
2.5.1 pH measurements 33
2.5.2 Conductivity measurements 33
2.5.3 Protein estimation 34
2.5.4 Acid-washed glassware 34
2.5.5 Glassware 34
2.5.5.1 General glassware 34
2.5.5.2 Pipettes 34
2.5.6 Dialysis 35
2.5.7 Lyophilisation 35
2.5.8 Concentrations of'protein samples 35
2.6 Maintainance and production of biological material : 35
preparation of cell free extracts
2.6.1 Microbiological safety 35
2.6.2 Bacterial strain storage 36
2.6.3 Bacterial growth 36
2.6.4 Harvesting of bacteria 37
2.6.5 Preparation of crude extracts 37
2.6 .5.1 Bacterial crude extracts 37
2.6.5.2 Fractionation of plant crude extracts 38
2.7 Enzyme assay * 38
2.7.1 DHQ synthase (El) 39
2.7.2 Dehydroquinase (E2) 39
2.7.3 Shikimate dehydrogenase (E3) 39
2.7.4 Shikimate kinase (E4) 40
2.7.5 EPSP synthase (E5) 4T
2.7.6 Quinate dehydrogenase 41
VPage
2.8 Polyacrylamide gel electrophoresis (PAGE) 42
2.8.1 SDS PAGE (discontinuous system) 42
2.8 .1.1 Stock solutions 42
2.8.1.2 Gel plates 43
2.8 .1.3 Preparation of gels 43
2.8 .1.4 Sample preparation and electrophoresis conditions 43
2.8.2 Non-denaturing PAGE 45
2.8 .2.1 Stock solutions 45
2.8.2.2 Gel plates 45
2.8.2.3 Preparation of gels 46
2.8.2.4 Sample preparation and electrophoresis condition 46
2.9 Staining 46
2.9.1 Protein staining 46
2.9.1.1 Coomassie Blue staining 46
2.9.1.2 Silver staining 46
2.9.2 Activity staining 47
2.10 Enzyme preparations 47
2.10.1 Purification of arom complex from N. crassa 47
2.10.2 Purification of E3 from E. coli AB2834/pIA321 49
(E3 overproducing strain)
2.11 Enzyme denaturation 49
2.11.1 Dialysis 49
2.11.2 Reduction and carboxymethylation 49
2.11.3 Analysis of amino acid composition 51
2.11.4 Comparison by SDS PAGE 51
2.12 Preparation of antisera 51
2.12.1 Preparing immunogens 53
2.12.2 Preparing antisera 53
2.13 Antibody enzyme inhibition studies 55
2.14 Immunoprecipitation assay 55
2.15 Immunoprecipitation studies with S. aureus protein A 56
2.15.1 Preparation of concentrated protein A 56
2.15.2 Immunoprecipitation assay with protein A 56
2.16 Enzyme-linked immunosorbent assay (ELISA) 56
2.16.1 Stock solutions 56
2.16.2 ELISA procedure t 57
2.17 Immunoblotting method 58
2.17.1 Immunoblot from SDS PAGE 58
2.17.1.1 Stock solutions 58
2.17.1.2 Immunoblotting conditions 58
2.17.2 Immunoblot from non-denaturing PAGE 59
2.17.2.1 Stock solutions 59
2.17.2.2 Immunoblotting conditions 59
Page
2.18 Molecular weight determinations 59
2.18.1 Subunit molecular weight determination 59
2.18.2 Native molecular weight determination 60
CHAPTER THREE . „of
3. Cross reaction within five central enzymes shikimate 61 
pathway A
3.1 Introduction to immunology 61
3.1.1 Antigens and immunogens 61
3.1.2 Antigen(ic) determinants: epitopes 61
3.1.3 Antibody combining sitesrparatopes (antigen 63
binding sites)
3.1.4 Antibody specificity: cross reactivity 63
3.1.5 Antibody affinity and avidity 65
3.1.6 Properties of polyclonal antisera and monoclonal 67
antibodies and their use in assessing homology 
between proteins
3.1.6.1 Polyclonal antisera 67
3.1.6.2 Monoclonal antibodies 70
3.2 Production and characterisation of polyclonal antibodies 71
3.2.1 Production of antibodies 71
3.2.2 Antisera titre and specificity 73
3.2.2.1 Anti-shikimate dehydrogenase antisera 74
3.2.2.2 Antisera raised against E. coli enzymes of the 78
shikimate pathway
3.3 Immunological cross reactions between shikimate pathway 83
enzymes
3.3.1 Antigenic cross reaction within the shikimate 83
pathway enzymes of E. coli
3.4 Antibody against arom complex from N. crassa 91
3.4.1 Inhibition of activity of arom complex by 91
anti-arom-antisera
3.4.2 Proteolysis of arom complex 94
3.5 Cross reactions using enzyme preparations from different 97
species
3.5.1 Common epitopes between the arom complex from JN^ _ 97
crassa and yeast
3.5.2 Common epitopes between N. crassa arom complex 99
and the corresponding enzymes in E^ _ 6oli
3.5.3 Common epitopes among shikimate pathway enzyme 102
from various organisms
3.5.3.1 Shikimate dehydrogenase as a model system 102
3.5.3.2 Immune inhibition of shikimate dehydrogenase .106
activity in crude extracts
3.5.3.3 Partial purification of shikimate dehydrogenase 108
from bacterial species
3.5.3.4 Immunoblotting of partially purified shikimate 114
dehydrogenases
3.6 Discussion 116
vi i
CHAPTER FOUR Page
4. The purification and partial characterisation of 121
shikimate dehydrogenase from A_j_ calcoaceticus NCIB 8250
4.1 Introduction to A. calcoaceticus 121
4.1.1 A. calcoaceticus 121
4.1.2 Plausibility of two E3 isoenzymes in A. 
calcoaceticus
123
Purification of E3 from A. calcoaceticus NCIB 8250 124
4.2.1 The need for an improved purification scheme 124
4.2.2 Attempted induction of E3 125
4.2.3 Purification procedure 127
4.2.4 Purity of the A. calcoaceticus E3 128
4.2.5 Molecular weight determination 133
4.2.5.1 Subunit Mr of the A. calcoaceticus E3 133
4.2.5.2 Native Mr of the A. calcoaceticus E3 133
Summary of the purification procedure 133
Cross reaction with anti-E. coli E3 137
4.4.1 Immunoprecipitation assay with protein A 137
4.4.2 Antigen titration curve 137
4.4.3 Non-denaturing polyacrylamide gel 
electrophoresis and immunoblotting
140
4.4.4 Quinate dehydrogenase activity in purified E3 140
Summary of the cross, .reaction experiments 144
Separation of isoenzymes by immimo-affinity chromatography 144
4.6.1 General introduction 144
4.6.2 Purification of rabbit IgG 146
4.6.3 Checking the properties of purified anti-E3 147
4.6.3.1 Enzyme inhibition assay and immunoprecipitation 
assay with protein A
147
4.6.3.2 ELISA 150
4.6.3.3 Immunoblots 150
4.6.4 Coupling purified IgG to CNBr-activated 
Sepharose 4B
150
4.6.5 Enzyme purification by immunoaffinity 
chromatography
155
4. 6 .5.1 Purification of E. coli E3 by immunoaffinity 
chromatography
155
4.6.5.2 Separation of A. calcoaceticus isoenzymes by 
immunoaffinity column
157
The antigenic properties of the immunoaffinity purified 
enzymes
157
4.7.1 Enzyme inhibition assay and immunoprecipitation 
assay with protein A
157
4.7.2 Immunoblots 160
vi i i
Page
4.8 Separation of isoenzymes by isoelectric focusing 160
4.8.1 General introduction 160
4.8.2 Separation of A. calcoaceticus isoenzymes.by 162
isoelectric focusing electrophoresis
4.9 Discussion 164
4.9.1 Purification of A. calcoaceticus E3 164
4.9.2 Cross reaction with anti-E. coli E3 165
4.9.3 Specificity and role of the purified 165
calcoaceticus E3
4.9.4 Separation of the isoenzymes 167
CHAPTER FIVE
5. General discussion 169
REFERENCES 174
A P P E f O I X
LIST OF
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
FIGURES
L . l
L. 2
L. 3
L. 4 
L. 5 
L. 6 
L. 7
2.1
3.1 A
3.1 B
3.2
3.3
3.4
3.5
3.6
3.7
3.8
3.9
3.10
i x
Page
The reactions of the shikimate pathway
Some of the metabolic products derived from 
chorismic acid
Homologies between the S _^ cerevisiae arom 
multifunctional enzyme and the five 
corresponding E. coli enzymes
Quinic acid and related compounds
The reactions of the hydroaromatic pathway 16
The structure of pyrrolo-quinoline quinotvg (PQQ) 20
Possible molecular organisation of the 23
shikimate and the quinate pathways and their
interrelations in maize (from Boudet et al.,
1985)
Separation of non-carboxymethylated and 52
carboxymethylated proteins on SDS PAGE
7
15
2
3
Diagrammatic representation of antibody 64
combining site
The principle of antibody specificity and cross 66
reactivity .
The immune response to EL_ coli shikimate 72
dehydrogenase
Assay of anti-shikimate dehydrogenase antisera 
by enzyme inhibition assay
Assay of anti-shikimate dehydrogenase antisera 
by ELISA
Immunoblotting of shikimate dehydrogenase from 77
E. coli with anti-shikimate dehydrogenase
antisera
Assay of antibody titre for antisera against 80
aromatic pathway enzymes from Ej_ coli
Quantitative assessment of antigen detection by 85
immunoblotting
4
Antigenic cross reactions amongst five E. coli 87
central enzymes corresponding to crassa arom
complex
Antigenic cross reactions amongst five coli 88
central enzymes corresponding to crassa arom
complex
Antigenic cross reactions amongst five E. coli 89
central enzymes corresponding to N _^ crassa arom
complex
75
76
Figure 3.11 Antigenic cross reactions amongst five E. coli
central enzymes corresponding to N. • crassa arom 
complex
Figure 3.12 Anti-arom antiserum titre by enzyme inhibition
Figure 3.13 Proposal of mosaic model of N. crassa arom
complex
Figure 3.14 Immunoblot of arom proteolysate with anti-arom
antiserum
Figure 3.15 Immunoblot of N. crassa arom and yeast arom
using anti-N. crassa arom antiserum
Figure 3.16 Binding of anti-N. crassa arom antiserum and
anti-E. coli E3 antiserum to N^_ crassa arom 
complex by ELISA
Figure 3.17 Immunoblot of shikimate dehydrogenase (E3) from
E. coli and EL_ carotovora with anti-E. coli E3 
antiserum
Figure 3.18 Titration of inhibition and immunoprecipitation
of shikimate dehydrogenase (E3) activity from 
bacteria with anti-E. coli E3 antisera
Figure 3.19 Purification of shikimate dehydrogenase
Figure 3.20 Immunoblot of shikimate dehydrogenase (E3)
activity -from bacteria with antisera raised 
against native and carboxymethylated JL_ coli 
shikimate dehydrogenase
Figure 4.1 Purification profile of A. calcoaceticus NCIB
8250 on Ultrogel AcA44
Figure 4.2 Purification profile of A. calcoaceticus NCIB
8250 on Procion red
Figure 4.3 Purification profile of A. calcoaceticus NCIB
8250 on Mono Q
Figure 4.4 SDS PAGE showing the protein components at each
step of the A. calcoaceticus shikimate 
dehydrogenase purification
Figure 4.5 Standard curve for 12.5% SDS PAGE
Figure 4.6 Standard curve for gel filtration on Superose
12
Figure 4.7 Antigen titration curve of purified A.
calcoaceticus shikimate dehydrogenase
Figure 4.8 Non-denaturing gel electrophoresis of purified
A. calcoaceticus shikimate dehydrogenase
Page
90
93
95
96  
100 
101
105
109
113
115
129
130
131
132
134
135
139
141.
Figure 4.9 Probable mechanism of CNBr coupling of protein 
to Sepharose
145
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
XI Page
t.10 Purification of anti-E. coli-E3 on a DEAE 145
Affi-Gel Blue column
[.11 Purity of anti E. coli E3 purified on DEAE 149
Affi-Gel Blue
[.12 Test of the efficiency of purified anti-E. 151
coli-E3 in enzyme inhibition assay
[.13 Test of the efficiency of binding of the 152
purified anti-E. coli-E3 to native E. coli E3 
by ELISA
[.14 Test of the efficiency of binding of the 153
purified anti-E. coli E3 to denatured E3 by 
immunoblotting
[.15 Purification of E. coli E3 by immunoaffinity 156
chromatography
[.16 Attempted separation of the isoenzymes of A_;_ 158
calcoaceticus E3 by immunoaffinity 
chromatography
[.17 Immunoblots of shikimate dehydrogenase samples 161
after immunoaffinity chromatography.
[.18 Isoelectric focusing of A. calcoaceticus E3 163
X I 1
LIST OF TABLES 
Table 1.1 
Table 1.2
Table 2.1 
Table 2.2 
Table 2.3
Table 2.4
Table 2.5 
Table 3.1
Table 3.2
Table 3.3
Table 3.4
Table 3.5
Table 3.6
Table 3.7 
Table 4.1
Table 4.2 
Table 4.3
Table 4.4
Page
Gene and enzyme organisation of the shikimate 
pathway in different organisms
The polypeptide chain size and the subunit 
organisation of the five central shikimate 
pathway enzymes in EL_ coli and S^ _ cerevisiae.
Organisms used in this study
Ratio of polyacrylamide gel preparation (mis)
Purification scheme of the arom complex of N. 
crassa
Purification scheme of E3 from E. coli 
AB2834/pIA321
Immunogens used in this study
Inhibition and immunoprecipitation of shikimate 
pathway enzymes by antisera
Assessment of antibody titre against both 82
native and denatured enzymes by ELISA
Inhibition and precipitation of N. crassa arom 92
complex by anti-arom antiserum
Inhibition and immunoprecipitation by anti-arom 98
antiserum of arom after trypsin digestion
Shikimate dehydrogenase (E3) activity in 104
bacteria grown on different carbon sources
Inhibition and immunoprecipitation of shikimate 107
dehydrogenase (E3) from various organisms by 
anti-E. coli E3 antisera
Purification scheme for shikimate dehydrogenase 112
(E3) from bacteria
Effect of growth substrates on shikimate 126
dehydrogenase activities in crude cell free 
extracts of A^ calcoaceticus NCIB 8250
Purification scheme for A. calcoaceticus 136
shikimate dehydrogenase
i
Cross reaction of purified A. calcoaceticus 138
shikimate dehydrogenase with anti-E. coli 
shikimate dehydrogenase was tested by 
immunoprecipitation assay with protein A
Comparison of shikimate/quinate dehydrogenase 143
specific activities (u/mg protein) between A. 
calcoaceticus and E. coli with various electron 
acceptors
6
25
29
44
48
50
54
x j. i i
Table 4.5
Page
Antigenic properties of enzyme which either 159
failed to bind or bound to the immunoaffinity
column
xiv
Abbreviations
The abbreviations used in this thesis are as set out in 
'Instructions to Authors', Biochemical Journal (1989) 257, 1-21, 
except the following:
DAHP 3-deoxy-D-arabinoheptulosonate 7-phosphate
DCPIP 2,6-dichlorophenolindophenol
DTT dithiothreitol
EPSP 5-enolpyruvylshikimate-3-phosphate
HRP horseradish peroxidase
K kilodalton
PMS phenazine methosulphate
PMSF phenylmethanesulphonyl fluoride
PQQ pyrrolo-quinoline quinone
SDS PAGE polyacrylamide gel electrophoresis in the presence of
sodium dodecyl sulphate 
TEMED N,N,N',N'-tetramethylethylene diamine
ABSTRACT
1. Antibodies have been raised against the Neurospora crassa
arom complex, which is a pentafunctional enzyme that catalyses 
steps 2 to 6 in the shikimate pathway, and against the 
monofunctional enzymes from Escherichia coli, which catalyse the 
same reactions. In the case of the E. coli enzymes, antibodies 
were raised against both native and denatured proteins.
2. Antibodies raised against the E. coli enzymes were tested
for potency and specificity by enzyme inhibition assay, 
immunoprecipitation assay with protein A, ELISA and immunoblots 
against both native and denatured enzymes. Antibodies raised 
against a native protein were more active against that form than 
against the denatured form of the protein and vice versa. No cross 
reaction was detected between an antibody raised against any single 
enzyme and any of the other enzymes of the pathway.
3. The anti-N. crassa arom complex inhibits only the activities 
of 3-dehydroquinate synthase (El) and 5-enolpyruvylshikimate 
3-phosphate synthase (E5) in the complex and does not affect the 
other three activities. This suggests that the active sites of El 
and E5 are close to the surface of the arom complex and represent 
important surface epitopes while the active sites of 
3-dehydroquinase (E2), shikimate dehydrogenase (E3) and shikimate 
kinase (E4) are buried.
4. Partial proteolysis of the arom complex yields two major 
fragments one of M 110K that contains the El and E5 activities
xvi
and the other M 68K which contains the E2 and E3 activities, and 
r
a minor fragment, of M 74K that contains the E5 activity (Smith &
r
Coggins, 1983; Boocock, 1983). All of these fragments bind to the 
anti-N. crassa antibody. When enzyme activities are measured 
results similar to these observed with the complete complex are 
obtained. If the arom complex and arom proteolysate are 
immunoprecipitated by anti-arom, all activities are lost from the 
supernatant.
5. The anti-N. crassa arom complex cross reacts with the yeast 
arom complex by immunoblotting suggesting a greater than 60% 
sequence homology between these proteins. Since arom complex from 
yeast and Aspergillus nidulans are known to contain extensive 
primary sequence homology we would conclude that these three arom 
complexes are very similar.
6 . No cross reaction could be detected between any of the 
antibodies raised against the shikimate pathway enzymes from E. coli 
and the N. crassa arom complex. This is consistent with the low 
levels of sequence homology known to exist between these proteins 
(yeast arom complex and equivalent coli enzymes have less than 
30% overall sequence homology).
7. The anti-E. coli E3 binds and inhibits E3 from E. coli K12
(wild type), E. coli ML308, Salmonella typhimurium, Erwinia
i
carotovora but can bind to only 50% of E3 from Acinetobacter
calcoaceticus. Antibody titre studies in these gram negative 
microorganisms indicated considerable sequence homologies between 
these enzymes with E^ coli K 12J^ E^ _ coli M L 3 0 8 ^  S^_ typhimurium ^
xvii
E. carotovora y A. calcoaceticus. It was concluded that the E3 
gene from these organisms had evolved from the same primitive 
ancestor. The results with A. calcoaceticus E3 suggest that there 
are two isoenzymes in this species.
No cross reactions were observed with E3 from gram positive 
bacteria, fungi and a plant species.
8 . E3 has been purified from A. calcoaceticus and obtained in a
form which gives a single band on SDS PAGE. The purified
A. calcoaceticus E3 is a monomer which a subunit M of 31,000 and
r
+
uses NADP as a cofactor. A simple dye-linked assay procedure
has been developed to assay E3. Unlike the E. coli enzyme, E3 for
A. calcoaceticus shows significant levels of activities with the dye
as an electron acceptor at pH 7.5. In addition the enzyme from
+
A. calcoaceticus can use NAD as a cofactor to a greater extent 
than the E. coli enzyme at pH 10.6.
9. Based on immunoprecipitation results, the presence of two E3
isoenzymes was proposed. Additional supporting evidence for 
isoenzymes was provided by polyacrylamide gel electrophoresis under 
non denaturing condition followed by activity stain and by 
immunoblotting after non denaturing gel electrophoresis which showed 
that anti-E. coli E3 antibody can bind only to the one of the 
postulated isoenzymes. Attempts to separate the two isoenzymes by 
immunoaffinity chromatography and isoelectric focusing 
electrophoresis were unsuccessful.
1 Introduction
1.1 Introduction to the shikimate pathway
1.1.1 The shikimate or aromatic biosynthetic pathway
In plants and microorganisms the biosynthesis of aromatic 
compounds proceeds via the shikimate pathway (Haslam, 1974; Weiss & 
Edwards, 1980). Other eukaryotic organisms lack this biosynthetic 
capability and require a dietary intake of at least-two— of the three 
aromatic amino acids tyrosine, phenylalanine and tryptophan (Davis, 
1955; Sprinson, 1960).
The shikimate pathway, which contains seven steps, converts 
the intermediates of carbohydrate metabolism, erythrose-4-phosphate 
and phosphoenolpyruvate, via shikimate to chorismate (Fig. 1.1). 
Chorismate is probably one of the most versatile chemical 
intermediates in primary metabolism (Haslam, 1974; Dewick, 1989) 
(Fig. 1.2). Many pathways diverge from chorismate to yield not 
only the three aromatic amino acids but also ubiquinone, 
plastoquinone, folic acid and vitamins E and K. In plants 
phenylalanine is a precursor of the lignins which provide much of 
the tensile strength of woody tissues (Boudet et al., 1985). In 
recent years a number of new aromatic compounds derived from the 
shikimate pathway have been identified including a number of 
microbial antibiotics e.g. streptonigrin (Gould & Erickson, 1988), 
sarubicin A (Hillis & Gould, 1985), geldanamycin (Rinehart et a l . , 
1982), pactamycin (Rinehart _e_t a_l., 1981), mitomycin (Anderson 
et al., 1980), ansamycin and maytansinoid (Kibby et al., 1980).
In this thesis the work presented is exclusively on the five 
enzymes 3-dehydroquinate synthase, 3-dehydroquinate dehydratase 
(3-dehydroquinase), shikimate dehydrogenase, shikimate kinase and
Figure 1.1 The reactions of the shikimate pathway
The numbers refer to the enzymes of the pathway:
(1) 3-deoxy-D-arabino-heptulosonic acid 7-phosphate synthase; EO 
(EC 4.1.2.15)
(2) 3-dehydroquinate synthase; El (EC 4.6 .1.3)
(3) 3-dehydroquinase; E2 (EC 4.2.1.10, alternative name 
3-dehydroquinate dehydratase)
(4) shikimate dehydrogenase; E3 (EC 1.1.1.25)
(5) shikimate kinase; E4 (EC 2.7.1.71)
(6) 5-enolpyruvylshikimate 3-phosphate synthase; E5 (EC 2.5.1.19- 
alternative name 3-phosphoshikimate 1-carboxyvinyltransferase)
(7) chorismate synthase; E6 (EC 4.6 .1.4).
The arom multifunctional enzyme catalyses the reactions numbered 2 to 6 
in the above scheme.
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Figure 1.2 Some of the metabolic products derived from chorismic acid.
Some of these products are found in both plants and microorganisms 
while others are found only in plants or only in microorganisms.
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5-enolpyruvyl shikimate 3-phosphat.e synthase (Fig. 1.1). These 
enzymes- catalyse steps 2 to 6 in the pathway respectively and in 
this thesis are designated as El, E2, E3, E4 and E5. 
3-deoxy-D-arabino-heptulosonate 7-phosphate synthase (DAHP synthase) 
which catalyses the first step is designated EO and chorismate 
synthase which catalyses the seventh step E6.
1.1.2 The organisation of the genes and enzymes in the shikimate
pathway
The organisation of the genes and enzymes of this pathway in 
different organisms (prokaryotic and eukaryotic) is found to differ 
markedly, though the seven reactions of the pathway are the same in 
all organisms so far studied.
In the gram negative bacteria: Escherichia coli and
Salmonella typhimurium (Bachmann, 1983, Sanderson & Roth, 1983) the 
genes encoding the shikimate pathway enzymes (the aro genes) are 
widely scattered around the chromosome (Table 1.1) and they encode 
separate enzymes with monofunctional polypeptide chains (Berlyn & 
Giles, 1969; Berlyn & Giles, 1973; Chaudhuri & Coggins, 1985;
Coggins et al., 1985; Coggins et al., 1987a).
In the gram positive bacterium: Bacillus subtilis
(Nakatsukaya & Nester, 1972; Henner & Hoch, 1980) there is some 
clustering of the aro genes (Table 1.1) and the enzyme organisation 
is very much more complex than in E. coli. The enzymes 
dehydroquinate synthase and chorismate synthase are found in a 
trifunctional multienzyme complex along with a flavin reductase 
(diaphorase) activity (Hasan & Nester, 1978a,b,c). A bifunctional 
polypeptide has also been identified, catalysing the first reaction 
of the shikimate pathway (DAHP synthase) and a later reaction in 
aromatic biosynthesis (chorismate mutase). This bifunctional
polypeptide occurs in non-covalent association with shikimate kinase 
(Huang et a l ., 1974a,b, 1975).
In lower eukaryotic organisms for example Neurospora crassa 
(Giles et al., 1967a; Catcheside et al., 1985) Aspergillus nidulans 
(Ahmed & Giles, 1969; Charles jet cQ., 1986), Saccharomyces 
cerevisiae (de Leeuw, 1967; Larimer et al., 1983; Duncan et al., 
1987), Schizosaccharomyces pombe (Strauss, 1979; Nakanishi & 
Yamamoto, 1984) and Euglena gracilis (Berlyn et al., 1970) (Table
1 .1 ) the genes encoding steps 2 to 6 on the pathway are found to be 
clustered and in most of these cases it has been established that a 
single pentafunctional polypeptide chain, known as the arom complex 
or the arom multifunctional enzyme, catalyses all five reactions 
(Lumsden & Coggins, 1977; Gaertner & Cole, 1977; Boocock, 1983; 
Lambert et al., 1985; Coggins et a l ., 1987b; Duncan et al.,
1987). This polypeptide contains five functional domains which 
show strong sequence homology with each of the corresponding, 
monofunctional E. coli enzymes (Fig. 1.3) (Duncan _et al., 1987; 
Coggins et al., 1987a; Charles et al., 1985, 198 6)(,4U
In plants five of the seven shikimate pathway enzymes are
separable (Coggins, 1986) but two, 3-dehydroquinase and shikimate 
dehydrogenase, copurify and have been shown to occur as a 
bifunctional polypeptide (Table 1.1) (Polley, 1978; Koshiba, 1978; 
Coggins, 1986; Mousdale et al., 1987) (see section 1.2.8 .2 below).
1.2 The individual enzymes of the shikimate pathway
1.2.1 3-Deoxy-D-arabino-heptulosonic acid 7-phosphate synthase
(DAHP synthase)
DAHP synthase (EO, EC 4.1.2.15) catalyses the first . 
committed step of the shikimate pathway which is the condensation of 
pho.sphoenolpyruvate and erythrose-4-phosphate to form the seven 
carbon compound DAHP (Fig. 1.1).
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Table 1.1 Gene and enzyme organisation of the shikimate pathway in 
different organisms
Organism (gene organisation) Enzyme organisation
Bacteria
a) E. coli
(no gene clustering)
separable
b) B. subtilis
(some gene clustering)
trifunctional multienzyme complex 
(El+E6+diaphorase) and bifunctional . 
polypeptide or trifunctional complex 
[(EO/chorismate mutase)+E4]
Lower eukaryotes 
(arom cluster gene)
pentafunctional polypeptide 
(E1/E2/E3/E4/E5)
Plants bifunctional polypeptide 
(E2/E3)
+ = enzyme association
/ = enzyme resides on the same polypeptide
-  / -
Figure 1.3 Homologies between the S. cecevisiae arom multifunctional 
enzyme and the five corresponding E. coli enzymes
The S^ _ cerevisiae arom sequence is represented by the lower stippled 
box and the five corresponding E^ _ coli monofunctional enzymes by the 
upper boxes. Each box represents a complete protein sequence. The 
E. coli enzymes are labelled with the letters of the aro genes which 
encode them:
B , 3-dehydroquinate synthase?
A, EPSP synthase 
L, shikimate kinase;
D, 3-dehydroquinase;
E, shikimate dehydrogenase.
N C N C N C N C N • c
B A L D ■E 1
99
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Wild type E^ coli contains three DAHP synthase isoenzymes: 
phenylalanine-sensitive DAHP synthase (Phe), tyrosine-sensitive DAHP 
synthase (Tyr) and tryptophan-sensitive DAHP synthase (Trp) (Doy & 
Brown, 1965), which are encoded by the unlinked genes aroG, aroF and 
aroH respectively. The DAHP synthases of E^ _ coli are feedback 
inhibited by the aromatic end products and their genes are 
transcriptionally controlled by the tyrR (aroF and aroG) and the 
trpR (aroH) repressors. The three isoenzymes have all been 
purified to homogeneity (Hermann, 1983).
N. crassa, like E^ _ coli, has three DAHP isoenzymes that are 
each inhibited by one of the three aromatic amino acids. The 
tryptophan-sensitive DAHP synthase has been purified to homogeneity 
(Nimmo & Coggins, 1981).
B. subtilis contains only a single DAHP synthase which 
occurs with chorismate mutase and shikimate kinase as described in
1 .1.2 above.
1.2.2 Dehydroguinate synthase (DHQ synthase)
DHQ synthase (El, EC 4.6.1.3) catalyses the ring-closure of 
DAHP to form the saturated six-membered ring of dehydroquinate (Fig.
1 .1 ) which is the precursor of the aryl group in the three aromatic 
amino acids and in the other primary and secondary metabolites 
derived from the pathway.
The E. coli enzyme was first characterised by Sprinson and 
his collaborators (Srinivasan et al., 1963; Maitra & Sprinson,
1978). The enzyme requires a divalent transition metal cation and
+
catalytic amounts of NAD for activity. The cloning of the E. 
coli aroB gene encoding DHQ synthase has allowed the construction of 
an overproducing strain for DHQ synthase (Duncan & Coggins, 1983; 
Frost et al., 1984; Millar & Coggins, 1986). The enzyme was first 
purified to homogeneity in Knowles' laboratory (Frost et al., 1984).
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The B. subtilis enzyme, unlike the E. coli enzyme forms a 
trifunctional complex with chorismate synthase and a flavin 
reductase (diaphorase) as described in 1.1.2 above. The 
association1 with chorismate synthase is required for enzyme activity 
(Hasan & Nester, 1978c).
The DHQ synthase of N^ _ crassa is a part of the
pentafunctional arom complex. Like the E. coli enzyme it requires
+ 2+ 
both NAD and a metal cation (Zn ) for activity (Lambert
et a l ., 1985).
1.2.3 Dehydroquinase
Dehydroquinase (E2, EC 4.2.1.10) catalyses the
stereospecific dehydration of dehydroquinate to form
dehydroshikimate (Fig. 1.1). The cloning of the gene (aroD) for
this enzyme from E. coli (Kinghorn et al., 1981) and the
construction of a dehydroquinase overproducing strain (Duncan et
al., 1986) has facilitated the purification of this enzyme to
homogeneity (Chaudhuri et al., 1986). It is a dimeric enzyme
(Duncan et al., 1986) unlike the other four monofunctional E. coli
enzymes with activities corresponding to the fungal arom protein
which are monomeric (Frost et al., 1984a; Anton & Coggins, 1988;
a
Millar et al., 1986a; Duncan et al., 198^).
Dehydroquinase has been purified to homogeneity from peas 
(Pisum sativum) (Mousdale et al., 1987) and mung beans (Phaseolus 
mungo) (Koshiba, 1978). In both these higher plant species as well
as in the moss (Physcomitrella patens) (Polley, 1978) the enzyme 
occurs on a single bifunctional polypeptide chain with shikimate 
dehydrogenase (section 1.2.4).
The biosynthetic dehydroquinases of N_^_ crassa and EL_ coli
are mechanistically similar. Both enzymes work via formation of a
(
covalent intermediate with the substrate dehydroquinate. The keto
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group of the substrate forms a Schiffs base (imine) with the epsilon 
amino group of a lysine side chain of the enzyme. This 
intermediate can be trapped by reduction with sodium borohydride 
(Butler et a l ., 1974; Chaudhuri et al., 1986).
1.2.4 Shikimate dehydrogenase
Shikimate dehydrogenase or dehydroshikimate reductase (E3r
EC 1.1.1.25) catalyses the reduction of dehydroshikimate to
+
shikimate (Fig. 1.1). It is an NADP specific dehydrogenase and 
catalyses the transfer of a hydride ion from the A-side of the 
pyridine ring of NADPH (Dansette & Azerad, 1974). The E. coli 
shikimate dehydrogenase has been purified to homogeneity and is 
monomeric (Chaudhuri & Coggins, 1985). It is unusual in being the 
only monomeric, biosynthetic dehydrogenase reported to date (Anton & 
Coggins, 1988). The gene (aroE) which encodes shikimate 
dehydrogenase has been cloned from and overexpressed in E. coli 
(Anton & Coggins, 1988).
1.2.5 Shikimate kinase
Shikimate kinase (E4, EC 2.7.1.71) phosphorylates shikimate 
to give shikimate-3-phosphate (Fig. 1.1). Both E. coli (Berlyn & 
Giles, 1969) and S. typhimurium (Morell & Springson, 1968) contain 
two isoenzymes with this activity; shikimate kinase I and II. As 
already mentioned (1.2.1 above) in B. subtilis a single shikimate 
kinase occurs as a multienzyme complex with a bifunctional DAHP 
synthase and chorismate mutase; the kinase component has been 
purified to homogeneity and shown to be active only in the complex 
(Huang et al_., 1975).
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The E^ _ coli shikimate kinase isoenzymes are differentially 
expressed. Kinase I is expressed constitutively while kinase II is
transcriptionally regulated by the tyrR repressor (Ely & Pittard,
1979). Both of these isoenzymes coelute in gel filtration 
chromatography but can be separated by ion exchange chromatography 
(Ely & Pittard, 1979).
The E^ _ coli aroL gene which encodes the tyrR-regulated 
shikimate kinase II has been cloned and an overproducing strain 
constructed (Millar et al., 1986a).
N. crassa has a single shikimate kinase as a part of the 
pentafunctional arom complex (see section 1.2.8). This activity is 
very readily inactivated by limited proteolysis with trypsin (Smith 
& Coggins, 1983; Boocock, 1983).
1.2.6 5-enolpyruvylshikimate 3-phosphate (EPSP) synthase 
EPSP synthase (E5, EC 2.5.1.19) converts shikimate 
3-phosphate to EPSP (Fig. 1.1). The E. coli and P. sativum EPSP 
synthases have been purified and shown to be monomeric (Lewendon & 
Coggins, 1983; Mousdale & Coggins, 1984). The E. coli aroA gene 
encoding EPSP synthase has been cloned and used to construct an 
overproducing strain (Duncan & Coggins, 1983; Duncan et al., 1984b).
The discovery that glyphosate (N-phosphonomethylglycine), a 
potent, broad spectrum, post-emergence herbicide (sold as 'Round 
Up'), acts by inhibiting EPSP synthase (Steinrucken & Amrhein, 1980) 
has focussed a great deal of attention on this enzyme and its 
mechanism of action (Coggins, 1986; Amrhein, 1986; Kishore & Shah,
1988).
] z
1.2.7 Chorismate synthase
Chorismate synthase (E6, EC 4.6 .1.4) catalyses the seventh
elimination of orthophosphate from EPSP and introduces the second 
double bond of the aromatic ring to form chorismate (Fig. 1.1). All 
chorismate synthases studied so far require reduced flavin, either
1983; Mousdale & Coggins, 1986). This reduced flavin is provided 
by a flavin reductase (Hasan & Nester, 1978a,b). The cloning and 
overexpression of the E_;_ coli aroC gene encoding chorismate synthase 
has been achieved and chorismate synthase has been purified to 
homogeneity from a suitable overproducing strain (Millar et a l ., 
1986b? White et al., 1988).
(diaphorase) activities both reside on the same polypeptide chain 
(Welch ^t al., 1974; White et a l ., 1988). In subtilis the
chorismate synthase subunit is part of a trifunctional complex also 
containing DHQ synthase and NADPH-dependent flavin reductase 
activities already described (Hasan & Nester, 1978a,b,c) (see 
section 1.2.1). The E. coli chorismate synthase is less specific 
in its reduced flavin requirements accepting FADH^ or NADH but is 
sensitive to molecular oxygen and up until now has only been assayed 
under a N^ atmosphere (Morell et al., 1967; White et al., 1987).
1.2.8 The multifunctional enzyme complexes
1.2.8.1 The arom complex
In fungi, as described in section 1.1.2 above, the five 
enzymes at the centre of the shikimate pathway (those catalysing 
step 2 to 6 in Figure 1.1) occur on a single, pentafunctional,
and final reaction in shikimate pathway This involves the
FMNH or FADH 
2 2
, for activity (Morell et al., 1967; Boocock
In N. crassa the chorismate synthase and flavin reductase
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polypeptide chain (Lumsden & Coggins, 1977; Gaertner & Cole, 1977; 
Lambert et al., 1985; Duncan et al., 1987; Charles et al., 1985,
1986). Experiments involving genetics, limited proteolysis and 
chemical modification (reviewed in Coggins & Boocock, 1986) 
suggested that the crassa arom polypeptide consists of five 
essentially independent functional domains. This has now been 
confirmed by sequencing studies on the related A. nidulans and
S. cerevisiae arom polypeptides which clearly establish that the 
arom polypeptides consist of five domains each of which is 
homologous to one of the corresponding monofunctional E. coli 
enzymes (Duncan et al., 1987; Charles et a l ., 1985, 1986) )
1.2.8 .2 The bifunctional dehydroquinase/shikimate dehydrogenase 
polypeptide
In higher plant species, for example pea and mung bean, it 
has been shown that shikimate dehydrogenase and dehydroquinase occur
as a single bifunctional polypeptide chain of M 60,000 (Mousdale
r
et a l ., 1987; Koshiba, 1978). The co-purification of these two
enzymes has also been demonstrated in other higher plant species
(Boudet & Lecussan, 1974). This M of 60,000 is approximately
r
the sum of the* subunit M 's of the two corresponding E. coli
r
enzymes and o'f the corresponding domains located at the C-terminal 
end of the fungal arom multifunctional enzymes (Coggins et a l .,
1987a). Thus, it appears that the higher plant bifunctional 
enzymes represent an intermediate state of organisation in which two 
of the "bacterial" functional domains have become linked compared 
with the five that are linked in fungi. In this regard it is 
interesting to note that a functional C-terminal fragment of the 
N. crassa arom polypeptide carrying both dehydroquinase and
shikimate dehydrogenase activity has been isolated following limited 
proteolysis (Smith & Coggins, 1983; Boocock, 1983; Coggins &
Boocock, 1986).
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In young plant tissue the bulk of the dehydroquinase/ 
shikimate dehydrogenase activity, in common with the other shikimate 
pathway activities, is chloroplastidic (Mousdale & Coggins, 1985; 
Mousdale et al., 1987). There is also an increasing amount of 
evidence that in many plant species there are two or more isoenzymes 
of dehydroquinase/shikimate dehydrogenase (Rothe et al., 1983; 
Fiedler & Schultz, 1985; Jensen, 1986; Wendel et al., 1988; 
Benedettelli & Hart, 1988). It has also been suggested that, at 
least in some species, one of the isoenzymes may be non-plastidic 
(Rothe et al., 1983; Mousdale et al., 1987; Wendel et al., 1988).
1.3 Introduction to the quinate pathway
1.3.1 The quinate catabolic pathway
Some organisms such as N. crassa (Ahmed & Giles, 1969) and 
Acinetobacter calcoaceticus (Canovas & Stanier, 1967) can readily 
degrade quinate, a compound which is structurally related to 
shikimate (Fig. 1.4), and which is found at high levels in many 
plant species (Boudet et al., 1985). Organisms which have the 
quinate pathway enzymes (see Fig. 1.5) can use quinate as a major 
source of carbon energy. Metabolism of quinate occurs via the 
aromatic intermediate, protocatechuate, which is subsequently 
converted into succinate and acetyl CoA via the ^-ketoadipate 
pathway. The conversion of quinate into protocatechuate is carried 
out through the hydroaromatic pathway (Fig. 1.5). Clear 
relationships exist between the quinate pathway and the shikimate 
pathway. Three intermediates dehydroquinate, dehydroshikimate and 
shikimate and two enzymic reactions, shikimate dehydrogenase and 
dehydroquinase are shared by both pathways (Tresguerres et a l ., 
1970a,b; Ingledew et al., 1971). In fungi the quinate pathway
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Figure 1.4 Quinic acid and related compounds
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Figure 1.5 The reactions of the hydroaromatic pathway
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A diagram to illustrate the conversion of quinate and shikimate into 
protocatechuate through the hydroaromatic pathway (full arrows).
The metabolic interrelationships between this catabolic route and 
the aromatic biosynthetic pathway (dotted arrows) are also 
represented.
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enzymes are inducible and there is the possibility of competition 
between the two pathways for intermediates. Giles has suggested 
that this competition for substrates would be alleviated if the 
biosynthetic intermediates were channelled within the arom complex 
(Giles et al., 1967a). In A. calcoaceticus there is a feedback 
mechanism involving protocatechuate, the last intermediate product 
of the pathway, which inhibits dehydroshikimate dehydrase 
(Tresguerres et al., 1972; Berlyn & Giles, 1973).
It is known that dehydroshikimate reductase or biosynthetic 
shikimate dehydrogenase, the enzyme responsible for the biosynthesis 
of shikimate (Yaniv & Gilvarg, 1955) has no role in its catabolism 
via the quinate pathway although it is able to oxidise this 
substrate 'in vitro1 (Tresguerres et al., 1972). The catabolic 
function is performed by a dehydrogenase which also catalyses the 
oxidation of quinate (Tresguerres et al., 1970b, 1972; Ingledew et 
al., 1971). In fungi (Ahmed & Giles, 1969) there are two distinct 
dehydroquinases: one is an inducible catabolic enzyme which is
involved in quinate utilisation, while the second is a distinct 
biosynthetic isoenzyme, (part of the arom complex) which is involved 
in the biosynthesis of shikimate.
1.3.2 The organisation and regulation of the genes and enzymes of 
the quinate pathway
1.3.2.1 Organisation and regulation in fungi
In N. crassa the conversion of quinate and shikimate to 
protocatechuate is catalysed by three inducible enzymes which are 
the products of 3 a/gene cluster (Giles et al., 1967b; Giles et al., 
1985). Besides the three enzyme genes this cluster also contains 
two genes which regulate the inducible expression of the enzymes 
(Chaleff, 1974; Huiet, 1984).
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The regulation of the three c[£ structural genes take place
at the level of transcription (Patel ej^  al^., 1981). Huiet ( 1984)
has shown that two regulatory genes, qa-lS and qa-lF encode a
repressor and activator protein respectively, both of which are
• involved in the transcriptional control of qa gene expression.
The first of the inducible quinate pathway enzymes is the
bifunctional quinate (shikimate) dehydrogenase (encoded by qa3, EC
+
1.1.1.24) which catalyses the NAD -dependent oxidation of quinate 
to dehydroquinate. This has been purified to homogeneity and is a
monomer of M 41,000, with a single binding site for both 
r
substrate (Barea & Giles, 1978). The second enzyme, the catabolic
dehydroquinase (encoded by qa2, EC 4.2.1.10) has also been purified
to homogeneity and is a dodecamer M 20,000 (Chaudhuri & Coggins,
r
1982). The third enzyme dehydroshikimate dehydrase (encoded by 
ga4) has not yet been purified and characterised.
The inducible quinate pathway of Aspergillus nidulans is 
very similar to that found in N. crassa (Ahmed & Giles, 1969; da 
Silva e± al_., 1986).
1.3.2.2 Organisation and regulation in bacteria
The quinate pathway in A^ _ calcoaceticus has been
characterised more extensively than in other bacteria. As in
N. crassa, there are two dehydroquinase isoenzymes but these differ
from the N. crassa enzymes in thermostability (Ingledew et a l .,
1971; Berlyn & Giles, 1973). In A. calcoaceticus the inducible
catabolic dehydroquinase is heat labile while the constitutive
o
biosynthetic dehydroquinase is stable at 70 C for 10 min (Ingledew
et al., 1971; Berlyn & Giles, 1973). The average M values of
r
the degradative and biosynthetic isoenzymes based on sucrose 
gradients were 41,000 and 125,000 respectively (Berlyn & Giles,
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1973). The other two enzymes involved in quinate breakdown are 
quinate dehydrogenase (dye-linked hydroaromatic dehydrogenase) 
which, as in crassa has shikimate dehydrogenase activity and 
dehydroshikimate dehydrase (Tresguerres et al., 1970b; Ingledew 
et a l ., 1971). Both are inducible.
In A_^  calcoaceticus, Pseudomonas putida and Pseudomonas
aureofaciens the quinate/shikimate dehydrogenase is a 
+
NAD(P) -independent enzyme (EC 1.1.99.-) and is membrane
associated (Tresguerres et al., 1970a,b; Ornston, 1971; van Kleef
& Duine, 1988). The enzyme contains pyrrolo-quinoline quinone (PQQ
or 2,7,9-tricarboxy-lH-pyrrolo [2,3-f] quinoline-4,5-dione) or
methoxatin (Fig. 1.6) as a prosthetic group or cofactor, i.e. it is
a quinoprotein (van Kleef & Duine, 1988). The physiological
function and the biosynthetic pathway to PQQ have not yet been
elucidated (Dokter et al., 1988; Goosen et al., 1989). It is
possible that ubiquinone may act as a primary electron acceptor in
this system (van Kleef & Duine, 1988) as is the case for the
quinoprotein glucose dehydrogenase (Matsushita et al., 1989).
A particulate quinate dehydrogenase which does not require
pyridine nucleotides has also been found in Acetomonas
(Gluconobacter) oxydans, but in contrast with the enzyme of
A. calcoaceticus, its synthesis is apparently constitutive (Whiting
+
& Coggins, 1967). An NAD -dependent quinate dehydrogenase, 
similar to that found in N. crassa and other fungi, is also found in 
some bacteria, e.g. Aerobacter aerogenes (Mitsuhashi St Davis, 1954) 
and Pseudomonas aeruginosa (Ingledew St Tai, 1972).
1.3.2.3 Organisation and regulation in plants
Quinic acid and shikimic acid occur in many higher plants 
(Bohm, 1965; Boudet _et al^., 1985), often in appreciable 
concentrations. At the present time the enzymatic reactions .
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Figure 1.6 The structure of pyrrolo-quinoline quinone (PQQ)
The structures of PQQ and its reduction product are 
shown (from Duine et a l ., 1981; Geiger & Gorisch, 1989).
COOHCOOH
COOHCOOH
Pyrrolo-quinoline quinol-Pyrrolo-quinoline quinone
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involved in the synthesis and utilisation of quinic acid in plants
have not been clearly identified but it has been suggested that .
quinic acid may be an intermediate on an alternative aromatic
biosynthetic pathway which has developed during biochemical
evolution (Boudet el: aJU , 1985). Various studies have concluded
that both quinic acid and shikimic acid are actively metabolised in
plants (Haslam, 1974). Boudet and coworkers (Boudet et al., 1985)
have found that there are two dehydroquinase isoenzymes in monocot
species such as maize. Dehydroquinase-1 is associated with
shikimate dehydrogenase and is probably involved in the shikimate
pathway, whilst dehydroquinase-2 does not show any shikimate
dehydrogenase activity but is activated by shikimate. This
activation is very similar to that of the inducible dehydroquinase
in fungi (Giles et al., 1967a) and bacteria (Ingledew et al., 1971;
Berlyn & Giles, 1973) even though the plant enzyme differs from the
fungal and bacterial enzymes in that it is constitutive and
extremely heat labile. More detailed studies have shown that
+
dehydroquinase-2 is associated with an NAD -dependent quinate 
dehydrogenase. These two enzyme activities co-migrate during 
purification, suggesting their association in an enzyme complex or 
on a bifunctional polypeptide chain (Graziana et a l ., 1980). The 
occurrence of the dehydroquinase-2/quinate dehydrogenase complex in 
addition to the biosynthetic dehydroquinase-l/shikimate 
dehydrogenase bifunctional enzyme found generally in higher plants 
(see 1 .2.8.2 above), is almost certainly restricted to some families 
of monocots (Minamikawa, 1977; Boudet et al., 1985) and has not 
been found generally in plants.
The occurrence of these parallel enzyme complexes and 
isoenzymes in some plant species has led to the suggestion that the
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major role of the bifunctional enzymes may be . to channel intermediates 
(Boudet et_ a^L., 1985). This would allow the independent functioning 
of the biosynthetic pathways and the catabolic pathways even though 
they involve many intermediates in common. Work on the maize has led 
to the following specific suggestion about the molecular organisation 
of the shikimate and quinate pathway enzymes in this species (Boudet 
et al.f 1985) (Fig. 1.7). Quinic acid and shikimic acid originate 
independently from central metabolism and quinate can be directly 
converted to shikimate (Fig. 1.7). The quinate dehydrogenase/ 
dehydroquinase-2 complex produces dehydroshikimic acid from quinic 
acid and this is preferentially converted to protocatechuic acid and 
metabolised through a catabolic pathway. The dehydroquinase-1/ 
shikimate dehydrogenase bifunctional enzyme is part of the ’normal' 
shikimate pathway and produces dehydroshikimic acid which is used 
preferentially for biosynthesis of shikimate and the aromatic amino 
acids. Shikimate activates dehydroquinase-2 and this may serve to 
channel the carbon flow from quinic acid to protocatechuic acid and 
its metabolites (Boudet et al., 1985).
1. 4 Evolution of shikimate pathway
1.4.1 Evolution of individual enzymes in bacteria
Complete amino acid sequences have been deduced from gene 
sequence for all seven enzymes of the shikimate pathway of E. coli 
(section 1.2). Many of these sequences have been determined for more 
than one species. For example, the sequences of Erwinia carotovora 
and E. coli shikimate kinase are known (Minton et^ al^ . 1989; Millar 
et a l ., 1986a). The sequence information shows that each enzyme is 
not closely related at the primary structure level to any of the other 
pathway enzymes and it appears at this stage unlikely that all the 
pathway enzymes have diverged from a single common ancestor.
Figure 1.7 Possible molecular organisation of the shikimate and
the quinate pathways and their inter relations in maize 
(from Boudet et al., 1985)
Catabolic pathway
I
Protocatechuic
acid
OHSDHQCarbohydrates - - - > Q A
S A  iOHS■> d a h p - A dhq
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QA = quinic acid 
DHQ = dehydroquinate 
DHS = dehydroshikimate 
E4P = erythrose-4-phosphate 
PEP = phosphoenolpyruvate 
SA = shikimic acid
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However, comparison of the sequences of each individual enzyme from 
several species show very clear homologies (see Duncan et a l .,
1987). There is also clear evidence that three of the enzymes, 
dehydroquinate synthase, shikimate dehydrogenase and shikimate 
kinase contain regions that are clearly homologous to the 
characteristic nucleotide binding regions of other synthases, 
dehydrogenases and kinases, for example, (Walker et al., 1982;
Finch & Emmerson, 1984; Millar St Coggins, 1986; Millar et al., 
1986a; Anton St Coggins, 1988; Minton et a l ., 1989)('see.
1.4.2 Evolution of the arom complex in fungi
The mosaic structure of the fungal arom polypeptides 
described in section 1.2.8 suggests that these pentafunctional 
polypeptides may have arisen by a series of gene fusions. The gene 
fusion hypothesis is particularly attractive as a model for the 
origin of the entire arom' polypeptide because the subunit M
r
values of the five corresponding E]^_ coli polypeptide add up to 
159,686 (Coggins et a l ., 1987a) while the Neurospora and yeast arom 
subunits M^ are 165,000 (Coggins e± ^1_., 1987b) and 174,555 
(Coggins et al., 1987a) respectively and the sequence homologies 
with the five monofunctional coli enzymes are very convincing 
(Table 1.2) (Duncan et a).., 1987; Charles et al., 1985, 1986).
Gene fusion leading to multifunctional polypeptide chains have been 
reported for other enzymes involved in amino acid biosynthesis, for 
example, for E. coli anthranilate synthase (Miozzari & Yanofsky, 
1979) and for yeast tryptophan synthase (Zalkin & Yanofsky, 1982).
1.5 Aims of this project
As described above, structural and evolutionary 
relationships between enzymes can be evaluated from amino acid and
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nucleotide sequences. Alternatively antibodies raised against the 
enzyme from one organism can be used to detect structural 
similarities with the same enzyme isolated from other organisms by 
analysis of cross reactions. The degree of cross reaction can be 
related to similarities of amino acid sequences and can in addition 
give information on structural similarity. The aims of this 
project were three fold.
1) to use antibodies to detect sequence and structural
similarities between the enzymes of the shikimate pathway 
within one species;
2) to use antibodies to detect sequence and structural
similarities between the shikimate pathway enzymes of 
different species;
3) to purify the enzymes which were shown by immunological
techniques to be interesting, for further study.
It was expected that the immunological studies would help to throw 
further light on evolutionary relationships between the shikimate 
pathway enzymes of different species.
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2. Materials & Methods
2.1 Materials
2.1.1 Fine chemicals
All reagents used were the best grade available 
commercially. With the exceptions of the materials listed below, 
reagents were obtained from BDH Chemicals Ltd., Poole, Dorset, U.K.
Bovine serum albumin (Fraction V)-Armour Pharmaceuticals Co. Ltd., 
Eastbourne, Sussex, U.K.
HRP color development reagent (4-chloro-l-naphthol) - Bio-Rad 
Laboratories Ltd., Watford, Hertfordshire, U.K.
Freund's complete and incomplete adjuvant - Difco Laboratories, 
Central Avenue, West Molesey, Surrey, U.K.
HRP donkey anti-rabbit IgG, normal rabbit serum, normal donkey serum 
- Scottish Antibody Production Unit, Law Hospital, Carluke, 
U.K.
ADP, ATP, protein A S. aureus (Cowan strain) crude cell suspension,
PMSF, Coomassie Brilliant Blue G-250, Deoxyribonuclease I
(DNasel), SDS PAGE calibration proteins, Tween 20 - Sigma
Chemical Co. Ltd., Poole, Dorset, U.K.
+ +
NAD , NADP , NADPH, NADH, phosphoenolpyruvate, DTT, Tris,
lactate dehydrogenase/pyruvate kinase - Boeringer Corp., 
Lewes, East Sussex, U.K.
Shikimic acid, DCPIP, Benzamidine.HC1 - Aldrich Chemical Co. Ltd., 
Gillingham, Dorset, U.K.
DAHP, dehydroquinate, EPSP - gifts from Professor J.R. Coggins, 
Department of Biochemistry, University of Glasgow.
Partial purified yeast arom complex - gift from Ms. A. Stuart, 
Department of Biochemistry, University of Glasgow.
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Partial purified S. coelicolor shikimate dehydrogenase - gift from 
Dr. P.J. White, Department of Biochemistry, University of 
Glasgow.
Crude extract of graminis shikimate dehydrogenase - gift from 
Mr. M. Yasin, Department of Biochemistry, University of 
Glasgow.
2.1.2 Chromatographic media
Prepacked Mono Q, Phenyl superose and Superose 12 columns (f.p.l.c.
system) - Pharmacia Ltd., London, U.K.
CNBr-activated Sepharose 4B, DEAE-cellulose, DEAE-Sephacel, Blue 
dextran Sepharose, Sephacryl S-200, ADP-Sepharose - 
Pharmacia Ltd., London, U.K.
Ultrogel AcA44 - LKB Instruments Ltd., South Croydon, Surrey, U.K.
Red Sepharose CL-6B (Procion Red HE3B), DEAE Affi-Gel Blue (Cibacron 
Blue F3GA) - Ami.con Ltd., Upper Mill, Stonehouse, U.K. 
Trypsin inhibitor immobilised on agarose - Miles-Yeda Ltd., Slough, 
Berkshire, U.K.
2.2 Organisms
The organisms used in this study are shown in Table 2.1.
Some were obtained from stocks maintained in the Department of 
Biochemistry and Genetics but were ultimately derived from culture 
collection strains. Others were isolated in the Department of 
Biochemistry, University of Glasgow. The source of each organism 
is also indicated in the Table 2.1.
2.3 Sterilisation
2.3.1 Moist heat
Heat-stable solutions were autoclaved. All solutions were 
o
autoclaved at 109 C (5 psi) for times established by Fewson
*1. American Type Culture Collection
2. Millar & Coggins, 1986
3. Duncan et al., 1986
4. Anton & Coggins, 1988
5. Millar et al., 1986a
6. Duncan et al., 1984b
7. National Collections of Industrial and Marine Bacteria Ltd., 
Aberdeen, Scotland
8. SCRI. Invergowrie, Scotland
9. National Collection of Type Cultures, PHLS, London, England
10. Dr. I.S. Hunter, Department of Genetics, University of
Glasgow
11. Fungal Genetics Stock Center, Areata, California, U.S.A.
12. Genex Corp., Gaithersburg, Maryland, U.S.A.
13. Dr. A.J.P. Brown, Department of Genetics, University of 
Glasgow.
14. Clause (U.K.), Charvill, Reading, Berkshire.
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Table 2.1 Organisms used in this study 
Organism
Bacteria
Escherichia coli K12 (ATCC 14948) 
Escherichia coli K12: AB2826/pGM107 
Escherichia coli K12: AB2848/pKD201 
Escherichia coli K12: AB2834/pIA321 
Escherichia coli K12: HWllll/pGM450 
Escherichia coli K12: AB2829/pKD501
Escherichia coli ML308 (ATCC 15224) 
Salmonella typhimurium (NCIB 10255) 
Acinetobacter calcoaceticus (NCIB 8250) 
Erwinia carotovora ssp. atroseptica 1034 
Staphylococcus aureus Oxford (NCTC 6571) 
Bacillus subtilis (NCTC 3610) 
Streptomyces rimosus (NCIMB 40i8) 
Streptomyces coelicolor GLW209
Fungi
Neurospora crassa 74 OR23-1A 
Rhodotorula graminis KGX 39 
Saccharomyces cerevisiae 5228C
Plant
Genotype with respect Source*
to aromatic amino acid 
biosynthesis
wild type 1
El overproducing strain ■ . 2
E2 overproducing strain 3
E3 overproducing strain 4
E4.II.overproducing strain 5
E5 overproducing strain 6
wild type but lac i 1
wild type 7
wild type 7
wild type 8
wild type 9
wild type 9
wild type 7
wild type 10
wild type 11
wild type 12
wild type 13
Pisum sativum (variety Onward) wild type 14
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(unpublished results) as adequate for sterilisation. Efficiency of 
sterilisation was verified by using Browne's tube (type one, A.
Browne Ltd., Chancery Street, Leicester).
2.3.2 Dry heat
Pipettes were wrapped in either Kraft paper or placed in
metal cannisters before sterilisation. Each sterilisation 
o
(160 C, 1.75 h) was checked by including a Browne's tube (type 
three). Where necessary glassware was also sterilised by dry heat
at 160°C for 1.75 h.
2.3.3 Ethylene oxide
Plastic pipettes and other disposable apparatus were 
sterilised with ethylene oxide. All items were sealed with 
polythene film and exposed to ethylene oxide (Anprolene) for 12 h in 
a sterilising box (AN74; H.W. Anderson Products Ltd., 
Clacton-on-Sea, Essex). Sterilisation was verified by an Anprolene 
exposure indicator (AN85) or by a steritest unit (AN80). All 
apparatus was aired for at least 24 h prior to use to remove 
residual gas.
2.4 Media
2.4.1 Nutrient broth
Nutrient broth (Oxoid CM1; 13g/l) was prepared, sterilised 
by autoclaving and used for culture maintenance, for preparation of 
inocula and for both small and large scale growth of E. coli,
S. typhimurium, E. carotovora, S. aureus and JB^ subtilis.
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2.4.2 Nutrient agar plates
The nutrient agar (Oxoid CM3; 28g/l) was boiled, stirred to
ensure even suspension of agar and then autoclaved. The sterile
o
molten medium was mixed well, allowed to cool to 55 C and poured 
into petri dishes. After the agar had solidified the plates were
left inverted for 24 h at 37 C to dry the surface of the agar.
2.4.3 Soy broth
Soy broth (BBL and Trypticase; 30g/l) was used for growing 
inocula and large scale growth of S^ _ rimosus.
2.4.4 Complex medium
The complex medium (Allison et al♦, 1985) contained (g/1) :
The medium was adjusted to pH 7.0 with 5 M-NaOH, made to the correct 
volume with distilled water and autoclaved. This medium was used 
for preparation of inocula and for large scale growth of 
A. calcoaceticus.
2.4.5 Minimal medium I
This medium was adapted from Canovas & Stanier (1967) for 
induction the quinate dehydrogenase and shikimate dehydrogenase in 
A. calcoaceticus. The medium was prepared as several components 
which were separately sterilised by autoclaving.
o
Oxoid No. 1 nutrient broth 26.0
KH PO 
2 4
2.0
1.0
L-glutamic acid.HCl 0.9
MgSO .7H O 
4 2
0.4
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1) Chel metals
Chel metals was prepared as follows:- Nitrilotriacetic acid 
(Chel) (80g) was dissolved in 1 M-NaOH (625ml) and the 
solution was adjusted to pH 7.0 with 5 M-HC1. Salts were 
then added in the following order ensuring that each 
component was completely dissolved before the next was added:
FeSO .7H 0 
4 2
Na MoO .2H O 
2 4 2
MnSO .4H O 
4 2
ZnSO .7H O 
4 2
CuSO .5H 0 
4 2
CoCl . 6H O 
2 2
The solution was made up to 1 1 with distilled water, autoclaved and 
stored at room temperature until required (Beggs & Fewson, 1977).
2) Minimal medium I containing carbon source
This minimal medium contained (g/1):
KH PO 2.0
2 4
(NH ) SO 1.0
4 2 4
Carbon source (lOmM quinic acid or
lOmM p-hydroxybenzoic acid or 
20mM succinic acid)
The pH of the medium was adjusted to 7.0 with 5 M-NaOH, made to the
correct final volume with distilled water and autoclaved.
3) 2% (w/v) MgSO^.7H^O was prepared and sterilised by 
autoclaving.
Immediately before inoculation complete medium was prepared by 
adding aseptically 2ml chel metals and 20 ml 2% MgS0^.7H^0 to 
each litre of minimal medium.
l.lg
50mg
50mg
50mg
25mg
25mg
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2.4.5 Minimal medium II
Minimal medium II was prepared as four components which were 
autoclaved separately:
1) P medium contained 5.44g KH PO per litre, adjusted to
2 4
pH 7.0 with 5 M-NaOH.
2) MgNS contained 9.86g MgS0^.7H^0 and 105.7g
(NH ) SO per litre.
4 2 4
3) FeSO contained 0.22g FeSO .7H O per litre, and was
4 4 2
adjusted to pH 2.0 using 5N-HC1 before sterilisation.
4) Carbon source (stock solutions) (pH 7.0)
a) glucose 1 M
b) glycerol 1 M
c) sodium succinate 1 M
Before inoculation, 2ml MgNS and 2ml FeSO were added to a flask
4
containing 140ml P medium. Carbon source (glucose or glycerol or
succinate) was then added.to give the desired final concentration
(20mM) and the volume made to 160ml with sterile H 0. This
2
minimal medium was used for growth of JE^ coli and E^ _ carotovora.
2.5 General methods
2.5.1 pH measurements
The pH of solutions was measured using a direct reading pH 
meter and combination electrode. Calibration of the electrode was 
carried out immediately before use using a pre-prepared solution of 
known pH (BDH Buffer tablets).
2.5.2 Conductivity measurements
o
The conductivities of solutions were measured at 4 C using 
a Radiometer conductivity meter type CDM2e (Radiometer, Copenhagen, 
Denmark).
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2.5.3 Protein estimation
Protein estimation was made by the method of Bradford (1976)
using bovine serum albumin as standard.
Protein elution from column was followed by measuring the
A of the eluant using elution buffer for standardisation of 
280
A
280
2.5.4 Acid-washed glassware
All glassware used for protein chemistry (e.g. amino acid 
analysis, enzyme denaturation) was soaked overnight or boiled for 
15 min in 30% (v/v) nitric acid. The acid-washed glassware was 
rinsed extensively with distilled water and dried in an oven before 
use.
2.5.5 Glassware
2.5.5.1 General glassware
Glassware was washed routinely by soaking in approximately 
1% (w/v) Haemosol solution (Meinecke and Co., Baltimore, U.S.A.) 
then rinsed thoroughly in tap and glass-distilled water and dried in 
oven.
2.5.5.2 Pipettes
Before use all pipettes were washed by soaking in Haemosol 
solution (1% w/v) followed by thorough rinsing in tap and deionised 
water and drying in an oven. All pipettes were plugged with 
non-absorbent cotton wool.
2.5.6 Dialysis
Dialysis was carried out using Visking tubing (Scientific 
Instruments Centre Ltd., London), which had been immersed in boiling 
1% (w/v) EDTA solution, pH 7.0 for 15 min and then washed with 
distilled water. If not used immediately the prepared dialysis 
tubing was stored in 20% (v/v) ethanol and rinsed thoroughly in 
distilled water before use.
2.5.7 Lyophilisation
Samples were frozen over the surface of a suitable vessel by 
placing them into methanol/dry ice. The top of the vessel was 
covered with nescofilm (Nippon Shoji Kaisha Ltd., Osaka, Japan) and 
punctured with a needle. Frozen samples were placed in a 
dessicator connected to a Flexi-dry (FTS Systems Inc., Stone Ridge, 
U.S.A.) and maintained under vacuum by a high vacuum pump (Javac PTY 
Ltd., Farnham, U.K.) until completely dry.
2.5.8 Concentrations of protein samples
Samples of protein of less than 10ml volume were 
concentrated using Centricon 30 microconcentrators (Amicon Ltd., 
Stonehouse, U.K.).
2.6 Maintenance and production of biological material : 
preparation of cell free extracts
2.6.1 Microbiological safety
The recommendations as outlined in "Guidelines for 
Microbiological Safety" were followed.
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2.6.2 Bacterial strain storage
Wild type strains were stored on nutrient agar slants or on
o
sealed plates of nutrient agar at 4 C. Overproducing strains
were maintained in nutrient agar containing suitable drugs
[ampicillin (50jig/ml) or tetracycline (20yjg/ml)] to keep selective
pressure for plasmid retention during storage. For short term
storage all strains were maintained in 10ml nutrient broth, stored 
o
at 4 C. For mutant strains drugs were added to the medium, as 
necessary, for plasmid maintenance.
2.6.3 Bacterial growth
All bacterial growth was carried out in temperature
controlled rooms. Cultures of E. coli, S. typhimurium, S. aureus
o
and J3^ _ subtilis were grown at 37 C, of A^ _ calcoaceticus and
o o
S. rimosus at 30 C and of E_j_ carotovora at 23 C.
Small scale growth of cells was carried out by inoculating
into 500ml of the appropriate sterile medium in 2 litre conical
flasks which were stoppered with polystyrene foam bungs (A. & J.
Beveridge Ltd., 5 Bonnington Road Lane, Edinburgh, U.K.). Cultures
were grown on a rotary shaker at 120 rpm at the appropriate
temperature.
For larger scale growth of cells 4 litres of appropriate 
medium in 10 litre flat-bottomed flasks were used. These flasks 
were fitted with plugs of non-absorbent cotton wool through which 
passed a plugged 10ml glass pipette. After inoculation the flasks 
were vigorously mixed using a 45mm polypropylene-coated magnetic bar 
on apparatus built in Glasgow (Harvey et a l ♦, 1968). Adequate 
aeration was ensured by passing air (at 400ml/min) through the glass 
pipette in the bung.
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Bacterial growth was monitored by optical density at 420nm 
using an LKB ultrospec spectrophotometer (LKB/Pharmacia, Milton 
Keynes, U.K.). All samples were read within the linear range of 
this spectrophotometer for proportionality of optical density by 
light scattering to bacterial density (optical density values of 
less than 0.6). All samples above this range were diluted in the 
appropriate blank medium as necessary.
2.6.4 Harvesting of bacteria
Cultures at late exponential stage of growth were harvested
by centrifugation in 750ml polypropylene bottles (maximum volume
o
500ml) at 6000g for 30 min at 4 C in an MSE Mistral 6L centrifuge.
Each pellet was resuspended in about 50ml ice-cold sterile
50mM-Tris/HCl, pH 7.5 and the centrifugation repeated.
Supernatants were decanted and the bacterial pellets were stored at 
o
-20 C until required.
2.6.5 Preparation of crude extracts
2.6.5.1 Bacterial crude extracts
Pelleted cells were thawed and resuspended in an appropriate 
volume of chilled 50mM-Tris/HCl, pH 7.5 containing 0.4mM-DTT and 
1.2mM-PMSF. Cells were broken by three passages through a 
pre-chilled French pressure cell at 98 MPa (14,300 psi) (internal
pressure). The homogenate was then digested with 0.5mg DNasel at
o o
4 C for 1 h and centrifuged at 100,000g for 2 h at 4 C in
Beckman L5-65 ultracentrifuge. The supernatant was kept on ice and 
used for enzyme inhibition assay (section 2.13), immunoprecipitation 
assay with protein A (section 2.15) and preparation of purified 
enzyme (section 2,10).
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2.6.5.2 Fractionation of plant crude extracts
Seeds of pea (P^ _ sativum) were germinated and grown as 
described by Mousdale _et a_l_. (1987). Shoot tissue was taken from 
9 to 12-day old plants. 250g of fresh shoot tissue was homogenized 
in 500ml of chilled 50mM-Tris/HCl, pH 7.5, containing 0.4mM-DTT, 
ImM-EDTA, ImM-Benzamidine.HCl and ImM-PMSF. The chilled brei was 
filtered through muslin and centrifuged at 80,000g for 1 h. The 
supernatant was decanted, brought to 35% saturation with solid
(NH^J^SO^ and centrifuged at 12,000g for 20 min at 4°C.
The supernatant was again decanted, (NH ) SO added to 55%
4 2 4
saturation and the precipitated protein collected by centrifugation.
The precipitate was dissolved in a small amount of chilled
20mM-tris/HCl, pH 7.5, containing 0.4mM-DTT, ImM-Benzamidine.HCl and
o
ImM-PMSF and dialysed overnight at 4 C against 2 1 of this 
buffer. The extract was used for enzyme inhibition assay (section 
2.13) and immunoprecipitation assay with protein A (section 2.15).
2.7 Enzyme assay
Enzymes were generally assayed spectrophotometrically in
plastic 1 cm light-path cuvettes in a Ultrospec spectrophotometer at 
o
25 C. The reaction components, were added to the cuvettes and 
preincubated to the correct temperature by standing in a temperature 
controlled cuvette holder. The components of the reaction mixture 
were mixed and the reaction initiated by the addition of enzyme and 
further mixing. The rate of change in absorbance was measured over 
a period of 5 min during which time the assay was linear. One unit 
of enzyme activity is defined as the amount of enzyme required to 
catalyse the conversion of ljimole of substrate to product per min 
under the condition of the assay.
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2.7.1 DHQ synthase (El)
DHQ synthase activity was measured by coupling the release 
of dehydroquinate using dehydroquinase (E2) and shikimate 
dehydrogenase (E3) to dehydroshikimate then shikimate with oxidation 
of NADPH as shown in diagram below.
E2
DAHP — ►-dehydroquinate-----
This method was modified from Coggins et al. (1987b). The final
assay contained : 0.1 M-glycine/KOH (pH 8.4), 0.2mM-CoCl^,
+
0.2mM-NADPH, 0.4mM-DAHP, 50juM-NAD , 0.4 units/ml E. coli 
dehydroquinase and 0.4 units/ml E. coli shikimate dehydrogenase.
The oxidation of NADPH was monitored at 340nm and converted to
enzyme unit using the molar extinction coefficient of NADPH
r  3 - i  -l
(£,340 = 6.18 x 10 M cm ).
2.7.2 Dehydroquinase (E2)
Dehydroquinase activity was measured by coupling the release
of dehydroshikimate with NADPH using shikimate dehydrogenase to 
+
produce NADP and was modified from Coggins et a l . (1987b). The 
assay contained 0.1 M-dehydroquinate, 50mM-potassium phosphate 
buffer, pH 7.0, 0.2mM-NADPH and 0.4 units/ml E. coli shikimate 
dehydrogenase. The oxidation of NADPH was monitored at 340nm and 
converted to enzyme units as under 2.7.1.
2.7.3 Shikimate dehydrogenase (E3)
Shikimate dehydrogenase activity was measured in the reverse
+
direction by monitoring the reduction of NADP at 340nm (Coggins 
e_t a^., 1987b). The assay mixture contained lOOmM-sodium carbonate
E3
•dehydroshikimate —— ►shikimate
' +
NADPH NADP
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+
buffer, pH 10.6, 4mM-shikimic acid and 2mM-NADP . Shikimate 
dehydrogenase can also be assayed in the forward direction using the 
following assay mixture: 0.15 mM-dehydroshikimate, 0.17mM-NADPH and
lOOmM-pdtassium phosphate buffer, pH 7.0 and monitoring loss of 
absorption at 340nm. Enzyme units were calculated using the molar 
extinction coefficient of NADPH as above (section 2.7.1).
2.7.4 Shikimate kinase (E4)
Shikimate kinase was assayed spectrophotometrically at 340nm 
by monitoring the disappearance of NADH (Coggins et a l ., 1987b).
This was achieved by coupling the release of ADP produced by the 
reaction to the pyruvate kinase and lactate dehydrogenase reactions 
as shown in diagram below.
shikimate ■►shikimate PO
ADP + phosphoenolpyruvateATP
pyruvate kinase
lactate dehydrogenase
lactatepyruvate
NADNADH
The final assay contained 50mM-triethanolamine.HCl/KOH pH 7.0, 
50mM-KCl, 2.5mM-MgCl^, 0.ImM-NADH, ImM-phosphoenolpyruvate 
(neutralised with KOH), 2.5mM-ATP (neutralised with KOH), 
ImM-shikimic acid (neutralised with KOH) and pyruvate kinase 
(3 units/ml)/lactate dehydrogenase (2.5units/ml). The oxidation of
NADH was converted to enzyme units using the molar extinction
rT 3 - 1 - 1
coefficient of NADH ( C.340 = 6.22 x 10 M cm )•
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2.7.5 EPSP synthase (E5)
EPSP synthase was also assayed in the reverse direction by 
coupling the release of phosphoenolpyruvate from the reactions to 
the pyruvate kinase and lactate dehydrogenase reactions as shown in 
diagram below (Coggins et al., 1987b).
Oxidation of NADH was monitored at 340nm. The assay contained 
(final concentrations) 0.05mM-EPSP, 2.5mM-ADP, O.lmM-NADH,
of pyruvate kinase and 2.5 units/ml of lactate dehydrogenase.
Enzyme units were calculated using the molar extinction coefficient 
of NADH as in section 2.7.4.
,2.7.6 Quinate dehydrogenase
Quinate dehydrogenase was assayed by the method of 
Tresguerres et a l . (1970a) and van Kleef & Duine (1988) using DCPIP 
as an electron acceptor. The reaction mixture contained (final 
concentrations) lOOmM-potassium phosphate buffer pH 6.0, 
lOmM-quinate (neutralised with KOH) and 0.4mM-DCPIP. The decrease
Pi Phosphoenolpyruvate
ADP
Pyruvate kinase
ATP
lactate dehydrogenase
pyruvate
NAD+NADH
2.5mM-MgCl^, lOOmM-potassium phosphate buffer, pH 7.0, 3 units/ml
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of absorbance at 60Qnm was measured and converted to enzyme units
using molar-extinction coefficient of DCPIP (£,600 = 22.0 x
3 - 1 - 1  
10 M cm ).
2.8 Polyacrylamide gel electrophoresis (PAGE)
2.8.1 SDS PAGE (discontinuous system)
SDS PAGE was performed by the method of Laemmli (1970) in a 
slab gel apparatus built in the Department of Biochemistry, 
University of Glasgow.
2.8.1.1 Stock solutions
Solution A (separating gel buffer): 36.6g Tris and 0.23ml
TEMED. The pH was adjusted to 8.8 with concentrated HC1 and the
volume made to 100ml with distilled water. The solution was stored
at room temperature.
Solution B (electrophoresis buffer): 6g Tris; 28.8g
glycine and 10ml 20% (w/v) SDS were made to 2 litres with distilled
water and stored at room temperature.
Solution C: 28g acrylamide and 0.735g N,N'-methylene
bisacrylamide were made to 100ml with distilled water. This 
solution was stored at room temperature and used within one month.
Solution D (stacking gel buffer): 1.16g Tris; 4ml 20%
(w/v) SDS and 0.25ml TEMED. The pH was adjusted to 6.8 with 
concentrated HC1 and the volume made to 100ml with distilled 
water. The solution was stored at room temperature.
Solution E: 20% (w/v) SDS. The solution was stored at
o
37 C to prevent the SDS coming out of solution.
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2.8.1.2 Gel plates
Glass plates (9.5cm x 20.0cm x 10.0cm) were washed in Decon 
75 to ensure they were free of silicon grease, then rinsed with 
distilled water. The plates were assembled using 1.5mm teflon 
spacers and silicon grease and placed into the custom-built casting 
box suitable for making up to 4 gels at a time.
2.8.1.3 Preparation of gels
1) Separating gel
Gels were prepared from the volumes (mis) of stock solutions 
shown on Table 2.2. Solution A, C and H^O were mixed and 
degassed; SDS and ammonium persulphate were added and the gel was 
poured into the casting box. The layer of propan-2-ol was 
carefully placed on the top of the gel and the gel allowed to 
polymerise for 30 min. • The layer of propan-2-ol was then washed 
off with distilled water and the top of the gels blotted dry with 
filter paper immediately before addition of stacking gel.
2) Stacking gel
The stacking gel was prepared as shown in Table 2.2 using
solutions C, D and After mixing the solution was degassed
before addition of ammonium persulphate. This mixture was then
poured on the top of the separating gel. The gel was allowed to
polymerise around a well-forming teflon template for 30-60 min.
After polymerisation the gels were wrapped in absorbent paper
moistened in electrophoresis buffer and clingfilm then stored at 
o
4 C. Gels were used within one week of preparation.
2.8.1.4 Sample preparation and electrophoresis conditions 
Protein solutions were mixed with sample buffer (1.5g SDS,
8g sucrose and 100^g pyronin Y in 10ml of 0.5M-Tris/HCl, pH 8.8) in 
the following way; 160pl sample, lOOpl 0.2M-DTT and 40ul sample
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Table 2.2 Ratio of polyacrylamide gel preparation (mis)
Stock solutions Separating gel Stacking gel
8% 10% 12.5% 16.5% 5.6%
____________________________________  (w/v)________________ ___________
solution A 25 25 25 25 -
solution C 57.2 71.5 89.3 118 17.5
solution D - - - - 10.0
20% SDS* 1 1 1 1 -
h 2° 114.3 100 82.2 53.5 55
solid ammonium 
persulphate (mg)
150 150 150 150 150
* For native gels omit the 20% SDS and add H 2O
-3
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buffer. The sample was then denatured by boiling for 2 min before 
application to the gel. The amounts of loading are defined in the 
legend in particular figures. Electrophoresis was carried out in 
solution B at 90 mA per slab gel. While the electrophoresis was 
taking place, the gel was cooled continuously by circulating water 
from an ice/water mixture through a chamber which was built into the 
electrophoresis apparatus. The electrophoresis was stopped when 
the dye (pyronin Y) had almost reached the bottom of the gel. The 
gel was then stained (section 2.9.1) or immunoblotted (section 
2.17.1).
2.8.2 Non-denaturing PAGE
This was carried out in 10% (w/v) polyacrylamide gel by the 
method of Davis (1964) as modified by Hayes & Wellner (1969).
2.8.2.1 Stock solutions
Solution A (separating gel buffer): 36.6g Tris and 0.23ml
TEMED, the pH was adjusted to 8.8 with concentrated HC1 and the 
volume was made to 100ml-with distilled water.
Solution B (electrophoresis buffer): 6g Tris and 28.8g
glycine were made to 2 1 with distilled water and stored at room 
temperature. Before use 0.01% (v/v) 2-mercaptoethanol was added.
Solution C: 28g acrylamide and 0.735g N,N'-methylene
bisacrylamide were made to 100ml with distilled water.
Solution D (stacking gel buffer): 1.16g Tris and 0.25ml
TEMED, the pH was adjusted to 6.8 with concentrated HC1 and the 
volume was made to 100 ml with distilled water.
2.8.2.2 Gel plates
These were prepared as described in Section 2.8.1.2.
- 4 6 -
2.8.2.3 Preparation of gels
Gels were prepared as described in Section 2.8.1.3 except 
that SDS was omitted £rom all solutions.
2.8.2.4 Sample preparation and electrophoresis condition
Protein solutions were mixed with 5p.l tracking dye [0.02%
(w/v) Bromophenol blue in 50% (v/v) glycerol] and layered into each
o
well. The gel was pre-electrophoresed for 1 h at 20mA at 4 C in
solution B before application of the protein solution.
o
Electrophoresis was then run at 20mA, 4 C until the tracking dye 
approached the bottom of the gel. The gel was then activity 
stained (section 2.9.2) or immunoblotted (section 2.17.2).
2.9 Staining
2.9.1 Protein staining
2.9.1.1 Coomassie Blue staining
Routinely, gels were stained with 0.1% (w/v) Coomassie
Brilliant Blue G250 in methanol/acetic acid/H O (50:10:40 by
2
o
volume) for 1 h at 60 C. Gels were destained overnight at room 
temperature in methanol/acetic acid/H^O (10:10:80 by volume).
2.9.1.2 Silver staining
This was a sensitive method, based on that described by Wray
et al. (1981). Before staining gels were soaked overnight in 50%
(v/v) methanol. Staining solution was prepared by adding silver
nitrate solution (0.8g AgNO^ in 4ml distilled water) dropwise with
vigorous stirring to an alkaline ammonia solution [1.4ml of
14.8M-NH OH added to 21ml 0.36% (w/v) NaOH]. Distilled water was 
4
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added to give 100ml. The gel was gently agitated in this staining 
solution for 15 min and then rinsed with many changes of distilled 
water for 1 h. The stain was developed by immersing the gel in a 
solution containing 2.5ml 1% (w/v) citric acid and 0.25ml 38% (v/v) 
formaldehyde in 500ml distilled water. Staining was stopped when 
the protein bands appeared by washing the gel immediately in 
distilled water.
2.9.2 Activity staining
Enzyme activity of shikimate dehydrogenase was detected
after non denaturing gel electrophoresis by the method of Lumsden &
o
Coggins (1977). Gels were soaked at 4 C in 4 changes of 0.25 
M-Tris/HCl, pH 9.0 for 30 min to remove 2-mercaptoethanol. The
gels were then transferred to the staining solution containing
+
0.25 M-Tris/HCl, pH 9.0, 0.5mM-NADP , 0.5mM-shikimic acid,
nitroblue tetrazolium (0.'5mg/ml) and phenazine methosulphate
o
(5^ig/ml). This was kept in the dark at 23 C with gentle shaking 
until shikimate dehydrogenase was indicated by a purple precipitate 
of formazan.
2.10 Enzyme preparations
These enzymes were prepared for raising antibodies against 
native configuration of the enzymes.
2.10.1 Purification of arom complex from N. crassa
The N. crassa arom complex was purified to homogeneity as 
described by Coggins et al. (1987b). The progress of the 
purification was followed by monitoring the E2 activity of arom 
complex. The results of the purification are shown in Table 2.3.
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2.10.2 Purification of E3 from E. coli AB2834/pIA321 (E3 
overproducing strain)
E3 from E. coli was purified to homogeneity as described by 
Chaudhuri et al. (1987). The purification steps and results of the 
purification are shown in Table 2.4.
Other purified enzymes used (e.g. El, E2, E4 and E5, from 
E. coli overproducing strains) were gifts from Mr. J.J. Greene, 
Department of Biochemistry, University of Glasgow.
2.11 Enzyme denaturation
To increase the number of epitopes available as antigens the 
five purified proteins (El to E5) from the E. coli shikimate pathway 
were denatured by reduction and carboxymethylation. The
carboxymethylated proteins were used as antigens.
2.11.1 Dialysis
Before denaturation approximately lmg/ml of each of the
purified proteins used were exhaustively dialysed against 0.5% (w/v)
o
ammonium bicarbonate, with 6 changes each of 2.5 1 for 24 h at 4 C 
then lyophilised to dryness.
2.11.2 Reduction and carboxymethylation 
Carboxymethylation of cysteine residue was carried out as
described by Lumsden & Coggins (1978). Lyophilised samples were
resuspended in 2ml 0.1 M-Tris/HCl, pH 8.2 containing 8M urea and
2mM-DTT and incubated in the dark for 1 h at room temperature under
an atmosphere of . Iodoacetate was then added to the solution
to give a final concentration of 15mM, and the solution incubated
for a further 1 h in the dark under N . The reaction was
2
terminated by addition of excess DTT (30mM, final concentration).
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The carboxymethylated (alkylated) proteins were dialysed against
0.5% (w/v) ammonium bicarbonate with 4 changes each of 2.5 1 for 
o
24 h at 4 C. The samples were then lyophilised to dryness.
2.11.3 Analysis of amino acid composition
The amino acid compositions of the native proteins and 
carboxymethylated proteins were determined after acid hydrolysis 
using an LKB 4400 amino acid analyser operated by Mr. J. Jardine, 
Department of Biochemistry, University of Glasgow. It was found 
that all cysteines present in the original proteins had been changed 
into carboxymethylcysteine (results not shown).
2.11.4 Comparison by SDS PAGE
The carboxymethylated and non-carboxymethylated proteins 
were compared by SDS PAGE (section 2.8.1). It was found that all 
of the carboxymethylated proteins moved more slowly than the 
corresponding non-carboxymethylated proteins (Bretscher, 1962) with 
the exception of E2 (Fig. 2.1). Although, it had been reported 
that E2 contains cysteine- (Duncan-et al.', 1986) it is now known that 
this enzyme contains no cysteine residues (E. Borthwick, L.D. Graham 
& J.R. Coggins, unpublished results) and consequently could not be 
carboxymethylated by this procedure.
2.12 Preparation of antisera
Antibodies were raised in the Department of Biochemistry, 
University of Glasgow against many of the enzymes of the aromatic 
amino acid biosynthetic pathway. Both native and denatured 
proteins (see section 2.10 and 2.11) were used as antigens to ensure 
that antibodies could be produced against as many epitopes as 
possible. All antisera were raised in New Zealand white rabbits of
Figure 2.1 Sepa ra t io n  of n on - ca r bo x y m e t h y l a t e d  and
carboxymethylated proteins on SDS PAGE
Approximately 3ug of protein was loaded on each track of the 
10% SDS PAGE; after electrophoresis protein bands were located by 
staining with Coomassie Blue (section 2.9.1.1). Tracks 1, 12, M
r
standard proteins (section 2.18.1); tracks 2, 4, 6, 8, 10, 
non-carboxymethylated samples of El, E2, E3, E4 and E5 
respectively; tracks 3, 5, 7, 9, 11, carboxymethylated, denatured 
samples of El, E2, E3, E4 and E5 respectively.
30K -----
1 2  3 4 5 6 7 8 9 10 11 12
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bodyweight about 2.5 Kg at the start of the immunisation 
procedure. All procedures involving animals were carried out by 
Dr. I .D . Hamilton under whose licence the procedures were authorised.
2.12.1 Preparing immunogens
A general procedure was used for preparation of material for 
immunisation and the details of amounts used are given in Table 2.5. 
In general, approximately 0.5mg immunogenic protein was dissolved in 
lml of buffer solution and then emulsified, either by repeatedly 
passing through a fine bore needle or by sonication, with an equal 
volume of Freund's complete adjuvant. The emulsion was injected 
subcutaneously at many sites (0.2ml/site) on the back and sides of 
the rabbit.
After 6 weeks a second (boost) immunisation was given. For 
this approximately 0.25mg protein was emulsified in Freund's 
incomplete adjuvant and injected as before. Animals were first 
bled two weeks after the boost injection.
In some cases rabbits were given more extensive boost 
injection either to produce more antisera or to produce antisera of 
higher potency. In particular anti-shikimate dehydrogenase 
antibody was used extensively for development work and antiserum 
against this protein was raised over a period of 3.25 years and 
required repeated boosting and bleeding of the rabbit. Details of 
the immunisation procedure for this rabbit are given in Figure 3.2.
2.12.2 Preparing antisera
Blood was removed from rabbits at the ear vein. At any one 
time about 25ml of blood was removed for antisera production.
Blood samples were allowed to clot at room temperature, reamed to 
prevent the clot sticking to the side of the container and placed at
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Table 2.5 Immunogens used in this study
This table shows the type and amount of protein injected 
into rabbits for raising antibodies.
Types of 
immunogen
Amount for initial 
immunisation (p.q)
Amount for boost 
immunisation (^g)
El 500 250
E2 500 250
E3* 500 250
E4 500 250
E5 500 250
arom gel preparation 250
denatured-El 400 200
-E2 400 200
-E3 400 200
-E4 400 200
-E5 400 200
*see Figure 3.2
- DO -
o
4 C overnight. The following morning the serum was separated 
from the clot and centrifuged at 15,000g for 10 min to remove
o
residual clotted material. Antisera were then stored at -20 C, 
either as 1ml aliquots or in larger quantities, until required.
Individual preparations of antisera were kept and used 
separately with no two batches being mixed. Consequently some 
antisera may have slightly different properties from others. To 
uniquely identify a particular preparation of antisera it was 
labelled with both the identification marker for the rabbit and the 
number of the antisera preparation. The identification code 159:8 
therefore indicates the 8th batch of antisera prepared from rabbit
159. Where it is relevant the code of the particular preparation
of antisera is given in the figure legend.
2.13. Antibody enzyme inhibition studies
Purified enzymes or enzyme containing extracts (crude
extracts) were diluted in 50mM-Tris/HCl, pH 7.5 to give appropriate 
concentrations and then incubated with an equal volume (usually 
20jal) of an appropriate dilution of antisera (diluted in normal 
rabbit serum) or purified IgG (diluted in 50mM-Tris/HCl, pH 7.5) for 
1 h with gentle rotation on a rotating wheel at room temperature. 
Enzyme samples were also incubated with normal rabbit serum or Tris 
buffer as controls. After the incubation period aliquots (20jil) 
were removed and assayed for enzyme activity.
2.14 Immunoprecipitation assay
The same procedure as in 2.13 was used except that at the 
end of the incubation period the samples were centrifuged for 5 min 
in an Eppendorf 3200 centrifuge (12,000g). Then aliquots (20jul) 
were removed from the supernatant and assayed for enzyme activity.
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2.15 Immunoprecipitation studies with S. aureus protein A
2.15.1 Preparation of concentrated protein A
lml of a crude aureus cell suspension containing protein
A (10% w/v) was centrifuged for 2.5 min in an Eppendorf 3200
centrifuge and the pellet washed twice with 50mM-Tris/HCl, pK 7.5
then resuspended in 50mM-Tris/HCl, pH 7.5 containing 50% (v/v)
glycerol to a final volume of 200^il. The concentrated protein A
o
S. aureus preparation was stored at -20 C until required.
2.15.2 Immunoprecipitation assay with protein A
Appropriate dilutions (20^1) of antisera (in normal rabbit 
serum) or purified IgG (in 50mM-Tris/HCl, pH 7.5) were incubated 
with an equal volume of appropriate concentration (diluted in 
50mM-Tris/HCl, pH 7.5) of purified enzymes or enzyme containing 
extracts for 15 min at room temperature with gentle rotation on a 
rotating wheel. Concentrated protein A (20^1) was added and the 
samples were further incubated for 1 h with gentle rotation at room 
temperature. Enzyme samples were also incubated with normal rabbit 
serum or with 50mM-Tris/HCl, pH 7.5 containing protein A, as 
described above, for use as controls. Protein A-immunocomplexes 
were sedimented by centrifugation for 5 min in an Eppendorf 3200 
centrifuge. Then aliquots (30^1) from the supernatants were 
removed and assayed for enzyme activity.
2.16 Enzyme-linked immunosorbent assay (ELISA)
2.16.1 Stock solutions
Coating buffer : 50mM-sodium carbonate buffer, pH 9.6.
Washing solution : 9g NaCl supplemented with 0.5ml Tween 20 
per litre.
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Incubation buffer : 3.5g NaCl; 1.28g Na2HPC>4 ; 0.156g
NaH^PO^. 2H^O; 22.5^1 Tween 20 per litre.
Substrate solution : O.lmg/ml o-phenylene diamine.diHCl with
0.03% (v/v) h2°2 ‘-^rate-phosphate buffer (25mM-citrie acid
in 50mM-Na HPO , pH 5.0). The substrate was prepared 
2 4
o
immediately before use from reagents preincubated at 23 C.
Stopping solution : 6N-H SO .
2 4
2.16.2 ELISA procedure
ELISA was performed in 96-well microtitre plates (Dynatech
MicroELISA Systems). The plates were washed with distilled water,
o
then incubated overnight at 4 C with lOOng antigen/well in 50^il of
coating buffer to coat the bottom surface of the well. Plates were
rinsed 5 times with washing solution which, because it contains
Tween 20 will also block the plate surface and so prevent further
adsorption of proteins onto the plate. lOO^il of a serial dilution
of antiserum or of purified IgG in the incubation buffer was added
to each well and the plates incubated at room temperature for 1 h.
Samples of normal rabbit' Serum and- 50mM-Tris/HCl, pH 7.5 buffer were
also diluted with incubation buffer and included as controls on each
plate. After incubation plates were washed 5 times with washing
solution and lOOpl of peroxidase-conjugated antibody (HRP donkey
anti-rabbit IgG) (1:1,000 dilution of conjugated antibody in
incubation buffer) was added to each well. Plates were again
incubated at room temperature for 1 h and subsequently washed 5
times with washing solution. 100^1 of substrate solution was added
o
to each well and the plates were incubated for 30 min at 23 C.
The reaction was terminated by addition of 50^1 stopping solution to
each well and the colour measured at 492nm in a Titretek Multiskan 
Spectrophotometer.
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2.17 Immunoblotting method
This method is based on that described by Towbin et al.
(1979) as modified by Batteiger et al. (1982). This modified 
technique has been used by Nimmo et al. (1986).
2.17.1 Immunoblot from SDS PAGE
2.17.1.1 Stock solutions
Transfer (blotting) buffer : 0.19 M-glycine; 0.025 M-Tris; 
0.02% (w/v) SDS and 20% (v/v) methanol.
Blocking buffer : 0.02 M-Tris/HClf pH 7.2; 0.15 M-NaCl and
0.5% (v/v) Tween 20.
Washing buffer : 0.02 M-Tris/HCl, pH 7.2 and 0.15 M-NaCl. 
Development solution : 30mg HRP colour development reagent
(containing chloronaphthol) in 10ml methanol was mixed with 50ml
lOmM-Tris/HCl, pH 7.4 and. 150^11 4% (v/v) H 2°2 before
use.
2.17.1.2 Immunoblotting conditions
When SDS PAGE was complete, the protein was transferred to
0.45^1 nitrocellulose paper using a Bio-Rad Trans-blot cell. The
transfer was carried out for 4 h in transfer buffer at 360-400mA
(0.70 V, constant voltage) with the temperature maintained constant
by cooling with tap water. After transfer the nitrocellulose paper
o
was placed in blocking buffer for at least 16 h at 4 C. Under
these conditions the unoccupied binding sites were blocked by Tween
20 (Batteiger et al., 1982). Specific antigens were detected on
the membranes by incubating the nitrocellulose paper in blocking
buffer containing 5% (v/v) normal donkey serum and 0.5% (v/v)
o
specific antisera or purified IgG at 23 C for 90 min with gentle
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agitation on an orbital shaker. The paper was washed four times in
blocking buffer to remove unbound antibodies and once in washing
buffer to reduce the Tween 20 concentration. The paper was then
incubated in washing buffer containing 5% normal donkey serum and
o
0.1% HRP donkey anti-rabbit IgG at 23 C for 90 min with gentle 
agitation. After being washed a further five times in washing
buffer, the blot was developed in freshly prepared development 
o
solution at 23 C for 5 min. The developed blot was then washed 
thoroughly in distilled water and dried at room temperature between 
sheets of filter paper.
2.17.2 Immunoblot from non-denaturing PAGE
2.17.2.1 Stock solutions
Stock solutions are the same as 2.17.1.1 except transfer 
buffer contained neither SDS nor methanol.
2.17.2.2 Immunoblotting conditions
o
Every step was carried out at 4 C but was otherwise the
o
same as 2.17.1.2. The development step was performed at 23 C as 
in 2.17.1.2.
2.18 Molecular weight determinations
M estimations were performed either by SDS PAGE or gel 
r
filtration chromatography. Standard curves were obtained from
proteins of known M .
r
2.18.1 Subunit molecular weight determination
The subunit M 's of the purified proteins were estimated 
r
using SDS PAGE followed by Coomassie Blue or silver staining of the 
gels. The electrophoretic mobilities of the proteins were obtained
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from the distance that each protein migrated through the separating 
gel. The following standard proteins (from Sigma) were used for 
calibration:
Protein Subunit M
r
Phosphorylase b 94,000
Bovine serum albumin 67,000
Ovalbumin 45,000
Carbonic anhydrase 30,000
Soybean trypsin inhibitor 20,100
OC-lactalbumin 14,400
2.18.2 Native molecular weight determination
The native values of purified enzymes were estimated by 
gel permeation chromatography at room temperature on a Superose 12 
column in a Pharmacia f.p.l.c. apparatus. The column was eluted 
with 50mM-Tris/HCl, pH 7.5 containing 0.4mM-DTT (flow rate
0.5ml/min, fraction size 0.5ml). The eluate was monitored at 
280nm. The column was calibrated with the following proteins from 
the shikimate pathway of E. coli whose molecular weights are known.
Protein Native M
r
dehydroquinate synthase 39,000
dehydroquinase 52,000
shikimate dehydrogenase 30,000
shikimate kinase 20,000
EPSP synthase 47,000
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3. Cross reaction within five central enzymes of shikimate   A---------
pathway
3.1 Introduction to immunology
3.1.1 Antigens and immunogens
The traditional meaning of antigen is any molecule which 
evokes a specific immune response but is also.used more broadly to 
denote mixtures of molecules, whole microorganisms or cells used as 
an immunizing entity or as a complex target for antibody binding in 
immunoassays; thus red cells may be described as an immunizing 
antigen or as the antigen in agglutination tests. To. distinguish 
between molecules that evoke antibody production and those that are 
the targets for antibody binding, it is the modern convention to use 
the term immunogen for the former and antigen for the latter , 
(Walter, 1986; Catty, 1988). Natural immunogens are usually 
macromolecules, with a molecular weight greater than 1,000 and 
normally above 5,000. Smaller structures are usually less 
immunogenic but it is possible to increase their immunogenicity if 
they are covalently coupled to larger carrier molecules where they 
act as haptens on constructed immunogens (Catty, 1988). Often, 
bovine serum albumin or keyhole limpet haemocyanin are used as 
carriers (Scheidtmann, 1989). Such, coupling also decreases the 
rate of degradation of haptens in the.animal (Scheidtmann, 1989).
3.1.2 .Antigen(ic) determinants; epitopes
These are structurally-defined sites of three-dimensional 
composition in both immunogens and antigens. Each determinant has 
a size corresponding to 4-6 amino acid or sugar residues, but the 
combination of shapes and charge distributions that can. be offered
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by determinants is nevertheless very large. It is common to divide 
determinants into two major categories (Benjamin et_ a_l., 1984; 
Berzofsky, 1985; van Regenmortel, 1987):
1. Segmental (continuous or sequential or linear) epitopes
recognise the structural features that reside in a single 
short segment of the polypeptide chain.
2. Assembled topographic (conformational) epitopes recognise
the amino acid residues that may be quite distant within the 
amino acid sequence but are brought into proximity during 
folding of the protein.
It is apparent that recognition by antibodies directed against, 
assembled topographic epitopes would depend greatly on the 
preservation of requisite secondary and/or tertiary structural 
features with denatured proteins showing greatly decreased or 
totally abolished antigenicity, while epitopes of the segmental type 
should be reactive, if accessible, in both native and denatured 
forms of the enzyme. Considering that the adjuvants commonly used 
as vehicles for injection of immunogen would hardly be selected as 
the solvents of choice for maintaining native protein structure, and 
considering all the trauma that must assault a protein's structure 
as it proceeds from being injected to actually evoking an immune 
response, so immunisation with native protein can give rise to 
antibodies specific for the denatured form. It also follows that 
reactivity with antibodies directed against epitopes of the 
assembled topographic type might be influenced by perturbation of 
the tertiary structure, such as conformational changes induced by 
ligand binding, whereas this seems less likely with segmental 
epitopes (Wilson, 1987).
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3.1.3 Antibody combining sites: paratopes (antigen binding sites) 
These are the sites on antibody molecules which have
stereochemical specific binding activity for complementary antigen
determinants. They are constructed.from the folding of variable
domains of light and heavy chains of antibody molecules to form
three-dimensional binding spaces with an internal surface shape and
charge distribution complementary to these features of antigen
determinants. It is estimated that the diversity-generating
6 7
potential of the immune system offers in the range 10 -10 
different specificities to the antibody response (Catty, 1988).
Most antibodies possess more than one functional binding 
site. For example, IgG molecules have two combining sites that can 
'bridge' two determinants either within an antigen molecule or 
between two antigen molecules (Catty, 1988; Steward, 1984)
(Fig. 3.1A). As a result, when interacting with a macromolecular 
antigen with more than one' epitope, large complexes can form between 
antibody and antigen molecules.
3.1.4 Antibody specificity: cross reactivity 
Antibody-antigen interactions can show a high degree of
specificity. This means that the antigen combining sites of 
antibodies directed towards determinants on one particular antigen 
are not complementary to determinants on a second antigen. The 
specificity of an antiserum, by contrast, reflects the many • 
specificities of the constituent antibodies . An antiserum may 
bind exclusively to one antigen if the range of its constituent 
antibody specificities extends to determinants exclusive to that 
antigen. Commonly, however, some antigen determinants are shared 
between molecules, especially if these are similar molecules of 
related species. In this case some antibodies induced in response
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Figure 3.1 A Diagrammatic representation of antibody combining site
(a) binding of single antibody to two determinants on a 
single antigen; (b) binding of antibody to two antigens (adapted 
from Steward, 1984).
(a)
Epitope FabFab
Antigen
/ / / / /
(b)
Fab
Antigen Antigen
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to one antigen may bind to another antigen and are then said to be 
cross-reacting and the containing antiserum is said to lack 
specificity or be cross-reactive. Cross-reactive antisera are 
shown in Figure 3.IB. Each antibody molecule within the antiserum 
to antigen A reacts with a different part of the same antigenic 
determinants (e.g. determinant X, Y and Z), and the combined 
reactivity of all the antibody molecules in the serum gives the 
antiserum its specificity (Fig. 3.1Ba). However, when some of the 
determinants on antigen A are shared by a second antigen B (e.g. 
determinant Y) (Fig. 3.1Bb) then a proportion of the antibody 
molecules directed to antigen A will also react with antigen B. 
Furthermore if the antiserum to A also, weakly recognises another 
determinant on B (e.g. X') then this will also contribute to this 
cross-reactivity of antiserum to X'. Obviously, if no antigenic 
determinants are shared between antigen A and antigen C, there will 
be no reaction of anti-A with antigen C (Fig. 3.1Bc).(Steward,
1984; Catty, 1988).
3.1.5 Antibody affinity'and avidity
The ability of antibodies to precipitate antigens from 
solution involves the formation of a lattice of cross-linked 
antibody-antigen complex which is sufficiently large to be easily 
sedimented from the solution by centrifugation. An 
immunoprecipitate will however not always be formed when antibody 
encounters antigen. The concentration of both antibody and antigen 
are very important and immunoprecipitation will only occur within a 
limited range close to the equivalence point (Johnstone & Thorpe, 
1987). Outside of this range conditions of either antibody or 
antigen excess exist and only small (soluble) complexes of 
antibody-antigen are formed. The affinity of antibody for antigen
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Figure 3.1 B The principle of antibody specificity and cross 
reactivity
(a) antiserum to antigen A (anti - X Y Z) reacts 
specifically with antigen A; (b) anti-A cross reacts with antigen B 
through recognizing determinant Y and partial recognition of X';
(c) anti-A shows no reaction with antigen C which has no shared 
determinants (from Steward, 1984).
Anti-A antiserum
Anti-ZAnti-YAnti-X
Antigen A
(a) Specific reaction
Antigen B Determinant Y shared
(b) Cross-reaction
Antigen C No shared determinant
(c) No reaction
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is important in immunoprecipitation; usually only high affinity 
antibodies give good precipitation. Affinity relates to the
exactitude of stereochemical fit of an antibody combining site to 
its complementary antigen determinant. Affinity is defined as the 
equilibrium constant when a monovalent antibody reacts with a 
monovalent antigenic determinant. In this case, where we use 
antisera of multiple specificity, to many determinants on a 
multivalent antigen, affinity cannot be assessed. Avidity can be 
considered and is defined as a combination of the individual, 
affinities of each antibody combining site (antigenic determinant 
interaction). The terms affinity and avidity are sometimes 
replaced by 'intrinsic affinity' and 'functional affinity' 
respectively (Cattyf 1988? Johnstone & Thorpe, 1987).
3.1.6 Properties of polyclonal antisera and monoclonal antibodies 
and their use in assessing homology between proteins
3.1.6.1 Polyclonal antisera
A polyclonal antiserum is the conventional serum product of 
an immunized animal, usually a rabbit, sheep or goat (Johnstone & 
Thorpe, 1987? Catty, 1988). It contains many different antibody 
specificities to the various epitopes of the structurally complex 
immunogen. The major advantage of polyclonal antisera lies in 
their capacity to form large insoluble immune complexes with 
antigen. It does so because the antiserum is the product of many 
clones of cells responding to the numerous antigenic sites present 
on the protein surface. Hence, the resulting polyclonal antibodies 
are extremely heterogeneous in their specificities, titre and 
affinity, and represent a collection of antibody molecules capable 
of simultaneously interacting with several different epitopes on the
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proteins. Consequently extensive cross reaction may occur amongst 
antibodies and proteins which have similar determinants (Campbell, 
1984; van Regenmortel, 1987). For all their value, animal 
antisera have certain limitations for exploitation in immunoassays, 
the main one being their heterogeneity in specificity, even when 
reacting to small antigens and their variability between animals and 
batches. In one antiserum there may be antibodies to many discrete 
antigens (multispecific or polyspecific), to a few antigens 
(oligospecific) or to a single antigen (unispecific), but even in 
the latter case the reagent is not homogeneous as single immunogens 
are still multi-determinant structures which stimulate a polyclonal, 
multi-determinant-specific response (Catty, 1988). In addition, 
the response to individual epitopes may be clonally diverse and 
antibodies of different affinity may compete for the same epitope. 
The significance of such heterogenicities within and between 
polyclonal antisera in practice means that each product is unique in 
specific antibody composition, in optimal binding conditions and in 
performance and requires to be separately assessed for its 
suitability in any particular immunoassay. Without affinity 
purification specific antibodies in antisera, or in the 
immunoglobulin fraction, are represented by, at most, 20-30% of.the 
immunoglobulin in most cases. This reduces their efficiency in 
some procedures and may lead to high background readings in others.
Because of their polyclonal, multispecific nature, 
conventional antisera cannot be prepared easily or routinely to the 
degree of specificity needed to determine the structure and 
antigenic differences between molecules at the individual epitope 
level (Catty, 1988? Wilson, 1987). Nevertheless, polyclonal 
antise'ra are still useful for assessing the extent to which proteins 
possess common features because firstly they are easy to produce and
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secondly because the broad range of determinants they can recognise 
ensures that any common features, whose actual structure is unknown, 
can be identified. Polyclonal antisera can be used to probe for 
common sequences in the primary structure before further analysis by 
protein or gene sequencing (Benyamin et al., 1986), for locating 
functional domains or detecting conformational changes in protein 
structures (Hue et al., 1989), to detect structurally similar 
regions in isoenzymes (Schwartz et al., 1980? Hirabayashi et al., 
1987), for immunological quantification or purification of protein 
and peptide mapping (Sibbald & White, 1987).
The ability of antisera to detect cross reactivity 
immunologically is related to the degree of amino acid sequence 
similarity with cross reactivity between proteins only being 
observed if the level of sequence homology is above 60% of the 
primary sequence (Prager & Wilson, 1971a,b? S ohwar-z- et-a-1-.,
-19-8-9-). The cross reactivity will be influenced by the 
immunogenicity of the common epitopes and so epitopes which contain 
amino acids or structures which are highly immunogenic will promote 
detection of cross reaction. In.this regard the amino acids 
histidine, lysine, alanine, leucine,, aspartate and arginine, which 
are found most often in epitopes (Scheidtmann, 1989) will be 
important.
Disruption of the structure of a protein can be useful 
because it exposes new epitopes on the surface of the protein and so 
alters the range of features which are immunogenic. Denaturation 
by reduction and carboxymethylation has been shown in some cases, to 
generate an immunogen which produces an antisera which will 
recognise common features in proteins which cannot be detected if 
the native proteins are used as immunogens (Arnon & Maron, 1971? 
Arnheim et al., 1971? Zakiri et al., 1978? Pekkala-Flagan &
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Ruoslahti, 1982). In contrast to native proteins, a sequence 
homology of only 40% is required for cross reaction to be detected 
in these proteins (Arnon & Maron, 1971; Arnheim et al., 1971; 
Pekkala-Flagan & Ruos lahti, 1982). Denaturation by detergents, 
such as SDS, results in the production of an immunogen quite 
different from the native protein in the sense that antisera raised 
against the SDS treated protein will not recognise the native 
protein despite a 100% sequence homology (Schwartz, 1980). Whether 
this is due to SDS covering or partially covering all native 
antigenic sites is not clear. Similar results have been obtained 
when antisera were raised against peptides corresponding to portions 
of the primary sequence of the protein. In this case antisera 
against peptides did not recognise any features of the native 
protein but could bind to the protein after denaturation by 
reduction and carboxymethylation (Walter, 1986).
Hence antibodies have been used to look for common features 
in protein but their usefulness is influenced by the degree of 
sequence homology between the proteins, by the nature of the 
antigenic sites on the proteins and by the way the proteins are 
treated before use as an immunogen.
3.1.6.2 Monoclonal antibodies
Monoclonal antibodies have been made by immunising an animal 
with the protein, and subsequently, lymphocytes are prepared from 
the spleen or lymph nodes (Catty, 1988; Wilson, 1987). These 
cells possess the capacity for producing antibodies but are not 
capable of being propagated in culture. However, if these cells 
are fused with a suitable myeloma cell line, the resulting 
'hybridoma' possesses two highly desirable properties: they are
capable of producing antibodies, a capability inherited from their 
lymphocyte precursor, and they can be propagated indefinitely in 
culture, a characteristic conferred by the myeloma (Wilson, 1987).
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The secreted antibody is homogeneous in specificity,, affinity and 
isotype and each monoclonal product is specific to a single antigen 
determinant of the immunogen (monospecific) (Catty, 1988). The 
major disadvantage of monoclonal antibodies is that, due to their 
monospecificity, they lack or have only poor antigen precipitation 
properties as single reagents (Campbell, 1984). Monoclonal 
antibodies active against a particular epitope are ideal for 
determining if an identical or even comparable epitope is present on 
another protein. However, in this Case, monoclonal antibodies are 
unsuitable for looking at common features on proteins because the 
nature of the epitopes are unknown. It would be necessary to raise 
a complete family of monoclonal antibodies before any meaningful 
comparative study could be carried out and this would only be 
worthwhile for doing detailed structural studies on proteins (van 
Regenmortel, 1987).
3.2 Production and characterisation of polyclonal antibodies
3.2.1 Production of antibodies.
Antibodies were raised against particular antigens as 
described in section 2.12. Figure 3.2 represents an idealised 
picture of antibody levels against shikimate dehydrogenase during 
the immunisation of rabbit No. 159 with the enzyme shikimate 
dehydrogenase from E. coli. In addition to showing antibody 
levels, the diagram illustrates when blood for antisera production 
was removed from the rabbit and explains the nomenclature used in 
defining particular batches of antisera against an immunogen. 
Normally when an animal is first injected with an immunogen, there 
is a period of several days when no antibody can be detected in the 
blood. After a period of 7-10 days, antibodies appear and reach a
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Figure 3.2 The immune response to E. coli shikimate dehydrogenase
The figure provides a diagramatic representation of the 
response of an animal to injection by immunogen. Injection of 
immunogen (E) stimulates antibody production. The initial 
injection produces a smaller response than subsequent (booster) 
injections. Samples of blood were taken at intervals, and antisera 
prepared as described in section 2.12.2.
The diagram illustrates the production of antibodies against 
shikimate dehydrogenase from E. coli where 12 batches of antisera 
were taken over a period of 36 months. The + indicates antisera 
used in this study.
For production of antibodies against other immunogens only a 
single boost injection was given and consequently the diagram is 
only applicable over the first two peaks. The antisera used for 
these immunogens would be equivalent to samples 5 and 6 on the 
diagram.
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peak at about 14-21 days after which the level falls. The first 
response to the immunogen is termed the primary antibody response. 
When the animal is given a second injection of the immunogen, the 
levels of antibody in the blood begin to rise within two or three 
days and within about 10 days reach a level which is constant for 
approximately 6 weeks and is in excess of that achieved in the 
primary response. This is termed the secondary antibody 
response. This accelerated response is the result of the 
stimulation by the immunogen of antibody-forming cells of the immune 
system which had been sensitized by the earlier injection of 
antigen. Subsequent immunisations result in responses like the 
secondary response although both the level and nature of the 
antibody molecules in the blood can vary after additional 
immunisation injections. After preparation, each batch of antisera 
is tested to measure its titre and specificity. In the work 
described here the only immunisation that was examined in any detail 
was that produced by rabbit 159 against shikimate dehydrogenase from 
E. coli. The results available (Fig. 3.3) suggest that this 
immunisation is consistent with Figure 3.2.
3.2.2 Antisera titre and specificity
Three distinct assays were used to assess antisera.
Initially the ability of the antisera to inhibit enzyme activity was 
used to show that an active antiser^ had been produced. This was 
supplemented by an ELISA which used purified enzyme protein and gave 
a measure of binding. Thirdly the antisera was used in a blotting 
assay both to measure binding but more importantly to determine how 
specifically the antisera could recognise a particular protein in a 
crude cell extract.
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3. 2. 2.1 Anti-shikimate dehydrogenase antisera
Several batches of anti-shikimate dehydrogenase antisera 
were assessed. These were all raised in a single rabbit with two 
batches (159:8 and 159:9) being prepared after one particular boost 
and the other two (159:11 and 159:12) after a later boost (Fig.
3.2). Antisera batch 159:10 was also assessed but gave a poor 
inhibition of enzyme activity and was not tested further. All four 
batches of antisera tested give very high levels of inhibiton of 
enzyme activity (approximately 100%) when mixed undiluted with 
enzyme. On assessing the titre of these antisera it was found that 
two of the batches 159:11 and 159:12 give a significantly higher 
titre than the others (Fig. 3.3). Similar results are obtained 
irrespective of whether a crude extract from a shikimate 
dehydrogenase overproducing strain of E. coli or a sample of pure 
shikimate dehydrogenase is used for the assay of titre (Fig.
3.3A,B). These results were confirmed by the ELISA using purified 
shikimate dehydrogenase as antigen. Batches 159:11 and 12 give 
significantly higher titres than the other two antisera (Fig. 3.4).
Immune blots were used to assess how specific the antisera 
were and the results are shown in Figure 3.5. Blotting, with all 
four batches of antisera, of both crude extracts of E. coli 
containing high shikimate dehydrogenase activity and samples of 
purified shikimate dehydrogenase, give similar results with crude 
extract samples showing the presence of a major band of the same 
molecular weight as purified shikimate dehydrogenase. When the gel 
is overloaded with enzyme subsidiary bands are obtained with samples 
of both pure enzyme and crude extract.
It was therefore concluded that the antisera raised against 
shikimate dehydrogenase all contain a high level of antibody against 
this protein and that overall the antisera are sufficiently specific
Figure 3.3 Assay o.f anti-shikimate dehydrogenase antisera by 
enzyme inhibition assay
Samples of anti-shikimate dehydrogenase (rabbit No. 159)
were diluted in normal rabbit serum and each dilution mixed with an 
equal volume of shikimate dehydrogenase (0.045eu/assay). Samples 
were gently mixed at room temperature for 1 h then assayed for 
shikimate dehydrogenase activity as described in section 2.1.3. A 
control using normal rabbit serum was included to confirm the 
stability of shikimate dehydrogenase over the period of 
incubation. The ability of antisera to inhibit enzyme activity was 
assessed using both purified shikimate dehydrogenase (Fig. A) and 
crude extract from the coli shikimate dehydrogenase overproducing 
strain (Fig. B).
dilution at 50% inhibition
A B
O :159:8 1:4 1:4
□  :159 :9 . .1:2 1:2
•  :159:11 1:32 1:32
•  :159:12 1:32 1:32
Antibody 
dilution 
(reciprocal)
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Figure 3.4 Assay of: anti-shikimate dehydrogenase antisera by ELISA
An aliquot of native, purified shikimate dehydrogenase from
E. coli (0.06 eu; lOOng protein/well) was added to each of the
wells^of a microtitre plate. After allowing binding to occur 
o
overnight at 4 C in coating buffer, the unbound material was 
washed from the plates and the plates used for ELISA as described in 
section 2.16.2.
Anti-shikimate dehydrogenase antisera were diluted in 
incubation buffer and added to the well. Normal rabbit sera, 
diluted in the same buffer, were included on each microtitre plates 
as controls.
After assay and reading at 492nm, the potency of the 
antisera was assessed as that dilution which gave an absorbance 
value of 0.5 above the normal rabbit sera control.
dilution for A ^  0.5
1:96,000 
1:6 ,000  
1:200,000  
1:200,000  
1:250
Antibody dilution (reciprocal xlO
A : 159:8 
•  :159 :9 
*:159:11 
□:159:12
0 :normal rabbit serum
Figure 3.5 Immunoblotting of shikimate dehydrogenase from E. coli 
with anti-shikimate dehydrogenase antisera
Samples of both purified shikimate dehydrogenase from 
E. coli and of a crude extract from E. coli strain K12 : 
AB2834/pIA321 (shikimate dehydrogenase overproducer) were prepared 
and applied to a 12.5% SDS polyacrylamide gel and electrophoresis 
carried out as described in section 2.8 .1.4.
After electrophoresis the proteins were transferred to 
nitrocellulose and immunoblotted using several batches of 
anti-shikimate dehydrogenase antisera (see Fig. 3.2) as described in 
section 2.17.1.2. All antisera were used at a dilution of 1:200 in 
blocking buffer containing 5% normal rabbit sera and 0.5%
Tween 20.
track No. Sample applied (ng protein)
1 1000 (crude extract)
2 100 (crude extract)
3 10 (crude extract)
4 50 (pure E3)
5 5 (pure E3)
6 0.5 (pure E3)
7 M standard proteins
159:8 159:9
7 6 5 4 3 2 17 6 5 4 3 2 1
159:11 159:12
7 6 5 4 3 2 1 7 6 5 4 3 2 1
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to be unable to detect any proteins, in crude extracts of E. coli, 
other than the immunogen against which they were raised. Antisera 
batches 159:11 and 159:12 were found to contain higher levels of 
antibodies than the other preparations and were the antisera chosen 
for further experiments.
3.2.2.2 Antisera raised against E. coli enzymes of the shikimate
pathway
In total ten different antisera were raised against enzymes 
of the shikimate pathway. The JE^ coli enzymes which corresponded 
to the activities observed in the arom complex were used, in both 
their native form and in the form produced by reduction and 
carboxymethylation of the native form, as immunogens. The antisera 
produced were tested using the same tests as those used to test the 
anti-shikimate dehydrogenase antisera.
Assays, which depended on inhibition of enzyme activity, 
were used to assess the ability of antisera to bind to/inhibit the 
native form of the protein against which they were raised. The. 
data show that antisera' raised against the native form of the enzyme 
are effective in reducing the enzyme activity remaining in the assay 
(Table 3.1a and Fig. 3.6). Antisera raised against denatured . 
protein have a lower titre in the enzyme inhibition assay (Table 
3.1b) but in three cases (anti-E2, E3 and E4) they contain 
substantial levels of antibodies able to bind to the native form of 
the protein. In three cases out of five the addition of protein A 
S. aureus to the enzyme inhibition assay eliminates all enzyme
activity from the supernatant (Table 3.1c). Since protein A 
S. aureus binds specifically to the Fc region of antibody (IgG) 
molecules (Langone, 1982), it will only remove enzyme activity from 
solution if the enzyme is bound to an antibody (IgG) molecule.
Table 3.1 Inhibition and immunoprecipitation of shikimate 
pathway enzymes by antisera
A^sample of pure native El (0.006 eu/assay) from E. coli 
overproducing strain was mixed with an equal volume of antisera 
raised against El. The mixture was incubated at room temperature 
as described in section 2.13 then assayed for enzyme activity. 
Similar incubations using the pure native samples of the other 
shikimate pathway enzymes and their corresponding antisera were also 
set up, incubated as above and assayed for residual enzyme activity 
(section 2.7). The results are shown in Table a.
A second set of incubation was set up in which pure native 
enzyme was mixed with antisera directed against the corresponding 
denatured protein and the residual activity remaining after 1 h was 
assayed (Table b ) .
A third set of incubations similar to set 2 were set up but 
after incubation for 15 min protein A -S. aureus was added as 
described in section 2.15.2. After centrifugation the activity 
remaining in the supernatant was assayed (Table c)
The results are expressed as the total activity lost 
(inhibition for enzyme inhibition assay and precipitation for 
immunoprecipitation assay) from the supernatant as a percentage of 
the control activity i.e.
% inhibition or 
precipitated 
enzyme
activity in _ activity in
control S/N experimental S/N x
activity in control S/N
Enzyme
Enzyme inhibition 
anti-native enzyme
assay
% inhibition
El 310:2 (anti-El) 100
E2 160:4 (anti-E2) 100
E3 159:11 (anti-E3) 100
E4 315:1 (anti-E4) 100
E5 163:2 (anti-E5) 100
Enzyme anti- denatured enzyme % inhibition
E1 420:2 (anti-denatured-El) 0
E2 421:2 (anti-denatured-E2) 92
E3 387:2 (anti-denatured-E3) 55
E4 423:2 (anti-denatured-E4) 60
E5 424:2 . (anti-denatured-E5) 0
Enzyme
Immunoprecipitation assay with protein A
anti-denatured enzyme % precipitated enzyme
El 420:2 (anti-denatured-El) 0
E2 421:2 (anti-denatured-E2) 100
E3 387:2 (anti-denatured-E3) 100
E4 423:2 (anti-denatured-E4) 100
E5 424:2 (anti-denatured-E5) 0
Figure 3.6 Assay of antibody titre for antisera against aromatic
pathway enzymes from EL_ coli
Antibodies, raised against the native enzymes of the
shikimate pathway from E. coli (see Table 3.1a), were diluted in 
normal rabbit serum and each of the dilutions was incubated with an 
equal volume of a sample of the purified protein (approximately 
0.006 eu/assay) against which it was raised. After incubation, 
with gentle mixing for 1 h, as described in section 2.13, the enzyme 
activity remaining was assayed as described in the methods section >^.7 
for assay of each enzyme activity (section 2.7). A control in 
which each enzyme was incubated with a sample of normal rabbit 
serum, was included to measure the stability of the enzyme under the 
conditions of the incubation. No loss of activity in the controls 
was found. The titre was estimated as that concentration of 
antibody which gave 50% less of activity under the conditions used.
Enzyme titre at 50% inhibition
•  I El (dehydroquinate synthase) 
OIE2 (dehydroquinase)
A:E4 (shikimate kinase)
□:E5 (EPSP synthase)
1:32
1:64
1:32
1:16
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0.03-H
0.02H
0.01 J
16
Antibody dilution (reciprocal)
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Two preparations of antisera, i.e. anti-denatured-El raised 
against denatured dehydroquinate synthase (El) and anti-denatured-E5 
raised against denatured EPSP synthase (E5), do not demonstrate a 
high antibody level against the native protein and even in the 
presence of protein A aureus are unable to remove enzyme activity 
from the supernatant (Table 3.1c).
It is clearly impossible to use an enzyme inhibition assay 
to assess the ability of antibody to bind to denatured enzyme and so 
an ELISA was used to assess the titre of antibody raised against 
denatured proteins to bind to both native and denatured proteins.
As observed with the inhibition assay results, it was found that the 
antisera raised against denatured El and denatured E5 are of much 
lower titre against the native enzymes than the other antisera.
All other antisera demonstrate substantial titres against both 
native and denatured enzymes (Table 3.2).
It was concluded from these results that, with the exception 
of anti-denatured-El and anti-denatured-E5, all of the antisera 
prepared contain high levels of antibodies against their immunogens 
and that antisera raised against denatured proteins contain 
substantial levels of antibodies which recognise the native 
protein. It was therefore thought likely that for each enzyme 
antibodies had been produced against a large number of the different 
epitopes present and that the antibodies would be able to recognise 
both assembled topographic and sequential epitopes of that enzyme.
All of these antisera were then tested in immunoblots, to 
assess their ability, firstly, to specifically identify particular 
proteins in crude extracts and, secondly, to recognise both the 
native and denatured forms of their own immunogen. The ability of 
the antisera to recognise specific proteins in crude extracts was 
carried out using extracts prepared from cultures which
Table 3.2 Assessment of antibody titre against both native and 
denatured enzymes by ELISA
ELISA plates were set up containing lOOng of purified 
protein/well and were used, as described in section 2.16, to measure 
the potency of antibody preparations. Antibodies were diluted in 
incubation buffer and the amount bound at each diluted measured by 
absorbance after processing at 492nm. A control of normal rabbit 
serum was included on each plate.
For each combination of enzyme and antiserum the titre was 
assessed as the greatest dilution which gave an absorbance of 0.5 
above the control serum.
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Table 3.2
Enzyme Antiserum dilution for A ^ O .
native enzyme 
El 
E2 
E3 
E4 
E5
anti-native enzyme 
310:2 
160:4 
159:11 
315:1 
163:2
titre
1:51,200
1:25,600
1:200,000
1:102,400
1:38,400
native enzyme 
El 
E2 
E3 
E4 
E5
anti-denatured enzyme titre
420:2 1:3,200
421:2 1:102,400
387:2 1:102,400
423:2 1:51,200
424:2 1:4,800
denatured enzyme 
denatured-El’ 
denatured-E2 
denatured-E3 
denatured-E4 
denatured-E5*
anti-native enzyme 
310:2 
160:4 
159:11 
315:1 
. 163:2
titre
1:204,800
1:38,400
1:51,200
1:204,800
1:51,200
denatured enzyme 
denatured-El 
denatured-E2 
denatured-E3 
denatured-E4 
denatured-E5
anti-native enzyme titre
420:2 1:12,800
421:2 1:51,200
387:2 1:38,400
423:2 1:51,200
424:2 1:76,800
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overexpressed one of the shikimate pathway enzymes. The results 
are shown in Figure 3.7 for each enzyme. In all cases it was found 
that the antibodies could identify, as a major band, the protein 
against which they were raised. There are three problems.
Firstly one of the antisera (310:2; anti-El) recognises one of the 
molecular weight markers. Secondly antisera 315:1 (anti-E4) 
recognises many proteins in the crude extract other than its own 
immunogen. Thirdly, the amount of enzyme required to be loaded 
onto the gel to ensure reliable detection (see legend to Fig. 3.7) 
is high and with the exception of E3, would be difficult to detect 
in an extract from a wild type strain. It was therefore concluded 
that in order to examine cross reactions it was essential to use 
purified enzymes (or at least partially purified enzymes) rather 
than crude extracts. Using purified proteins, applied to the gel 
at levels able to be detected by the antisera, it was found that 
antibody prepared against: a particular immunogen is able to detect 
both the native and denatured form of the antigen. This result is 
true if either the native or denatured form of the protein is used 
as the immunogen (Figs.. 3.8, 3.9,. 3.10 and 3.11).
3.3 Immunological cross reactions between shikimate pathway 
enzymes
3.3.1 Antigenic cross reaction within the shikimate pathway 
enzymes of E. coli
Considerable attempts were made to demonstrate that the five 
enzymes of the shikimate pathway against which antisera had been 
prepared contained epitopes in common. . Initially this was assessed 
using the enzyme activity assay and measuring the extent to which 
enzyme activity could be reduced by different antibody preparations.
Figure 3.7 Quantitative assessment of antigen detection by 
immunoblotting
Crude extracts were prepared from cells of each of the 
overproducing strains (section 2.6.5.1) and the specific activity of 
the overproduced enzyme measured. Samples, containing known amounts 
of enzyme activity, were run on 12.5% SDS slab gels (section 2.8.1.4) 
and blotted to nitrocellulose (section 2.17.1.2). A sample of pure 
enzyme (*) and molecular weight standards were run on each gel as 
markers.
After blotting each enzyme was detected using antisera 
specific for that enzyme (see Table 3.1a).
The data are shown on Figure 3.7 (A to E).and are summarised
below.
detection limits/track 
^units ngprotein
Figure A El blotted with anti-El 13 50
Figure B E2 blotted with anti-E2 950 750
Figure C E3 blotted with anti-E3 . 5450 250
Figure D E4 blotted with anti-E4 400 1000
Figure E E5 blotted with anti-E5 62 150
A. anti-El (310:2)
12.8* Markers12.83.21 .60.8
Amounts of enzyme (eu/track x 10 6 )
anti-E2 (160:4)B.
0.2 0.5 1.0 2.0 3.8 3.8* Markers
Amounts of enzyme (eu/track x 10~5 )
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C. anti-E3 (159:11)
Markers 0.3 1.4 21 .8 87.2 Markers
87.2
Amounts of enzyme (eu/track x 10'-5) 
D. anti-E4 (315:1)
0.2 0.4 0.8 1 .6 3.2 3.2* Markers
Amounts of enzyme (eu/track x 10'5 ) 
E. antl-E5 (163:2)
0.8 1 .6 6.23.1 12.5 12.5* Markers
Amounts of enzyme (eu/track x 10 5 )
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Ho reduction in activity is observed when an enzyme is mixed with 
any antisera other than the antisera raised against it (either as a 
native or denatured protein). The sensitivity of this assay was 
increased by using protein A S. aureus to precipitate all enzyme 
molecules bound to antibodies. After incubation in the presence of 
protein A S^ _ aureus and centrifugation no loss of activity from the 
supernatant is observed suggesting no binding of enzyme to antibody 
occurs.
Similar results were obtained when immunoblotting was used 
as a technique to assess cross reaction. As with enzyme 
inhibition, antisera could only detect the protein that had been 
used as an immunogen in preparation of the antisera (Fig. 3.8, 3.9,
3.10, 3.11). The only consistent cross reaction that is observed 
is with the antisera raised against denatured dehydroquinate 
synthase (anti-denatured-El) which is able to detect the denatured 
but not the native form of the enzymes El, E3, E4 and E5 (Fig. 3.11, 
box 1). No cross reaction with denatured-E2 is observed (Fig.
3.11, box 1). The only group these four denatured proteins have in
common is the carboxymethyl group derived from iodoacetate which is
present as a result of the denaturation reaction. It was concluded
that this group acted as a hapten or haptenic determinant on the
dehydroquinate synthase protein molecules during immunisation and
the antisera generated are able to detect this structure on all the
denatured proteins. This conclusion was confirmed by the non cross
reaction of denatured-E2 because this protein contains no cysteine
residues (E. Borthwick, L.D. Graham & J.R. Coggins, unpublished 
Act A  pp-C^ d 4 >c
results^) and is therefore unable to be carboxymethylated. This 
cross reaction serves as a very good positive control for the assay 
system because the denaturation of shikimate dehydrogenase, for 
example, results in the insertion of only 3 carboxymethyl 
groups/molecule of enzyme. The result shows that the technique is
Figure 3.8 Antigenic cross reactions amongst five E. coli central
enzymes corresponding to N_;_ crassa arom complex
1) Native enzymes + antisera against native enzymes
Approximately lOOng samples of each of the purified shikimate 
pathway enzymes from E±_ coli which correspond to the arom complex and 
of the N. crassa arom complex were loaded onto 12.5% SDS 
polyacrylamide slab gels and were electrophoresed and blotted to. 
nitrocellulose as described in section 2.17.1.2.
The blots were then incubated with antisera (see Table 3.1a) 
specific for one of the proteins on the gel and binding of antibody 
to the protein detected.
Each blot contained: 
track 1 
track 2 
track 3 
track 4 
track 5 
track 6 
track 7:
purified El 
purified E2 
purified E3 
purified E4 
• purified E5 
purified arom complex
M standard proteins 
r
The antisera used to detect the proteins are shown above each
blot.
an
ti
-E
l 
an
ti
-E
2 
an
ti
-E
3
s ' ?
CM
cn
CD
CN
cn
CD
CM
cn
I i
Figure 3.9 Antigenic cross reactions amongst five E. coli central
enzymes corresponding to N. crassa arom complex.
2) Denatured enzymes + antisera against native enzymes
A second set of blots were set up as for Figure .3.8 except 
that the purified enzymes from E. coli were denatured by reduction 
and carboxymethylation (section 2.11.2) before loading to the gel. 
Electrophoresis, blotting and protein detection by antibody was 
carried out as for Figure 3.8.
Each blot contained:
carboxymethylated El
carboxymethylated E2
carboxymethylated E3
carboxymethylated E4
carboxymethylated E5
M standard proteins 
r
track 1: 
track 2: 
track 3: 
track 4: 
track 5: 
track 6:
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Figure 3.10 Antigenic cross reactions amongst five E. coli central
enzymes corresponding to N_^_ crassa arom complex
3) Native enzymes + antisera against denatured enzymes
A third set of blots were set up as for Figure 3.8 except 
that the antisera used to detect proteins was raised against enzymes 
which had been denatured by reduction and carboxymethylation before 
use as an immungen (see Table 3.1b). All other conditions were as 
described in Figure 3.8.
Each blot contained: 
track 1: 
track 2 
track 3 
track 4 
track 5 
track 6 
track 7
purified El 
purified E2 
purified E3 
purified E4 
purified E5 
purified arom complex 
M standard markers

Figure 3.11 Antigenic cross reactions amongst five E. coli central
enzymes corresponding to crassa arom complex
A fourth set of blots were set up as for Figure 3.8 except 
that the purified enzymes were denatured by reduction and 
carboxymethylation before loading to the gel. As with Figure 3.10 
the antisera used to detect the proteins was raised against enzymes 
denatured by reduction and carboxymethlation before use as an 
immunogen.
4) Denatured enzymes + antisera against denatured enzymes
Each blot contained:
track 1 carboxymethylated El
track 2 carboxymethylated E2
track 3 carboxymethylated E3
track 4 carboxymethylated E4
track 5 carboxymethylated E5
track 6 M standard proteins
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able to demonstrate a cross reaction when a protein has only 3 
epitopes able to bind antibody.
The conclusion from these experiments must therefore be that 
there is insufficient sequence or structural homology among these 
proteins of the shikimate pathway in E. coli togenerate common 
antigenic determinants.
3.4 Antibody against arom complex from N. crassa
Antibody against arom complex was raised in rabbits using 
purified arom complex from N. crassa as an immunogen (section 
2.12). The nature and titre of the antisera was determined using 
the enzyme inhibition assay.
3.4.1 Inhibition of activity of arom complex by anti-arom-antisera
Initially it was observed that the antibody preparation 
could only inhibit the El and E5 activities of the arom complex, 
with the E2, E3 and E4 activities being unaltered by incubation in 
the presence of antibody (Table 3.3a). All activities could 
however be precipitated by centrifugation of the arom complex/ 
antibody mixture even in the absence of protein A aureus 
(Table 3.3b).
Inhibition of El and E5 activities were dependent on the 
concentration of antisera added with a 1:8 dilution being sufficient 
to reduce both activities by 50% (Fig. 3.12). The potency of this 
antisera was therefore comparable to the other antisera prepared for 
this study.
Since it is known that all 5 activities are associated with
the complex and are all precipitated by antibody, the inability of
the antisera to inhibit E2, E3 and E4 activities suggests that the
active site for these activities is buried within the structure of 
the complex and thus not susceptible to inhibition.
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Table 3.3 Inhibition and precipitation of N. crassa arom complex 
by anti-arom antiserum
A sample of arom complex (6.6^ig or 0.02eu of E3) was mixed 
with an equal volume of undiluted anti-arom antiserum (311:3) and 
incubated at room temperature with gentle mixing as described in 
section 2.13. After incubation, aliquots were taken from the 
mixture and assayed for each of the activities in the arom complex. 
Activities assayed were compared to control activity obtained by 
incubating arom complex with normal rabbit serum (Table a).
The sample was centrifuged at 12,000g for 5 min and the 
supernatant assayed for residual activity. As for Table a the 
activities assayed were compared with those from a control incubation 
containing normal rabbit serum (Table b).
a) enzyme inhibition
enzyme in arom complex % inhibiton
El 100
E2 . . 0
E3 0
E4 0
E5 100
immunoprecipitation 
enzyme in arom complex % precipitated enzyme 
El 100
E2 100
E3 100
E4 100
E5 100
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Figure 3.12 Anti-arom antiserum titre by enzyme inhibition
Samples of antiserum raised against N. crassa arom complex 
(311:3) were diluted in normal rabbit.serum and aliquots of each 
dilution were mixed with equal volumes of purified N. crassa arom 
(S.S^g or 0.02eu of E3). After incubation for 1 h at room 
temperature with gentle mixing (section 2.13) the activity remaining 
of the five enzymes of the complex was assayed. A control 
incubation with normal rabbit serum showed no change in activities 
from that observed with the 1:64 dilution of arom specific antiserum.
0.14-1
0.12-P
0 .10-
0 . 0 8 - i “
o
crS  0.06-h
<=c
•O E3
E2
•  E4
0 .02-
6
Antibody dilution 
(reciprocal)
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3.4.2 Proteolysis of arom complex
Limited proteolysis of the arom complex has been shown to 
generate 2 major and 1 minor fragments (Fig. 3.13). Of the two 
major fragments one of them (110K) contains the El and E5 activities 
while the other (68k ) contains the E2 and E3 activities.. The minor 
fragment (74K) contains only E5 activity (Coggins et a l ., 1985; 
Boocock, 1983). Limited proteolysis therefore represents a method 
of separating the E2/E3. activities from the complex and allows the 
ability of the antisera to bind to different parts of the complex to 
be ascertained.
Limited proteolysis was carried out as described by Boocock
(1983). Purified arom complex was diluted in 50mm-potassium
phosphate, pH 7.0, to a protein concentration of lOOyug/ml. Trypsin
(lmg/ml stock solution in ImM-HCl) was added to a concentration of
o
lOOpg/ml and the mixture incubated at 25 C. The reaction was 
terminated after 2 min by'passing the mixture through a 1ml column 
of immobilised trypsin inhibitor. 1ml fractions were collected and 
active fractions pooled.
The interaction of the antibody with the proteolysed arom
complex was tested in two ways. Firstly the arom complex was run 
on SDS-PAGE and immunoblotted. The results (Fig. 3.14) showed that
a) unproteolysed arom complex binds.antibody (track 1)
b) the proteolysis was complete with no unhydrolysed arom 
complex remaining after hydrolysis (track 2) .
c) antibody recognises all three breakdown fragments produced 
by the hydrolysis.
The antiserum therefore contains antibodies which can bind to all of 
the fragments including the 68K fragment which contains. E2 and E3 
activities.
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Figure 3.13 Proposal of mosaic model of N. crassa arom complex
Boocock (1983) has proposed the mosaic model for the 
structure of the M 165K arom complex based on data from limited
proteolysis. The immediate products of an initial rapid cleavage by 
trypsin of the intact arom complex are two fragments of M 110K and
68K respectively. The 68K fragment or C-terminal domain contains 
the E2 and E3 activities while the 110K domain or N-terminal region 
contains the El and E5 activities. If proteolysis is continued, 
the 110K fragment disappears and a 74K is produced. El activity 
also disappears. The 74K fragment carries E5 activity and does not 
overlap the 68K fragments.
r
r
E5 E4
165K
intact arom complex"
trypsint
trypsint
+ s m a l 1 peptides
VFigure 3.14 Immunoblot of a r o m  p roteolysate with a n ti-arom
ant iserum
N . crassa aroro complex was digested with trypsin for 2 min and 
the digestion terminated by passing the mixture through an immobilised 
trypsin inhibitor column as described in section 3.4.2. The active 
fraction (ca. 50ng protein) was loaded onto a 12.5% SDS PAGE and then 
electrophoresed and immunoblotted as described in section 2.17.1.2.
A sample of undigested N. crassa arom complex (ca. lOOng) was used as 
a control.
track no. protein (ng)
1: undigested arom 100
2: digested arom 50
3: E. coli E3 100
4: M standard proteins 
r
anti-arom
4 3 2 1
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The proteolysed arom complex mixture was then incubated with 
anti-arom antiserum. All five activities were measured. The 
results obtained (Table 3.4) were the same as those obtained using 
the unproteolysed arom complex (except for E4 which is destroyed by 
proteolysis). El and E5 activities are inhibited by antibody. E2 
and E3 activities are not despite the fact that antibodies which 
bind to the E2/E3 arom fragment (Fig. 3.14) are present in the 
anti-arom a n t is e ru w * .  After centrifugation all activities are lost 
from the supernatant.
The antisera prepared against arom complex is therefore able 
to bind to many sites on the arom complex but binding is unable to 
inhibit activity of E2, E3 and E4 in the complex.
3.5 Cross reactions using enzyme preparations from different
species
Antibodies were used to assess the presence of common 
epitopes between proteins with the same enzymic activity from 
different species using a combination of inhibition of activity and 
immunoblotting techniques. Three particular combinations were 
analysed:
a) comparison of arom complex from different species
b) comparison of arom complex from N. crassa with the
corresponding enzyme activities from E^ _ coli
c) comparison of E3 (shikimate dehydrogenase) activity from 
several organisms.
3.5.1 Common epitopes between the arom complex from N. crassa and 
yeast
The presence of common epitopes between arom complex 
prepared from both yeast and N_j_ crassa was investigated by immune 
blotting. The results indicate that these two complexes contain
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Table 3.4 Inhibition and immunoprecipitation by anti-arom 
antiserum of arom after trypsin digestion
Purified arom complex (lOOpg) was digested with trypsin and 
the hydrolysis terminated by passing the mixture through an 
immobilised trypsin inhibitor column (section 3.7.1). The fraction 
containing active arom fragments was mixed with an equal volume of 
anti-arom antiserum, incubated with mixing at room temperature for 
1 h then assayed for the activities of the arom cmplex (section 2.13) 
(Table a). After assay the sample was centrifuged at 12,000g for 
5 min and the activity remaining in the supernatant assayed (Table b).
A control incubation containing normal rabbit serum and 
proteolysed arom fragments was set up and assayed as above. Results 
presented here are activities found after incubation with arom 
specific antiserum compared to normal rabbit serum.
a) enzyme inhibition
enzyme in arom complex % inhibiton
El - 100
E2 0
E3 0
E5 100
b immunoprecipitation
enzyme in arom proteolysate % precipitated enzyme
El 100
E2 100
E3 100
E5 100
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common epitopes (Fig. 3.15). As far as can be assessed from the 
position of the bands on the SDS-PAGE the complexes from the two 
organisms have the same molecular weight.
3.5.2 Common epitopes between N. crassa arom complex and the
corresponding enzymes in E. coli
Considerable attempts were made to demonstrate the presence 
of common epitopes between these activities. Samples of purified 
arom complex were incubated with each of the ten antibodies raised 
against the EL_ coli enzymes. No loss of activity of any of the 
component enzymes of the arom complex is found as a result of 
incubation. The sensitivity of this system was increased by use of 
protein A Sj^  aureus to promote precipitation of any arom complex 
bound to antibody. No arom complex is precipitated by 
centrifugation. The reciprocal experiments were also carried out 
with pure samples of each of the five coli enzymes being 
incubated with anti-arom antiserum and the activity remaining in 
solution assayed. Again these incubations were repeated using 
protein A S. aureus to precipitate any active enzyme bound to 
antibody. In none of these incubations is the activity of any of 
the enzymes decreased as a result of the incubation with the 
antisera.
The analysis was extended by using ELISA to measure the
amount of antibody bound to an antigen fixed to the ELISA plate.
Figure 3.16 shows the results obtained for an ELISA in which pure
arom complex from N. crassa was bound to the plate and the binding
to this protein of antibodies raised against arom and against
shikimate dehydrogenase from E^ _ coli measured. No binding above
background can be detected between the arom complex and either of
the anti-shikimate dehydrogenase antisera. These binding studies 
were extended by using blotting rather than the ELISA method and the
Figure 3.15 Immunoblot of N. crassa arom and yeast arom using 
anti-N. crassa arom antiserum
50ng of N_^  crassa arom complex and yeast arom complex were 
loaded onto a 12.5% SDS PAGE, then electrophoresed and immunoblotted 
as described in section 2.17.1.2.
track no.
1: crassa arom complex
2: yeast arom complex
3: M standard proteins
r
anti-arom
3 2 1
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Figure 3.16 Binding of anti-N. crassa arom antiserum and anti-
E. coli E3 antiserum to N. crassa arom complex by ELISA.
lOOng of purified arom complex was bound to the surface of 
the wells of an ELISA microtitre plate and the ability of dilutions 
of antibody preparations in incubation buffer to bind under 
conditions as described in section 2.16.2 determined. All assayed 
were carried out in duplicate with controls, using normal rabbit 
serum, included on each plate.
•!311:3 anti-N. crassa arom complex 
A :159 :8 anti-E. coli E3 antiserum
□*159:11 anti-E. coli E3 antiserum
q : normal rabbit serum
32 64 128 256' 512 1024
Antibody dilution (reciprocal x l 0 ~ 2)
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results are shown in Figures 3.8 and 3.10. The blots shown on 
Figure 3.8 include arom complex in track 6. The first five boxes 
of this figure show that the presence of arom cannot be detected by 
any of the antisera raised against 'native* E. coli enzymes as 
immunogen and the final box shows that anti-arom antibody cannot 
bind to any of the E. coli enzymes. Figure 3.10 shows a similar 
experiment using antisera raised against the carboxymethylated E. 
coli enzymes. As before no binding of these antisera to arom can 
be detected. In some cases faint bands are seen on blots e.g. 
Figure 3.8, box 6 where an apparent cross reaction between anti arom 
antiserum and El is found. These cross reactions are due either to 
artifacts or to a low level of contamination of the pure proteins.
In no cases where a band indicating a cross reaction is seen, does 
the band correspond to the location of the enzyme on the gel.
These experiments show that no antigenic cross reaction can be 
detected between the arom'complex and the corresponding enzyme 
activities in E^ _ coli. It follows that if these proteins do have 
homologies in their amino acid sequence it must be less than 40% of 
the total sequence as thi£ is the generally accepted minimum level 
of homology necessary to detect common antigenic features.
3.5.3 Common epitopes among shikimate pathway enzyme from various 
organisms
3.5.3.1 Shikimate dehydrogenase as a model system
Shikimate dehydrogenase has been chosen to investigate the
degree to which common features occur and can be detected among the
enzymes of the shikimate pathway in different organisms. It was
selected because adequate supplies of antisera against the E^ coli
is
enzyme were available and because the activity- both sensitive and
-  1 0 3  -
easy to use even in crude extracts when E3 activity is only present 
in small amounts. The other activaties of the pathway suffer 
either because their assay procedure is less sensitive than the 
assay for shikimate dehydrogenase or because they are coupled to 
NADH as a cofactor. NADH oxidase activity in crude extracts is 
high and even after steps, such as ultracentrifugation, ammonium 
sulphate precipitation and cyanide inhibition, are taken the oxidase 
activity is still too high to allow easy assay of the NADH coupled 
enzymes.
Initial experiments were to be carried out using crude 
extracts and it was therefore essential to ensure that the extracts 
prepared contained the highest possible specific activity of 
shikimate dehydrogenase and that the method chosen to assess cross 
reaction was able to give a reliable answer.
To produce extracts of high specific activity three 
organisms (two strains of E. coli and one of E. carotovora) were 
chosen and grown on media containing different carbon sources. 
Extracts prepared from cells grown on each of these media were 
prepared and assayed for shikimat.e dehydrogenase activity. The 
results, shown on Table 3.5, indicate that growth conditions have 
little affect on the specific activity of the enzyme and that growth 
on any medium would be acceptable.
These extracts were then used to assess the suitability of 
immune blotting as a technique for measuring cross reactions. The 
results (Fig. 3.17) show that immune blotting of crude extracts is 
not suitable. The antiserum is able to detect shikimate 
dehydrogenase protein in crude extracts from both strains of E^ _ coli 
but as suggested when blots of the overproducing strain were being 
carried out (Fig. 3.7) the amount able to be loaded on the gel in 
extracts of wild type strains is close to the detection limit of the
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Table 3.5 Shikimate dehydrogenase (E3) activity in bacteria grown 
on different carbon sources
E « coli (K12 and ML308) and E. carotovora were grown on 
nutrient broth (section 2.4.1) or on minimal medium II with one of 
glucose, glycerol and succinate as carbon source (section 2.4.6) and 
harvested at late exponential phase. The harvested cells were used 
to prepare crude cell extracts (section 2.6.5.1) and assayed for E3 
activity (section 2.7.3) and protein (secton 2.5.3). The specific 
activity of E3 in each of the cell extracts was calculated.
Bacteria C-source specific activity (u/mg proteins)
E. coli K12 nutrient broth 0.044
glucose 0.041
glycerol 0.049
succinate 0.055
E. coli ML308 nutrient broth 0.043
glucose. , 0.044
glycerol 0.030
succinate 0.031
E. carotovora nutrient broth 0.045
glucose 0.055
glycerol 0.068
succinate 0.052
1 VJ }
anti-E3
technique. Immune blotting was not able to detect shikimate 
dehydrogenase from erwinia extracts (Fig. 3.17) and the blot 
background was showing many other proteins as faint bands. These . 
bands, which were as dark as any positive band could, if the gel 
were overloaded further, give false positives.
Since the immunoblot could not detect shikimate 
dehydrogenase from carotovora, and the negative result could have 
been due to the amount being loaded onto the gel being below the 
detection level of the technique, no assessment of the level of 
common antigenic determinants between this enzyme and the JE^ coli 
enzyme could be made. It was therefore decided that blotting 
experiments would be carried out on preparations of pure or 
partially purified enzymes and that to decide which enzymes to 
purify, it was essential to use inhibition of enzyme activity as the 
method of screening extracts for antigenic cross reaction with 
antisera against the E. coli enzymes.
3.5.3. 2 Immune inhibition of shikimate dehydrogenase activity in
crude extracts
Specific antibody inhibition of shikimate dehydrogenase 
activity was carried out using antisera prepared against both the . 
'native' and 'denatured' forms of the enzyme. . The ability of an 
antibody preparation to interact with the enzyme was assessed both 
directly by assaying loss of activity in the presence of antibody 
and by assessing the antibody-enzyme. binding using protein A 
S. aureus as an immune precipitant. The results obtained are shown 
in Table 3.6 and those incubations which suggested interactions were 
occurring were examined in more detail (Fig. 3.18).
The results (Table 3.6) show that the enzyme from E. coli is 
the only one inhibited by both antibody preparations. The enzyme
Table 3.6 Inhibition and immunoprecipitation of shikimate 
dehydrogenase (E3) from various organisms by 
anti-E. coli E3 antisera
Three aliquots of crude extracts prepared as described in 
sections 2.6.5.1 and 2.6.5.2 from cells grown, as defined below, 
were mixed with equal volumes of each of normal rabbit serum, 
anti-E. coli E3 serum (anti-E3:159:11) and anti-carboxymethylated 
E. coli E3 (anti-denatured-E3:387:2) and incubated for 1 h with 
gentle mixing at room temperature. After incubation all mixtures 
were assayed for loss of E3 activity (section 2.7.3).
A second series of aliquots from the crude samples were 
similarily mixed with antisera as above and incubated for 15 min 
before addition of a protein A S. aureus suspension (section 2.15.2) 
and incubation for a further 1 h. After incubation the mixtures 
were centrifuged at 12,000g for 5 min and the activity of E3 
remaining in the supernatants assayed.
All results are expressed as % inhibition or % precipitated 
enzyme as described for Table -3.1. .
growth medium 
(section)
2.4.1
2.4.1
2.4.1
2.4.1
2.4.4
2.4.3
2.4.1
2.4.1
2.10.1
gift from M. Yasin 
2.6.5.2
organisms
E. coli K12 
E. coli ML308 
S. typhimurium 
E. carotovora
A. calcoaceticus 
S . rimosus
S. aureus
B. subtil is 
N. crassa 
R. qraminis 
P. sativum
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from S. typhimurium is inhibited and that from E. carotovora 
partially inhibited by the antibody raised against the native 
E. coli enzyme. The enzyme from the erwinia strain is however 
totally precipitated from the incubation mixture of protein A 
S. aureus is added to precipitate immune complexes. The activity 
in the extract from A_^  calcoaceticus is not inhibited by either 
antibody preparation but does form immune complexes with the 
anti-native-enzyme antisera because 50% of the activity is lost from 
this incubation supernatant when protein A S. aureus is added (Table 
3.6). In all the other extracts examined no interaction between 
the enzyme and antibodies against the E^ _ coli enzyme could be 
detected.
For these incubations which demonstrated an enzyme antibody 
interaction, an inhibition titre was carried out. The results 
(Fig. 3.18) confirmed the inhibiton results and demonstrated that 
the 70% inhibition of the.erwinia enzyme was not caused by 
limitation of antibody because a 1:4 dilution of the antibody gave 
the same result (Fig. 3.18-D). The acinetobacter enzyme 
precipitation could have been due to an antibody limitation (Fig.
3.18e ) but for the experiment (section 4.4.1) which showed that 
addition of more antisera^did not increase the amount of enzyme able 
to be precipitated by protein A S. aureus.
As a result of these experiments, it was decided to 
partially purify the shikimate dehydrogenase (E3) enzymes from 
S. typhimurium, E. carotovora and A^ _ calcoaceticus.
3.5.3.3 Partial purification of shikimate dehydrogenase from
bacterial species
Shikimate dehydrogenase was purified from S_^_ typhimurium,
E. carotovora and A^ calcoaceticus using a procedure developed for
Figure 3.18 Titration of inhibition and immunoprecipitation of 
shikimate dehydrogenase (E3) activity from bacteria 
with anti-E. coli E3 antisera
Anti-E. coli E3 (159:11) was serially diluted in normal 
rabbit serum then mixed with aliquots of crude extracts prepared as 
described for Table 3.6. As for Table 3.6 one series of mixtures 
were assayed for residual E3 activity after 1 h incubation while a 
second set was incubated for 15 min before addition of protein A S . 
aureus (section 2.15.2) followed by a further incubation of 1 h 
before centrifugation and assay of the E3 activity remaining in the 
supernatant.
Enzyme activities were calculated as change in absorbance 
per min per lOul of original extract used and the activity graphed 
against the antisera dilution.
As controls samples of crude extracts were mixed with normal 
rabbit serum and treated as experimental samples. In all cases 
controls gave results very similar to these obtained with the 
highest dilutions of active antisera used.
In Figure 3.18 E, F and G antisera raised against the 
carboxymethylated E3 (anti-denatured-E3) was used.
Figure No. source of extract antisera
A E. coli K12 # / 0  anti-E3
B E. coli ML3Q8 # , O a n t i - E 3
C S. typhimurium # , O a n t i - E 3
D E. carotovora # , o a n t i - E 3
E A. calcoaceticus # , o a n t i - E 3
anti-denatured-E3
F E. coli K12 0,0 anti—denatured—E3
G E. coli ML308 0,oanti-denatured-E3
In all cases filled in symbols loss of activity in absence of 
protein A, opened symbols in presence of protein A.
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the purification of this enzyme from coli. No attempt was made 
to optimise the procedure for use with each species.
Cells were* grown either in nutrient broth (section 2.4.1) or 
in complex medium (section 2.4.4) to late exponential phase. Cells
were harvested washed in 50mM-Tris/HCl, pH 7.5 then harvested by
o o
centrifugation at 6,000g for 30 min at 4 C and stored at -20 C
until required.
Details of the purification procedure used are described in
the following sections. All procedures, unless otherwise stated,
o
were carried out at 4 C.
Step 1: Extraction and centrifugation
20g wet weight of cells were thawed, resuspended in 10ml.of
50mM-Tris/HCl, pH7.5 containing 0.4mM-DTT and 1.2mM-PMSF (Buffer A)
and broken by three passages through a French pressure cell.
DNasel (0.5mg) was added and the extract stirred for 1 h. The
extract was then centrifuged at 100,000g for 2 h and the supernatant
diluted to 70ml with buffer A.
Step 2: Fractionation with (NH ) SO , ___ ^ 2 4
The crude extract was made ImM in benzamidine.HCl and
adjusted carefully to 30% saturation with solid (NH ) SO
4 2 4
(176g/l). After stirring for 30 min the precipitate was removed by 
centrifugation at 38,000g for 30 min. The supernatant was adjusted 
to 55% saturation (160g/l) and stirred for 30 min. The precipitated 
protein was collected by centrifugation at 38,000g for 30 min then 
resuspended in buffer A before dialysing against 2 1 of 
50mM-Tris/HCl, pH7.5 containing 0.4mM-DTT (Buffer B).
Step 3: Mono Q chromatography
This step was carried out at room temperature. The 
dialysed material was applied to a f.p.l.c. preparative scale Mono Q 
anion exchange column and eluted over 30 min with a linear gradient
- 1 1 1 -
of 0-0.5M-NaCl in buffer B (flow rate 4ml/min). 2.0ml fractions 
were collected and the active fractions pooled and dialysed 
overnight against 1 1 of 50mM-Tris/HCl, pH 8.5 containing 0.4mM-DTT 
(Buffer C).
Step 4 ; Procion red chromatography
The dialysed extract was loaded, at 20ml/h, onto a Procion
red column (20ml bed volume) which had been equilibrated with buffer
C. The column was then washed with linear gradient of 0.1-lM-NaCl
containing O.lmM-NADPH in buffer C (flow rate 20ml/h). 2ml
fractions were collected, the active fractions pooled and dialysed
against buffer B containing 1M-(NH ) SO .
4 2 4
Step 5 : Phenyl superose chromatography
The enzyme from the previous step was applied onto a
f.p.l.c. hydrophobic interaction phenyl superose column at room
temperature and eluted over 25 min with a decreasing linear gradient
of 0-1.0-M (NH ) SO in buffer B (flow rate 0.5ml/min).
4 2 4
0.5ml fractions were collected, active fractions pooled and dialysed 
against buffer B.
Details of the results obtained using this purification 
procedure from the three organisms are shown in Table 3.7, with 
monitoring of the progress of the purification, by SDS PAGE, shown 
on Figure 3.19.
Despite the large purification factors achieved, the final 
preparations did not always give a single band on SDS PAGE to
4
indicate a pure sample of enzyme. The final sample of enzyme from 
E. carotovora gives a single band on SDS gel electrophoresis but the 
other two preparations still contain substantial quantities of 
contaminating proteins. Based on analysis by SDS-PAGE, gel 
filtration for the acinetobacter enzyme (section 4.2.5) and
- 1 1 2 -
Purification scheme f o r  shikimate dehydrogenase 
(E3) f rom bacter ia
In all cases 20g wet weight of bacteria after growth on 
complex media (section 2.4.1 and 2.4.4) to late exponential phase was 
used as starting material and E3 purified from all three extracts by a 
procedure developed for purification of this activity from Eb_ coli 
(section 3.5.3.3).
Table 3.7 (a) Purification table of S. typhimurium
Purification
step
Vol
(ml)
Protein 
(mg/ml)
total
protein
(mgs)
activity 
(u/ml)
total 
activity 
( ;units)
specific 
activity 
u/mg)
pur ificatlon 
(fold)
1: crude extracts 
2: 30-55%
55 16 880 .23 12.65 .014 1.0
(n h 4 )2s o 4 12 34 408 .78 9.36 .023 1.6
3: MonoQ 8 10 80 .74 5.92 .074 5.3
4: Procion red 16 0.75 12 .18 2.88 .24 17.1
5: Phenyl superose O.S 0.45 .225 1 .22 0.61 2.7 192.8
Table 3.7(b) Purification Table of E. carotovora
total total specific
Purification Vol Protein protein activity activity activity purification .
step (ml) (mg/ml) (mgs) (u/ml) (units) u/mg) (fold)
l: crude extract 80 16.5 1.320 0.9 73 .055 1
2: 30-55%
(NH4 )2S0 4
10 55 550 8.0 80 .145 2.6
3: Mono 0 6 5.7 34.2 5.5 33 .965 17.5
4: Procion red 16 .045 ■ ' ;*72 .56 • 9 12.5 227.2
5: Phenyl superose 1 .04 .04 2.3 2.3 57.5 1,045
Table 3.7(c) Purification Table of A. calcoaceticus
Purification
step
Vol
(ml)
total
Protein protein 
(mg/ml) (mgs)
activity 
(u/ml)
total 
activity 
(units)
specific
activity
u/mg)
purification
(fold)
1: crude extract 70 12 860 .2 8 19.82  . .0 23 1
2: 30-55% 19 41 680 .94 17.83 .028 1 .2
(nh4 ) 2s o 4
3: Mono Q 8 3 .8 30.4 1 .68 13.46 .443 19.3
4: Procion red 13 .08 1 .05 .10 1.29 1 .23 53.4
5 : Phenyl superose 1 .04 .04 .6 9 .69 17.18 747
Figure 3.19 Purification of shikimate dehydrogenase
Samples taken during the purification of shikimate 
dehydrogenase from typhimurium, E. carotovora. and A^ _ calcoaceticus 
were prepared (section 3.5.3.3) and run on 12.5% SDS PAGE as described 
in section 2.8.1.4.
Gels were stained either by Coomassie Blue (section 2.9.1.1) 
or by silver stain (section 2.9.1.2).
Gel A Purification from S. typhimurium (Coomassie blue stain)
Track N o . amounts
1 Mr standard proteins -
2 crude extract 25
■ 3 (NH4)2SC>4 fractionation 25
4 Mono Q 15
5 procion red 10
6 phenyl super'ose 7
7 M r standard proteins -
Gel B Purification from E. carotovora (silver stain)
Track No.
1 Mr standard proteins -
2 crude extract 10
3 (NH4)2SC>4 fractionation 10
4 Mono Q 7
5 procion red 5
6 phenyl superose 2
7 M r standard proteins -
Gel C Purification from A. calcoaceticus (silver stain) 
Track No.
1 Mr standard proteins —
2 crude extract 10
3 (NH4)2S04 fractionation 10
4 Mono Q 7
5 procion red 5
6 phenyl superose 2
7 superose 12 1
8 Mr standard proteins -
9 purified E. coli E3 2
■ 0
A.
94 K 
6 7 K  
4 3 K
30 K
20.1K
1 4 . 4 K
1 2 3 4 5 6 7
B.
9 4 K - -
6 7 K - -
4 3 K --
3 0 K - -
2 0 . 1 K - -
1 4 . 4 K - -
C.
9 4 K - -
6 7 K --
4 3 K - -
3 0 K - -
2 0 . 1 K - -
1 4 . 4 K --
1 2 3 4 5  6 7 8 9
information from the literature for sucrose density analysis of the 
salmonella enzyme, it is possible to identify provisionally the 
bands on the gel which corresponds to the E3 activity.
Organisms bands on 
SDS-PAGE
M r of 
E3
Source for 
assignment
S. typhimurium many 30,000 Berlyn & Giles, 1969
E. carotovora 1 30,000 Figure 3.19B
A. calcoaceticus 4 31,000 Figure 3.19C and 
section 4.2.5
Since the band on the gel associated with E3 activity could be 
assigned these preparations were used for blotting experiments.
3.5.3.4 Immunoblotting of partially purified shikimate dehydrogenases 
The partially purified shikimate dehydrogenases (phenyl 
superose fraction) from S. typhimurium, E. carotovora and A. 
calcoaceticus described in section 3.5.3.3 and a sample of partially 
purified enzyme from Streptomyces coelicolor (gift from P.J. White), 
which has also been reported to have a subunit M similar to that
of the E. coli enzyme (Berlyn & Giles, 1969) were run on SDS gels 
and immunoblotted with both anti-native-E3 and anti-denatured-E3 
from E. coli. The results (Fig. 3.20) show that both antisera can 
identify the enzyme from erwinia and that the antisera against the 
denatured enzyme binds strongly to the enzyme from acinetobacter. 
All other enzymes used show more than one faint bands on the gel. 
Thus, it could not be confirmed which one corresponded to shikimate 
dehydrogenase. These results indicate that the antisera can bind 
to the erwinia enzyme and may be able to bind to the streptomyces 
and salmonella enzymes.
r
Figure 3.20 Immunoblot of shikimate dehydrogenase .(E3.) acitvity
from bacteria with antisera raised against native 
and carboxymethylated E. coli shikimate 
dehydrogenase
Samples of E3 from S^ _ typhimurium, E. carotovora and
A. calcoaceticus, purified as described (section 3.5.3.3, Table 3.6)
and from S. coelicolor (gift from P. White) were applied to a 12.5%
SDS polyacrylamide slab gel along with a sample of purified E3 from E^
coli and M standards as markers, 
r
After electrophoresis (section 2.8.1.4) and blotting to 
nitrocellulose (section 2.17.1.2) antibodies raised against native E3 
(anti-E3) (159:11) and carboxymethylated E3 (anti-denatured-E3)
(387:2) were used to blot the shikimate dehydrogenase protein.
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3.6 Discuss ion
Antibodies are proteins with specific binding sites able to
recognise and bind small M compounds. With larger molecules the
r
antibodies recognise a defined structure, within the larger 
structure, which complements the antibody binding site. In this 
way an antibody can be used to identify a specific feature of a 
molecule and to recognise features which are common to two 
molecules. Antibodies can therefore identify proteins that are 
structurally related and which may have evolved from common ancestor 
molecules. The use of antibodies to look for common features in 
molecules has been used with lysozyme from different species (Arnon 
& Maron, 1971; Arnheim et al., 1971), to demonstrate homology 
between the bifunctional aspartokinase/homoser.ine dehydrogenase 
isoenzymes in E. coli (Zakin et al., 1978) and to identify blood 
proteins which share common features (Benjamin et al., 1984; Rodda 
et al., 1986; Pekkala-Flagan & Ruoslahti, 1982).
These studies have indicated that for protein molecules to 
cross react antigenically they need to possess considerable amino 
acid sequence homology .with an average value of 60% sequence 
homology being proposed as a minimum (Prager & Wilson, 1971a,b).
This level of amino acid sequence homology can be reduced.if the 
proteins are denatured before use as immunogens and denaturation by 
reduction and carboxymethylation can generate antisera able to cross 
react with proteins with only 40% amino acid sequence homology 
(Arnon & Maron, 1971; Arnheim et al., 1971; Pekkala-Flagan & 
Ruoslahti, 1982).
Antibodies, therefore, represent useful reagents for 
identifying molecules and antibodies, raised against one protein as 
an immunogen, can be used to detect fragments of that protein 
synthesised in mutants or related proteins synthesised in other 
systems. It was partly with these uses in mind, that antibodies
- 1 1 7 -
against the enzymes of the shikimate pathway were prepared. In the 
work described in this chapter antibodies against the enzymes of the 
shikimate pathway were investigated to determine the extent to which 
these antibodies would be useful reagents for investigations of the 
synthesis of aromatic compounds.
To maximise the ability of the antibody preparations to 
recognise features of proteins, antibodies were raised against those 
enzymes of the shikimate pathway in E. coli that could be prepared 
in sufficient quantity. Antisera was prepared against both the 
'native* and 'denatured' (by reduction and carboxymethylation) forms 
of the enzymes. In this way it was hoped that the ability of 
antibodies to recognise common features between protein would be 
maximised and that proteins with amino acid homology as low as 40% 
could be found. These antisera were shown to possess high titres 
against their immunogen, usually in both native and denatured form, 
and to be able to specifically identify their immunogen in crude 
extracts containing high levels of the immunogen. In addition 
antisera was raised against arom complex from N. crassa and was 
shown to contain, at high titre, antibodies able to recognise not 
only the complete complex but also fragments produced by limited 
proteolysis (Boocock, 1983).
The antibodies were used to investigate the degree to which 
common epitopes could be detected using a range of techniques. The 
limit to which these techniques are able to detect common epitopes
has not been determined but in theory a single common epitope should
\
be able to be detected by the protein A aureus precipitation 
technique and the blotting technique is able to identify a protein, 
which if assessed by the carboxymethyl group antibody, has only 
three antibody binding sites.
Two different systems were investigated using antibodies
- 1 1 8 -
with varying degrees of success.
a) Common groups among the shikimate pathway enzymes in
E. coli.
In this investigation all five enzymes were used and common 
epitopes were searched for using the antisera raised against both 
the native and denatured forms of the enzymes. No cross reactions 
were detected. It follows that these proteins have little 
structure in common and this is confirmed by the knowledge the
amino acid sequences. These enzymes show very little homology 
(Millar & Coggins, 1986; E. Borthwick, L.D. Graham & J.R. Coggins, . 
unpublished results; Anton & Coggins, 1988; Millar et al., 1986a; 
Duncan et al., 1984b). The proteins do not appear to share any
A
common ancestry and the antisera are specific'reagents only suitable 
for detection in E^ coli of the protein or fragements of the protein 
against which they were raised.
b) Common groups between proteins with the same function but
from different species.
Three different experiments were set up which fell into this 
category. In the firstt in which the ability of antisera raised 
against arom complex from crassa was used, it was found that this 
antisera was able to detect, using blotting, the partially purified . 
arom complex from yeast. Since only a single antisera raised 
against ’native' arom complex was used for this investigation there 
should be a greater than 60% amino acid sequence homology between 
these two proteins. In this system the antisera therefore would be
i
useful, not just to detect arom complex from N. crassa but also to
detect the corresponding protein from other species. In addition
the ability of the antisera to detect fragments of arom complex
generated by limited proteolysis shows that it would also be useful
in detecting fragments of the arom complex which could be produced 
in mutants.
In the second series of experiments common epitopes were 
searched for between arom complex from N^ crassa and the, coli 
enzymes which catalyse the same reactions. No cross reactions were 
found. Since many antisera were used in this study, the conclusion 
must be that the extent to which these proteins have common features 
is low and the amino acid sequence homology should be less than 
40%. This conclusion is consistent with what is known about the 
amino acid sequences of these proteins. The sequence of arom 
complex from yeast but not neurospora is known and it contains only 
30% homology with the E. coli enzymes (Fig. 1-.3 and Table 1.2). If 
the N. crassa enzyme is similar to the yeast enzyme, it is 
reasonable to assume that sequence homology between N. crassa arom 
and the E. coli enzymes would also be about 30% and so insufficient 
to show common antigenic determinants.
The third series of experiments was to examine the shikimate • 
dehydrogenase from many organisms. In this case cross reactions 
indicating the presence of common epitopes were found using both 
enzyme inhibition and immune blotting techniques but the results 
obtained were dependent on the bacteria from which the enzyme, was 
prepared. Common epitopes were only found among enzymes prepared 
from gram negative bacteria. All other extracts did not show any 
significant interaction. In enzyme inhibition assays a comparative 
sequence of E_;_ coli y  S^ _ typhimurium y  E^ _ carotovora y  A. 
calcoaceticus was suggested but in blotting assays, when enzyme
denatured by SDS is being detected, the acinetobacter enzyme gave a 
strong reaction. It was concluded that the shikimate dehydrogenases 
from gram negative bacteria contain epitopes in common.
S. typhimurium and E_;_ coli have a number of groups in common,
Erwinia E3 much less and these largely surface antigens because 
denatured protein does not give a strong signal. Acinetobacter has
- 1 2 0 -
many groups in common but these are based in the protein and are not 
exposed, for antibody binding, at the surface of the protein while 
it is active.
One interesting feature of the enzyme inhibition assays was 
that the enzyme from acinetobacter was not inhibited but could be 
precipitated, to 50% of the total activity by the addition of 
protein A S. aureus. This observation has been confirmed by 
studies described in Chapter 4. Since only 50% of the activity 
could be precipitated, only 50% of the enzyme molecules could bind 
antibody. There must therefore be at least two types of shikimate 
dehydrogenase present in extracts from acinetobacter. It was this 
observation and the postulate -of- two shikimate dehydrogenases exist 
in acinetobacter that is investigated in Chapter 4.
In general the results from these studies was disappointing. 
It had been hoped that the antisera, such as the anti-E. coli-E3 . 
preparations, would have been able to cross react much more 
extensively with this enzyme isolated from other species of 
bacteria. The results we obtained however show that the,ability to 
cross react with the same' enzyme from other species i$ very variable 
and generally gives a result which is at the limit of detection 
using the techniques used in this work. The antisera that have 
been prepared are essentially reagents specific for the proteins 
used as immunogens.
The only antiserum of more general applicability is the anti 
arom antiserum. This antiserum does cross react with the 
equivalent protein from other species and can be used to identify 
mutants which only express part of the whole complex. As such the 
antisera will be valuable for several types of experiments.
4. The purification and partial characterisation of shikimate
dehydrogenase from A. calcoaceticus NCIB 8250
4.1 Introduction to A. calcoaceticus
4.1.1 A. calcoaceticus
A. calcoaceticus NCIB 8250, which grows at an optimal 
o
temperature of 30 C (Fewson, 1967), is unable to metabolise
carbohydrates (Cook & Fewson, 1973) but can utilise a wide variety
of organic compounds, including many aromatics, as sole sources of
carbon and energy (Fewson, 1967).
All acinetobacters are aerobic, gram-negative, non-motile,
catalase positive and oxidase negative organisms, with DNA
compositions varying from approximately 38-47 mole % G + C
(Henriksen, 1976; Juni, 1978). Most strains have an optimum
.. o
growth temperature of 34-35 C (Breuil et al., 1975).
Acinetobacters have a ubiquitous distribution in nature as a 
result of their nutritional versatility and have been isolated from 
soil, sewage and many parts of the human body (Baumann, 1968;
Warskow &.Juni, 1972; Juni, 1972; Henriksen, 1973; Gaughan 
et al., 1979). Acinetobacters are also been found associated with 
oil pollution in aquatic environments and industrial effluents 
(Gutnick & Rosenberg, 1977; Bartha & Atlas, 1977) and are very 
important in biological phosphate removal from waste water (van
Groenestijn et al., 1989). In addition A. calcoaceticus is of
\
industrial importance since it can produce 'emulsans* which are 
extracellular polyanionic emulsifiers (Rubinovitz et al., 1982) and 
'biodispersans' which are extracellular, non-dialysable polymers of 
monosaccharides that are able to disperse limestone (calcite) 
powders in water (Rosenberg et al., 1988a,b).
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Recently, acinetobacters although not obligatory pathogens, 
have been implicated in various pathogenic conditions such as 
septicaemia, urinary tract infections (Glew et a l ., 1977;
Retailliau et al., 1979; Lowes et al., 1980; Hoffman et al.,
1982), endocarditis (Henriksen, 1973; Cohen et a l ., 1980; Rao
et al., 1980), meningitis (Ghoneim & Halaka, 1980; Berk & McCabe, 
1981; Kabayashi et al., 1983), pneumonia (Rudin et al., 1979;
Holton & Shorvon, 1982; Markham & Telfer-Brunton, 1983), 
respiratory tract disease (O'Connell & Hamilton, 1981; Vila et al., 
1989), skin and wound infections (Glew et al., 1977), peritonitis 
(Roxe & Santhanam, 1983; Larson, 1984), bacteremia (Biliau et al., 
1989) and corneal ulcer (Zabel et al., 1989).
Acinetobacters are relatively resistant to many antibiotics 
(French et al., 1980) and also contain transferable plasmids 
(Hinchliffe & Vivian, 1980; Devaud et a l ., 1982; Goldstein et al.,
1983). In addition they are relatively resistant to the ionising 
radiation (Kairiyama et al., 1979) which is used in food 
preservation and they can therefore be an economically important 
cause of food spoilage (Ito et al., 1976; Firstenberq-Eden et al., 
1980).
The wide nutritional versatility, frequency of occurrence 
and possible economic and clinical importance of acinetobacters has 
stimulated researchers in the development of Systems to study both 
their physiology and biochemistry. The recent developments of
systems of genetic transformation (Juni, 1978); Ahlguist et al.,
\
1980), conjugation (Towner, 1978) and transduction (Herman & Juni, 
1974) including genetic mapping (Towner, 1983) should help to 
complement the biochemical work.
4.1.2 Plausibility of two E3 isoenzymes in A. calcoaceticus
As described in section 1.3, A. calcoaceticus can use both
quinate and shikimate as sources of carbon and energy. It appears
to have two dehydroquinase isoenzymes: one inducible and involved in
quinate utilisation and the other constitutive and biosynthetic
(Ingledew et al., 1971; Berlyn & Giles, 1973). It was also known
that the biosynthetic shikimate dehydrogenase had no role in the
degradation of shikimate (Yaniv & Gilvarg, 1955). This.function is
performed by a dye-linked hydroaromatic dehydrogenase which can also
catalyse the oxidation of quinate (Tresguerres et al., 1970a,b,
1972). This suggested that both the degradative quinate
dehydrogenase and shikimate dehydrogenase activities might rely on a
single enzyme. However, recently evidence showed that quinate
+
dehydrogenase is a membrane bound NAD(P) -independent.enzyme and .
uses PQQ as a cofactor (van Kleef & Duine, 1988). This indicated
that quinate dehydrogenase differed from shikimate dehydrogenase
because shikimate dehydrogenase has been generally found to be a 
+
soluble NADP -dependent enzyme (Yaniv & Gilvarg, 1955) and raised 
the question of whether, there mj.ght be two isoenzymes of shikimate 
dehydrogenase in calcoaceticus, one involved in biosynthesis and 
the other involved in the catabolic utilisation of shikimic acid. 
Recently, isoenzymes of shikimate dehydrogenase have been found in. 
the cytosol of Triticum aestivum (Chinese spring wheat) (Benedettelli 
& Hart, 1988) and Zea mays (maize) (Wendel et al. 1988) by 
polyacrylamide and starch gel electrophoresis and by genetic linkage
i
analyses. It has been suggested that these isoenzymes unlike the 
chloroplastidic isoenzymes which are biosynthetic, may be involved in 
the quinate catabolic pathway (see section 1.3.1.3). The 
experiments described in Chapter 3 showed that A. calcoaceticus may 
contain two E3 isoenzymes since anti-E. coli E3 can bind only 50% of
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the total E3. To confirm the existence of isoenzymes and to try
and establish their metabolic role it was decided to purify
shikimate dehydrogenase from A. calcoaceticus. Of particular
interest was the question whether one of the isoenzymes was both a .
quinate and a shikimate dehydrogenase. In this connection it is
interesting to note that Mitsuhashi & Davis (1954) found, in
+
A. aerogenes, an NAD -dependent quinate dehydrogenase which was 
unable to oxidise shikimic acid.
4.2 Purification of E3 from A. calcoaceticus NCIB 8250
4.2.1 The need for an improved purification scheme .
The constitutive E3 from E. coli K12 wild type has already 
been purified to homogeneity and shown to be a monomeric protein of 
30,000 (Chaudhuri & Coggins, 1985). This purification had the 
major disadvantage that it involved many chromatographic steps and 
took over two weeks to complete and there were many opportunities to 
lose enzyme activity. Therefore a new and simplified purification . 
procedure has been developed. This procedure has three advantages:
a) It takes only about three days as the conditions for eluting 
the columns have been speeded up.
b) Procion red (Dyematrix Red A) chromatography is used in a 
single step instead of DEAE Sephacel chromatography followed 
by ADP-Sepharose chromatography. Procion red is a combined 
anionic exchanger and affinity column and has proved very
t
+
useful in the purification of NADP -linked enzymes
(Procion red binds NADP -linked enzyme more strongly than 
+
NAD -linked enzymes) (Scopes, 1987).
c) a single range of buffer solutions was used.
The yield from this simplified protocol was better than the yields 
found previously for the E. coli enzyme purification.
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4.2.2 Attempted induction of E3
It is much easier to purify an enzyme, if the amounts of the 
enzyme are very high in the cells. Tresguerres et al. (1970b) found 
that quinate and p-hydroxybenzoate are powerful inducers for 
increasing the quinate (shikimate) dehydrogenase activity in 
A. calcoaceticus strain 73; in comparison succinate is not a good 
inducer. However, they pointed out that the ability of the 
dehydrogenase to catalyse Jji vitro the oxidation of quinate and 
shikimate does not necessarily mean that this enzyme acts in vivo in 
the dissimilation of both compounds. To establish whether quinate 
and p-hydroxybenzoate were also inducers for A^ calcoaceticus NCIB 
8250 this organism was grown in the presence of quinate and of 
p-hydrozybenzoate. Cells were also grown in the presence of 
succinate as a control. When A. calcoaceticus NCIB 8250 was grown 
on the medium containing potential inducers, the E3 activity was 
found to be the same as'in the cells grown in the presence of 
succinate and in cells grown on nutrient broth (Table 4.1). This
suggested that the E3 in A. calcoaceticus NCIB 8250 is the 
constitutive enzyme which is found in all organisms. Presumably, 
selection for constitutivity may be due to shikimic acid being a 
normal metabolite, since it is an intermediate in the biosynthesis 
of aromatic compounds including the amino acids. Thus, shikimate 
can be available as source of carbon and energy all the time in the 
same way as intermediates of the glycolytic pathway. It should
also be noted that these cells grow very well on succinate and
'  \
nutrient broth but growth is slower on p-hydroxybenzoate and very 
slow on quinate. In addition, there is a transient accumulation of 
a polyphenol compound whose presence is detected by the typical blue 
colouring characteristic of the chelates of polyphenol and iron when 
cells were grown on quinate and p-hydroxybenzoate. These
- 126 -
Table 4.1 Effect of growth substrates on shikimate dehydrogenase 
activities in crude cell free extracts of A. 
calcoaceticus NCIB 8250
A. calcoaceticus was grown on nutrient broth (section 2.4.1) 
or on minimal medium I with different carbon sources (section 2.4.5) 
and harvested at late exponential phase. The harvested cells were 
used to prepare crude extracts (section 2.6.5.1) and assayed for E3 
activity (section 2.7.3) and protein (section 2.5.3). The specific 
activity of E3 in each of the crude extracts was calculated.
growth substrate specific activity (u/mg protein)
quinate 0.05
p-hydroxybenzoate 0.05
succinate 0.056
nutrient broth 0.048
- I z / -
observations were made under conditions which corresponded to 
Tresguerres et al.'s experiment (Tresguerres j3t a_l., 1972). All of 
the E3 from the cell free extracts of calcoaceticus grown on 
these carbon sources was still only 50% precipitated by treatment 
with protein A and anti-E. coli-E3.
4.2.3 Purification procedure
Unless otherwise stated all steps after the breaking of the 
o
cells were performed at 4 C.
Step 1 : Extraction and centrifugation
A. calcoaceticus NCIB 8250 was grown on complex medium as
described in section 2.4.4. A 20g batch of cells (which had been
o
stored as a frozen paste at -20 C) was suspended in 10ml of
50mM-Tris/HCl, pH 8.5, 0.4mM-DTT containing ImM-EDTA and 1.2mM-PMSF,
(extraction buffer) and broken by three passages through a French
pressure cell. DNasel (0.5mg) was added and after 1 h stirring the
resulting suspension was centrifuged at 100,000g for 2 h. The
supernatant was diluted with extraction buffer and this was the
crude extract from which the enzyme was purified.
Step 2 : Fractionation with (NH ) SO 
------------------------- 4 2— 4
The crude extract was made ImM in benzamidine.HCl and
adjusted to 40% saturation with solid (NH ) SO (242g/l).
4 2 4
After the mixture had been stirred for 30 min, the precipitate was 
removed by centrifugation at 28,000g for 30 min. The supernatant 
was adjusted to 60% saturation with solid (NH^)^SO^ (130g/l) 
and stirred for 30 min. The precipitated protein was collected by 
centrifugation at 28,000g for 30 min, redissolved in a small volume 
of 50mM-Tris/HCl, pH 8.5 containing 0.4mM-DTT (buffer A).
Step 3 : Ultrogel AcA 44 chromatography 
Concentrated enzyme from ammonium sulfate fractionation step was 
directly applied to a Ultrogel AcA 44 column (90cm x 2.1cm) that had
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been pre-equilibrated with buffer A (flow rate 20ml/h). . The enzyme
was eluted with the same buffer (flow rate 20ml/h,5ml fractions) 
(Fig. 4.1). Fractions containing E3 activity were pooled.
Step 4 : Procion red chromatography
The enzyme from the previous step was applied directly to a.
Procion red column (10cm x 2.1cm) that had been washed with 10
column volumes of 8M-urea in 0.5M-NaOH, followed by copious amounts
of water, then pre-equilibrated with buffer A.. The column was
washed with buffer A until the A was zero (flow rate 20ml/h).
280
The protein was eluted with an 80ml linear gradient of NaCl 
(0.1-1.0M-NaCl) in buffer A containing O.lmM-NADPH (flow rate 
20ml/h, 2ml fractions) (Fig. 4.2). The fractions containing enzyme 
activity were pooled and dialysed overnight against 2 1 of 
50mM-Tris/HCl, pH 7.5 containing 0.4mM-DTT (buffer B) and 
ImM-benzamine.HCl.
Step 5 : Chromatography on Mono Q
This step was carried out at room temperature with a
Pharmacia f.p.l.c. system. The dialysed material from the previous
step was loaded onto a Mono Q column (1ml bed volume). The enzyme
was eluted with a linear gradient of 0-0.5M-NaCl in buffer B (flow
rate lml/min, 0.5ml fractions in 30 min) (Fig. 4.3). The
fractions containing E3 activity were pooled and dialysed overnight
in buffer B containing 50% (v/v) glycerol before long-term storage. 
o
at -20 C.
i
4.2.4 Purity of the A. calcoaceticus E3
An SDS polyacrylamide gel showing the protein components at. 
each stage is shown in Figure 4.4. The purified enzyme showed a 
single band with the silver staining (Fig. 4.4, track 6) and the 
subunit molecular weight was found to be a little larger than that 
of the purified E. coli E3 (Fig. 4.4, track 8).
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Figure 4.1 Purification profile of A^ _ calcoaceticus NCIB 0250 on 
Ultrogel AcA44
(Step 3 of purification scheme detailed in section 4.2.3)
Concentrated enzyme from Step 2 was loaded onto a column 
(2.1 x 90cm) of Ultrogel AcA 44 pre-equilibrated with buffer A. The flow 
rate was 20ml/h and 5ml fractions were collected. Fractions containing 
E3 activity were pooled.
•  : A2qq ; O: E3 activity
r-3
2.8-1
2.0 - - 2
‘280
o o
o
-1
0.8-
!0 30 H0 50
Fraction number (5ml fractions)
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Figure 4.2 Purification profile of A. calcoaceticus NCIB 0250 on 
Procion Red
(Step 4 of purification scheme outlined in section 4.2.3)
The pooled active material from Step 3 was directly loaded onto a 
column of Procion red (2.1cm x 10cm) pre-equilibrated with buffer A. The 
column was washed with buffer A until the absorbance at 280nm was zero, 
then a linear gradient (total volume 80ml) of 0.1-l.OM-NaCl in buffer A 
containing O.lmM-NADPH was applied. The flow rate was 20ml/h and 2ml 
fractions were collected.
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Figure 4.3 Purification profile of A. calcoaceticus NCIB 8250 on Mono Q 
(Step 5 of purification scheme in section 4.2.3).
Enzyme from Step 4 was dialysed overnight against buffer B
containing ImM-benzamidine.HC1. The dialysed enzyme was applied to a
Mono Q column equilibrated with buffer B. The enzyme was eluted with a
linear gradient of 0-0.5 M-NaCl in buffer B. The flow rate was lml/min
and 0.5ml fractions were collected. The purified enzyme was dialysed
overnight against buffer B containing 50% (v/v) glycerol before long-term 
o
storage at -20 C.
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Figure 4.4 SDS PAGE showing the protein components at each step of the 
A. calcoaceticus shikimate dehydrogenase purification
The gel was a 12.5% gel and protein bands were visualised by 
silver staining (section 2.9.1.2).
Track No. amounts loaded ( ug)
1 Mr standardproteins 
crude extract
-
2 10
3 Ammonium sulphate fractionation 10
4 ultrogel AcA44 5
5 Procion red 3
6 Mono Q 1
7 Mr standard proteins -
8 purified E. coli E3 1
9 4 K
6 7 K
4 3 K
3 0 K  
2 0 . 1K 
1 4 . 4K
1 2 3 4 5 6 7 8
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4.2.5 Molecular weight determination
The native M of A. calcoaceticus E3 was determined by gel 
r
permeation chromatography. The subunit M was determined by SDS
r
PAGE.
4.2.5.1 Subunit M of the A. calcoaceticus E3
r :
The mobility of the purified A^ calcoaceticus E3 was
compared with mobilities of standard proteins of known M using
r
SDS PAGE (Fig. 4.5). Comparison with these markers gave a subunit
M 31,000. 
r
4.2.5.2 Native M of the A. calcoaceticus E3
r : ‘
The native M of the A. calcoaceticus E3 was determined by 
r
gel filtration on a Superose 12 column using a Pharmacia f.p.l.c.
apparatus. The column was calibrated with 5 purified E. coli
enzymes of known M and a.standard curve of peak elution volume 
r
against M was constructed (Fig. 4.6). The measured peak elution 
r
volume for A. calcoaceticus E3 correspond to a M of 31,000.r
4.3 Summary of the purification procedure
The purification of A. calcoaceticus E3 from a typical
purification procedure is summarised in Table 4.2. To minimise the .
risk of proteolysis during the purification procedure, either PMSF
or benzamidine.HCl was included in buffers (Lumsden & Coggins,
1977). After (NH ) SO fractionation the E3 activity was 
4 2 4
found in the 40-60% saturation fraction; the corresponding E. coli 
enzyme is found in the 30-55% saturation fraction. The enzyme was 
purified approximately 10,000 fold and in 32% overall yield by . 
ammonium sulphate fractionation,, gel filtration, chromatography on a . 
Procion red column and ion exchange chromatography in Mono Q. The
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Figure 4.5 Standard curve for 12.5% SDS PAGE
Migration distance of each protein marker from the top of the 
separating gel is plotted against log M .
The O indicates the average distance of migration of the 
A. calcoaceticus NCIB 8250 E3 subunit on the gels. This corresponds to 
an M of 31,000. The migration positions of the standard proteins are . 
shown as •  .
100—,
90-
80-
70-
50-
o
X 30-
Dlstance migrated (cm)
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Figure 4.6 Standard curve for gel filtration on Superose 12
The elution volumes of the five purified E. coli shikimate pathway 
enzymes is plotted against log M .
The O  indicates the elution volume of native E3 from
A. calcoaceticus NCIB 8250. This corresponds to an M of 31,000. ------------------  r
Further details are given in section 2.18.2 and 4.2.5.1.
50 -
i
o
x  30 -
20 -
Elution volume (ml)
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pure enzyme, like the corresponding E. coli enzyme (Chaudhuri &
Coggins, 1985), was monomeric and had a subunit M of 31,000.
r
4.4 Cross reaction with anti-E. coli E3
4.4.1 Immunoprecipitation assay with protein A
The purified A^ _ calcoaceticus E3 was subjected to a cross
reaction test with anti-E. coli-E3 as described for the crude enzyme
preparation in section 3.5.3.2. It was still found that protein A
precipitated only 50% of the enzyme activity as an immunocomplex and
left 50% of the enzyme activity in the supernatant. After
immunocomplex precipitation with protein A, an aliquot of the
supernatant was again tested for cross reaction with anti-E3. There
was no cross reacion (Table 4 . ^ .  Similar -results- had been -obta-kied- '
3*6 a<vcL 4, 3 (p y
-w-ith-crude extract of- E 3* (see secbi-em - 3.5-r-3;-2). This experiment
suggested that A. calcoaceticus contained two isoenzymes, only one of
which was precipitated by the anti-E. coli-E3 antibodies. One
isoenzyme cross-reacted and gave an immune complex precipitate with
protein A and the other did not. This suggests that one of the
isoenzymes is homologous to, or at least has common antigenic sites
with, the E. coli E3. Both of the postulated isoenzymes have the
same M since they are not resolved on SDS-PAGE. 
r
4.4.2 Antigen titration curve
To confirm the result obtained in section 4.4.1, an antigen
*
titration curve was done on the purified enzyme. If either antigen 
or antibody is in excess in antigen-antibody binding experiments, the 
immunocomplex may not form or may not form completely (see section 
3.1.5). To avoid artifacts of this kind various dilutions of 
antigen must be tried (Fig. 4.7). This antigen titration curve 
showed that the complex was not formed at either high or low
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Table 4.3 Cross reaction of purified A. calcoaceticus shikimate
dehydrogenase with anti-E. coli shikimate dehydrogenase 
was tested by immunoprecipitation assay with protein A
Purified A. calcoaceticus E3 or crude extract was treated with 
normal rabbit serum (NRS) and protein A or anti-E. coli E3 and protein 
A as described in section 2.15.2. After centrifugation aliquots of 
the supernatant were assayed for enzyme activity. the supernatant 
from experiment 2, which still contained 50% of the E3 activity was 
subjected to a second series precipitations (experiments 3 and 4).
(a)
enzyme treated activity
u/ml
% precipitated enzyme
1. E3 + NRS + protein A 0.38 0
2. E3 + anti-E3 + protein A 0.19 50
Aliquots taken from the supernatant of 2 and tested atain as above
3. E3+ + NRS + protein A 0.09 0
4. E3+ + anti-E3 + protein A 0.09 0
+ = activity of E3 remaining in supernatant from experiment 2
(b)
enzyme treated activity
u/ml
% precipitated enzyme
1. CE3 + NRS + protein A 0.43 0
2. CE3 + anti-E3 + protein A 0.21 50
Aliquots taken from the supernatant of 1 and 2 and tested again
3. CE3 + NRS + protein A 0.16 0
4.. CE3 + anti-E3 + protein A 0.07 56
CE3 = crude extract containing E3
/r
ai
n.
- 139 -
Figure 4.7 Antigen titration curve of purified A. calcoaceticus
shikimate dehydrogenase
The purified enzyme was serially diluted with 50mM-Tris/HClr pH
7.5 then 20ul samples were treated with an equal volume of anti-E. coli-E3 
and protein A as described in section 2.15.2. The E3 activity was 
assayed in supernatant after centrifugation.
O: E3 + NRS + protein A 
#: E3 + anti-E3 + protein A
O
cr
<C
0 .2 -
1 4 16 64 256 1024
Antigen dilution (reciprocal)
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concentration of antigen; it did form at suitable intermediate 
concentrations of antigen and antibody. However there were no 
conditions under which A. calcoaceticus E3 was wholly precipitated 
as an immunocomplex with anti-E. coli-E3 and protein A. It was 
found that at most only 50% of the A ^  calcoaceticus E3 was 
precipitated and 50% removed in the supernatant which was entirely 
consistent with the experiments described in sections 3.5.3.2 and 
4.4.1. Nevertheless, when enzyme was in high dilution the 
difficulty of assay might have led to a false interpretation.
4.4.3 Non-denaturing polyacrylamide gel electrophoresis and
immunoblotting
To try and provide further evidence for the existence of two 
isoenzymes of A^ _ calcoaceticus E3 samples were electrophoresed on 
non-denaturing (native) gels and stained for activity. The A. 
calcoaceticus E3 gave two major bands and four minor bands while E.
coli E3 showed only one band. One major band of A_;_ calcoaceticus 
E3 had the same mobility as the E. coli E3 whereas the second major 
band had a lower mobility (Fig. 4.8). When these bands were 
immunoblotted with anti-E3 and anti-denatured-E3, only the upper 
band and minor band gave a cross reaction with anti-E3. Neither 
band cross-reacted with anti-denatured-E3 (Fig. 4.8). These 
experiments provided further evidence for the occurrence of two 
isoenzymes. The only obvious explanation for the multiple bands is 
proteolytic cleavage. While this is a reasonable explanation for 
the two faint, high mobility bands, it is a less likely explanation 
for the two strong bands.
4.4.4 Quinate dehydrogenase activity in purified E3
Tresguerres et al., (1970b) reported that the quinate
dehydrogenase of A _^ calcoaceticus also possessed shikimate 
dehydrogenase activity as is found for the inducible quinate 
dehydrogenase of N. crassa (Giles et a l ., 1967b) (see section 
1.3.2.2). It thus appeared that A. calcoaceticus had both a 
quinate (shikimate) dehydrogenase and a second enzyme which is 
simply a shikimate dehydrogenase. To investigate whether the
Figure 4.8 Non-denaturing gel electrophoresis of purified 
A. calcoaceticus shikimate dehydrogenase
A 10% polyacrylamide slab gel of purified E3 from both _E. coli 
and A. calcoaceticus is shown. The gel was electrophoresed and 
immunoblotted with anti-_E. coli-E3 and anti-E. coli-denatured-E3 as 
described in section 2.17.2.2. Bands of E3 were visualised by activity 
staining (left hand gel) (section 2.9.2) or by immunoblotting (centre and 
right hand gel). Only one of the two activity bands cross reacts with 
anti-E. coli-E3.
Track No.
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purified A. calcoaceticus E3 had quinate dehydrogenase activity
+ +
assays were carried out at pH 6, 7.5 and 10.6 using NAD , NADP
and DCPIP as electron acceptors. Purified E. coli E3 was also
assayed in the same way and the results are presented in Table 4.4.
It was found that the A^ calcoaceticus E3 did not have any
detectable quinate dehydrogenase activity. This result is
consistent with earlier work that showed that the quinate
dehydrogenase of aerogenes had no shikimate dehydrogenase
activity (Mitsuhashi & Davis, 1954). The data in Table 4.4 also
shows that DCPIP was a good electron acceptor with an optimum at
pH 7.5 which differs from the findings of Tresguerres et a l . (1970a)
who observed optimal activity at pH 6.0. At this pH A.
calcoaceticus E3 gave a specific activity with this dye-rlinked assay
6-fold higher than that for E. coli E3 in the presence of 6pM PMS..
It was also found that if the concentration of PMS was increased to
60pM, the specific activity of E3 both in A^_ calcoaceticus and E.
coli increased approximately five times (from Table 4.4) but there
was still no detectable quinate dehydrogenase activity. Both
+
isoenzymes were able to-use NADP .as a cofactor at all p H ps while 
+
NAD was only used by both enzymes at pH 10.6. The specific
+ + 
activity with NADP is five times higher than NAD for the A^ _
calcoaceticus enzyme and around ten times higher for the E. coli
enzyme at pH 10.6. In summary the shikimate dehydrogenases of A.
calcoaceticus and E. coli have, like the corresponding A. aerogenes
enzyme, no quinate dehydrogenase activity and are therefore distinct
from the inducible quinate (shikimate) dehydrogenase of N. crassa
and k*_ nidulans. Some very low levels of quinate dehydrogenase
activity were detected in crude extracts of A^ calcoaceticus by
using DCPIP as an electron acceptor. Activity was found both in
cells grown on minimal medium containing inducers and in cells grown 
only on nutrient broth.
“ 1 4 J -
Table 4.4 Comparison of shikimate/quinate dehydrogenase specific 
activities (u/mg protein) between A. calcoaceticus and 
E. coli with various electron acceptors
The electron acceptors used in this experiment were DCPIP, 
NAD+ , NADP+ and DCPIP in the presence of 6jiM electron carrier 
PMS. Quinate dehydrogenase was assayed as described in section 
2.7.6. Exactly the same procedure was used for estimating the 
shikimate dehydrogenase activity but shikimic acid was used instead of 
quinic acid. The assays were performed at pH 6.0, 7.5 and 10.6 using 
lOOmM phosphate buffer at pH 6.0, lOOmM Tris/HCl buffer at pH 7.5, and 
lOOmM sodium carbonate buffer at pH 10.6.
A. calcoaceticus E. coli
Quinate
dehydrogenase
Shikimate
dehydrogenase
Shikimate
dehydrogenase
pH 6.0 
DCPIP nd nd. nd
NAD+ nd nd nd
NADP+ nd 23.7 27.64
DCPIP + PMS nd 2.2 0.67
pH 7.5 
DCPIP nd nd nd
NAD+ nd nd 2.02
NADP+ nd 129.4 120.68
DCPIP + PMS nd 12.94 2.16
pH 10.6 
DCPIP nd nd nd
i
NAD+ nd 110.0 63.4
NADP+ nd 504.8 660.7
DCPIP + PMS nd nd nd
nd = no activity detected
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Although no detailed studies were carried out it seems likely that 
the quinate dehydrogenase of A^ calcoaceticus is a membrane-bound 
enzyme as proposed by Tresguetres jit al_. (1970a,b) and by van Kleef & 
Duine (1988) and will require emulsifiers, such as triton X-100, to 
extract it from the membrane.
4.5 Summary of the cross reaction experiments
The experiments described in section 4.4, which confirm the 
preliminary experiments reported in section 3.5.3.2, provide strong 
evidence that A. calcoaceticus has two isoenzymes with shikimate 
dehydrogenase activity. Neither of these isoenzymes has quinate
dehydrogenase activity. In vivo it is possible that these
isoenzymes may have different functions: one may be a biosynthetic
enzyme and the other may be a catabolic enzyme involved, for example, 
in quinate utilisation. To try and further characterise these 
isoenzymes an attempt was made to separate them by immunoaffinity 
chromatography as described in the next section.
4.6 Separation of i-soenzymes by immuno-affinity chromatography
4.6.1 General introduction
Cyanogen bromide activated Sepharose is a convenient solid
support which has been widely used for the preparation of antibody
affinity columns. Cyanogen bromide reacts with the free hydroxyl
groups of Sepharose or agarose at high pH to give imidocarbonates
(activated products) which c a n .then be reacted with any compound such
as a protein, that contains primary amino groups.. The final
products are isoureas which carry a partial positive charge at
neutral pH (Fig. 4.9) (Porath et al., 1967; Boegman & Crumpton,
1970; Cuatrecasas, 1970; Porath, 1974); the activated 
intermediates are probably imidocarbonates but this is still
- 14'5 -
Figure 4.9 Probable mechanism of CNIir coupling of protein to Sepharose 
(adapted from Johnstone & Thorpe, 1987)
Agarose bead latdocarbonate Isourea
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uncertain (Johnstone & Thorpe, 1987). In the present study, the 
starting material used was commercially available CNBr-activated 
Sepharose 4b . The availability of this product made it unnecessary 
to handle free cyanogen bromide, an unpleasant and hazardous reagent 
(Plummer, 1987).
Cyanogen bromide activated Sepharose 4B is an ideal material 
for the preparation of immunoaffinity columns for the following 
reasons (Johnstone & Thorpe, 1987):
(a) It is suitable for column chromatography as it has a loose 
porous network and gives good flow rates.
(b) Non-specific absorption is minimal.
(c) It has a high capacity and the chemical linkages when formed 
are stable so that the ligand is rendered permanently 
insoluble and the columns can be reused.
Very high concentrations of ligand molecules per unit 
insoluble support can be* obtained with Sepharose 4B. However it is 
important to avoid too high substitution since this may increase 
non-specific binding and steric hindrance of the ligand and make 
subsequent elution difficult. When coupling the ligand, in this 
case the antibody, it is also important to maintain it in its native 
conformation.
4.6.2 Purification of rabbit IgG
Before coupling to CNBr-activated Sepharose 4B the anti-E3 
antibody was purified by chromatography on a DEAE Affi-Gel Blue
i
column. The column was prepared and treated as recommended in the 
manufacturers instruction booklet. Crude rabbit serum (4ml) was 
dialysed against 1 1 of 0.02 M-Tris/HCl, pH 8.0, 0.028M-NaCl, 0.02% 
NaN^ (buffer A). The dialysed serum was applied to a column (15cm 
x 2.1cm) of DEAE Affi-Gel Blue which had been pre-equilibrated
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with three bed volumes of buffer A. The column was eluted with 
three bed volumes of buffer A (flow rate 60ml/h, 2ml fractions).
Fractions were collected and the A recorded (Fig. 4.10). For
280
further use, the column was regenerated with two bed volumes of 
2M-Guanidine.HCl in buffer A, followed by three bed volumes of 
buffer A. The fractions containing IgG were pooled and then 
lyophilised to dryness. The resulting solid was dissolved by 
adding small aliquots of buffer A to give finally the same total 
volume as the original crude antiserum. This solution was then 
dialysed overnight against 2 1 of coupling buffer (0.1M— NaHCO^, pH
8.3 containing 0.5M-NaCl). The purified antibody was checked for
purity by SDS PAGE (Fig. 4.11); track 2 showed the IgG heavy chain
and light chain of M 50,000 and 27,000 respectively. The
r
o
purified antibody solution in coupling buffer was stored at -20 C 
until required.
When using new samples of DEAE Affi-Gel Blue, which had not 
been previously used for serum chromatography, the following 
pre-wash procedure was always used. The gel is transferred to a 
funnel and washed with at least .five bed volumes of O.lOM-acetic 
acid, pH 3.0 containing 1.4M-NaCl and 40% (v/v) isopropanol. This 
wash elutes from new preparations of gel any residual dye which 
might otherwise be eluted in serum protein fractions.. . The gel is 
then washed with at least ten bed volumes of buffer A to reduce the 
ionic strength to that required for the serum chromatography.
4.6.3 Checking the properties of purified anti-E3
4.6.3.1 Enzyme inhibition assay and immunoprecipitation assay with 
protein A
Before coupling the purified anti-E3 to CNBr-activated 
Sepharose 4B, it was tested for its ability to bind and inhibit both
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Figure 4.10 Purification of anti-E. coli-E3 on a DEAE Affi-Gel Blue column
The dialysed crude antiserum was applied to a DEAE Affi-Gel Blue 
column (2.1cm x 15cm) equilibrated with buffer A. The column was eluted
with three bed volumes of buffer A as in the text. The flow rate was
60ml/h, 2ml fractions were collected and the absorbance at 280nm was 
recorded. The arrows indicate the pooled fractions.
AjM.
Fraction number (2 ml fractions)
1 4 y  -
Figure 4.11 Puri ty  of anti-E. coli— E 3 purif ie d  on DEAE Affi-Gel Blue
This 10% SDS PAGE was stained with Coomassie Blue as described in 
section 2.9.1.1.
Track No.
1 : crude antiserum
2 : purified IgG
3 : M standard proteins
r
amounts loaded (jig) 
30 
15
20.1 K
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native E. coli E3 and native A. calcoaceticus E3. It was found 
that purified IgG had the same activity as the crude antiserum i.e. 
it totally inhibited and precipitated E. coli E3 but only inhibited 
and precipitated, as an immunocomplex with protein A, 50% of the E3 
activity of purified A. calcoaceticus E3.
To compare the efficiency of binding, antibody titration 
curves were measured against E^ coli E3 for both the crude antiserum 
and the purified IgG fraction (Fig. 4.12). Under these conditions 
the purified IgG totally inhibited JE^ coli E3 activity at a dilution 
1:8 while crude antiserum totally inhibited E. coli E3 at a dilution 
1:16. Some IgG must have been lost during the purification since 
the efficiency of binding is less than for the crude antiserum.
4.6.3.2 ELISA
To further compare the efficiency of binding of the crude 
antiserum and the purifiecf IgG fraction to native E. coli E3 an 
ELISA experiment was carried out. The titres above background of 
normal rabbit serum (0.5 O.D.) for the crude antiserum and purified 
IgG were 1:112,000 and .1:56,000 respectively (Fig. 4.13).
4.6.3.3 Immunoblots
The efficiency of binding to SDS-denatured E. coli enzyme 
was measured by immunoblotting both for the crude antiserum and the 
purified IgG (see Fig. 4.14). The efficiency of binding of the 
purified IgG is less than that found for crude antiserum; this can
i
be seen by comparing the tracks corresponding to the low 
concentrations of antigen (Fig. 4.14).
4.6.4 Coupling purified IgG to CNBr-activated Sepharose 4B
The immunoaffinity column was prepared by coupling purified 
anti-E3 (approximately 15mg of IgG) to 3.5ml of CNBr-activated
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Figure 4.12 Test of the efficiency of purified anti-E. coli-E3 in enzyme 
inhibition assay
Data are shown for crude antiserum (A) and purified IgG (□).
The crude extract from the E. coli overproducing strain was serially 
diluted and then equal amounts of anti-E. coli-E3 was added and after 
incubation for 1 h enzyme activity was assayed (section 2.13).
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Figure 4.13 Test of the efficiency of binding of the purified anti-E.
coli-E3 to native JS._ coli E3 by ELISA
Data are shown for control normal rabbit aritiserum (O), crude
anti-E. coli E3 ( □ )  and the purified IgG (A) .  lOOng of purified E.
coli E3 was coated onto the microElisa plate and left overnight at 
4°C. lOOjil aliquots of serial dilutions of antiserum or purified IgG 
were added. After incubation the peroxidase-conjugated antibody was 
added. The reaction was terminated after adding substrate solution by
addition of 6N-H SO . The colour was monitored at 492nm as described 
2 4
in detail in section 2.16.2.
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Figure 4.14 Test of the efficiency of binding of the purified anti-E. 
coli E3 to denatured E3 by immunoblotting
Various concentrations of purified enzyme and crude extract were 
investigated. The crude extract and purified enzyme from the E. coli 
overproducing strain was serially diluted, then electrophoresed on 10% SDS 
PAGE and immunoblotted with crude antiserum and purified IgG as described 
in section 2.17.1.2.
Track No.
crude extract 
crude extract 
crude extract 
purified E3 
purified E3 
purified E3 
Mr standard proteins
amounts loaded (ng) 
1,000 
100 
10 
50 
5
0.5
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Sepharose 4B. The coupling condition employed were those 
recommended by the manufacturers. lg of the freeze dried (about 
3.5ml swollen gel) CNBr-activated Sepharose 4B was suspended in 10ml 
ImM-HCl (pH 2-3). The gel swelled immediately and was then washed 
for 15-20 min with ImM-HCl (200ml) on a Wintered glass filter 
(G3). The washing of the gel at low pH preserves the ligand 
binding of the Sepharose better than washing at pH 7.4. The 
CNBr-activated Sepharose 4B contains dextran and lactose to preserve 
its activity during freeze drying and these are removed by the 
washing procedure. Activated Sepharose was then washed with 
coupling buffer (500 ml) to raise the pH. The washed gel was 
collected by filtration on the sintered glass funnel and transferred 
to a 20ml universal tube containing purified antibody (15mg) in 
coupling buffer (12ml). The bottle was closed tightly and mixed
continually by end-over-end rotation on a mechanical rotator for 2 h
* • o
at room temperature and then overnight (16 h) at 4 C. Coupling
appeared to be complete since all the A2go absorbing material
(IgG) had bound to the gel. The gel was washed with 100ml
coupling buffer and any remaining, reactive groups were blocked by
treatment with 12ml O.IM-Tris/HCl, pH 8.0 for 2 h at room
temperature with continual mixing on the rotator. The resulting
gel was washed with three cycles of solutions of alternating pH.
Each cycle consisted of 100ml O.IM-acetate buffer, pH 4 containing
0.5M-NaCl followed by 100ml O.IM-Tris/HCl, pH 8 containing 0.5M—
NaCl. The final product was packed into a column and stored in
4
o
phosphate buffer saline containing 0.05% NaN^ at 4 C.
4.6.5 Enzyme purification by immunoaffinity chromatography
The general procedure used for immunoaffinity chromatography
o
is outlined below. All steps should be carried out at 4 C.
Step 1: Column equilibration
The column with immobilised antibody is first washed with 
10ml 50mM-Tris/HCl, pH7.5 followed by 5ml 0.5M-ammonium hydroxide 
containing 3M-potassium thiocyanate (chaotropic salt) and then with 
20ml 50mM-Tris/HCl, pH 7.5. The flow rate should be 5ml/h.
Step 2: Sample loading
The enzyme (antigen) sample is then applied to the 
pre-equilibrated immunoaffinity column and the column washed with 
50mM-Tris/HCl, pH 7.5 until no activity of the enzyme and no 
absorbance at 280nm can be detected in the effluent (flow rate 
lml/h, 1ml fractions).
Step 3: Elution
The column i s ‘then eluted with 5ml 0.5-M ammonium hydroxide 
containing 3M-potassium thiocyanate, followed by 10ml 50mM-Tris/HCl, 
pH 7.5 (flow rate 5ml/h, 1ml fractions). Fractions containing 
enzyme activity and/or protein are pooled as required.
4.6.5.1 Purification of E. coli E3 by immunoaffinity chromatography
Partially purified E. coli E3 (approximately 10 units) was 
loaded onto the immunoaffinity column and after washing the column 
was eluted with thiocyanate solution as described above. All of 
the E3 activity bound to the column and was subsequently eluted with 
the thiocyanate solution. The overall yield was 80% (Fig. 4.15).
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Figure 4.15 Purification of E. coli E3 by immunoaffinity chromatography
Approximately 10 units of E. coli E3 were loaded onto the column; 
the flow rate was lml/h and 1ml fractions were collected. The column was 
washed with 50mM-Tris/HCl, pH 7.5 applied at the first arrow. The bound 
E3 was eluted with 0.5M ammonium hydroxide containing 3M-potassium 
thiocyanate applied at the second arrow. The flow rate was 5ml/h and 
lml/fractions were collected as described in section 4.6.5. E3 activity 
was monitored in all fractions.
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4.6.5.2 Separation of A. calcoaceticus isoenzymes by immunoaffinity 
column
Purified A. calcoaceticus E3 (approximately 10 units) was 
loaded onto the immunoaffinity column as in section 4.6.5.1. Only 
0.2 units bound to the column (Fig. 4.16) which indicated that the 
binding capacity of the anti-E. coli-E3 column for the 
A. calcoaceticus E3 was very low when compared with its capacity to 
bind the coli enzyme. The bound enzyme was then eluted with 
thiocyanate.
4.7 The antigenic properties of the immunoaffinity purified enzymes
4.7.1 Enzyme inhibition assay and immunoprecipitation assay with
protein A
After elution with thiocyanate the bound material from the 
immunoaffinity column was ‘dialysed overnight against 2 1 of 
50mM-Tris/HCl, pH 7.5 and was then tested in the enzyme inhibition 
assay and in the immunoprecipitation assay with protein A. The 
immunoaffinity purified,,E. coli E3 was totally inhibited and 
precipitated whilst the immunoaffinity purified A. calcoaceticus E3 
was only 80% precipitated; 20% of the enzyme activity remained in 
the supernatant. In comparison a control sample of A^ _ calcoaceticus 
E3 which had not been immunoaffinity purified, was only 49% 
precipitated by protein A with 51% of the activity remaining in the 
supernatant (Table 4.5).
4
These immunoaffinity chromatography results were 
disappointing. The column appears to bind selectively the A. 
calcoaceticus isoenzyme which is precipitated by the anti-E. coli-E3 
but the binding capacity was too low for this to be practically 
useful.
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Figure 4.16 Attempted separation of the isoenzymes of A. calcoaceticus E3 
by immunoaffinity chromatography
Approximately 10 units of A_;_ calcoaceticus E3 were loaded onto the 
column with flow rate lml/h and 1ml fractions were collected. The column 
was washed with 50mM-Tris/HCl, pH 7.5 applied at the first arrow. The 
bound material was eluted with potassium thiocyanate in alkaline solution 
applied to the second arrow. The flow rate was 5ml/h and 1ml fractions 
were collected as described in section 4.6.5. The E3 activity was 
monitored in all fractions.
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Table 4.5 Antigenic properties of enzyme which either failed to 
bind or bound to the immunoaffinity column
The immunoaffinity column was prepared by reacting purified 
anti-E. coli-E3 with cyanogen bromide activated Sepharose as 
described in the text. The material which failed to bind to the 
column and the material which bound and was subsequently eluted with 
potassium thiocyanate was tested by immunoprecipitation with anti-E. 
coli-E3 and protein A.
Enzyme samples % precipitated % enzyme
and reagents enzyme in solution
1. bound E3 (E. coli) + 100 -
anti-E3 + protein A
2. bound E3 (A. calcoaceticus) +
anti-E3 + protein A 80 20
3. unbound E3 (A. calcoaceticus) f
anti-E3 + protein A 49 51
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4.7.2 Immunoblots
Although the yield from the immunoaffinity chromatography of
the A^ _ calcoaceticus enzyme was very low, the purified material was
%
l
still tested by immunoblotting to confirm the Riding assay 
results. Both the immunoaffinity purified enzyme and enzyme that 
failed to bind to the immunoaffinity column gave positive results 
both with crude antiserum and with purified IgG (Fig. 4.17A,B).
This confirmed the immunoprecipitation results which indicated that 
the immunoaffinity purified A_^  calcoaceticus E3 was still a mixture 
of the two isoenzymes.
4.8 Separation of isoenzymes by isoelectric focusing
4.8.1 General introduction
Isoelectric focusing is one of the most powerful techniques 
for the resolution of protein mixtures. The components are 
separated according to their isoelectric point (pi) which is the pH 
at which they possess no net electric charge.
In isoelectric focusing electrophoresis, a pH gradient is 
formed in a gel between cathode and anode, and proteins migrate (due 
to the attraction of their charged groups for anode and cathode) 
until they reach their pi. As the protein is not charged in this 
position it remains stationary. Isoelectric focusing is therefore 
a steady state process and components should theoretically never run
off the end of a gel containing the correct pH gradient.
1
A pH gradient will form automatically if a potential
+ + 
difference is applied to an H containing ionizable solvent (H
ions will be displaced towards the cathode). However, such 
gradients are unstable and so gradient stabilizing molecules are 
added. These are normally purpose-made amphoteric compounds known
Figure 4.17 Immunoblots of shikimate dehydrogenase samples after 
immunoaffinity chromatography.
M standard proteins 
r
12.5% SDS PAGE immunoblotted with crude antiserum (159:11) 
Track No.
1
2 : purified JE^ _ coli shikimate dehydrogenase
3 : purified A_;_ calcoaceticus shikimate dehydrogenase
4 : purified shikimate dehydrogenase from A^ _ calcoaceticus
which failed to bind to immunoaffinity column
5 : immunoaffinity purified A^ calcoaceticus
shikimate dehydrogenase
Immunoblot of 12.5% SDS PAGE with crude antiserum (left panel) a m  
purified IgG (right panel) (159:11)
Track No.
1 : E. coli E3 after elution from the column
2 : A^ _ calcoaceticus E3 after elution from the column
3 : jE^ _ coli E3 before passage through the column
4 : calcoaceticus E3 before passage through the column
5 : M standard proteins
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as 'carrier ampholytes'. These zwitterions have sharply defined . 
pi's and the mixture is chosen to have pi values.evenly distributed 
over the desired pH range. Such mixtures are commercially 
available.
Polyacrylamide gel is an ideal anticonvection medium for 
isoelectric focusing because it is robust, permeable to most 
proteins, easy to prepare and shows very little electroendosmosis. 
This latter property is very important in isoelectric focusing as 
electroendosmosis will cause the whole pH gradient to move toward, 
the cathode and thus disrupt the steady state process (Johnstone & 
Thorpe, 1987).
Recently Pharmacia have introduced a chromatographic version 
of isoelectric focusing. In this f.p.l.c. technique Mono P 
chromatofocusing chromatography is carried out on a Mono P column.
A pH gradient is formed using polybuffer which is a commercially 
available mixture of ampholytes.
4.8.2 Separation of A. calcoaceticus isoenzymes by isoelectric
focusing electrophoresis
Partial purified A. calcoaceticus E3 was loaded onto a Phast 
Gel (Pharmacia) isoelectric focusing gel designed to operate in the 
pH range 3 to 9. The gel was run on a PhastSystem apparatus under 
the conditions recommended by the manufacturers (Pharmacia). . The 
gels were stained for activity and for protein using the sensitive 
silver stain. The isoenzymes were not resolved and so they must 
have the same pi of 5.5 (estimated by comparing with the pi 
calibration Kit proteins) (Fig.' 4.18). This confirms that the 
isoenzymes are acidic proteins, a property in accordance with their 
chromatographic behaviour. This experiment provides further 
evidence that the two isoenzymes are very similar. Again activity 
staining showed three minor bands which could arise from proteolysis.
Figure 4.18 Isoelectric focusing of A. calcoaceticus E3
The partially purified A^ calcoaceticus E3 was loaded onto a 
PhastGel isoelectric focusing gel (pH range 3 to 9) as described in 
section 4.8.2. (A) silver stained gel (section 2.9.1.2) : track 1,-3/E
7, pi calibration kit proteins; track 2, 4, 6, 8, partially purified E3. 
(B) activity stained gel (section 2.9.2). : track 2, 3, 4, partially 
purified E3. The band which has enzyme activity has a pi of 5.2.
(A) silver stain
(B) activity stain
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4.9 Discuss ion
4.9.1 Purification of A. calcoaceticus E3
Three fast chromatographic steps were required to produce
homogeneous calcoaceticus shikimate dehydrogenase in comparison
with the four slow steps in the purification procedure developed for
the E. coli enzyme (Chaudhuri & Coggins, 1985). At the ammonium
sulphate fractionation step the A. calcoaceticus shikimate
dehydrogenase activity was found in the 40-60% saturation fraction
while the E. coli E3 was found in the 30-55% fraction. The first
chromatographic step was ultrogel AcA44 which could be run overnight
after the first day. This step eliminated a lot of unwanted
proteins. The pooled active fractions could then be passed
directly onto the Procion red column on the second d a y . . Procion
+
red is very useful for purifying NAD(P) -binding proteins since it
acts as both an anion exchange and an affinity column (Scopes, .
1987). The E3 activity was eluted at a salt.concentration of 416mM
in the presence of 0.ImM-NADPH. The material from this step had
only five protein components when analysed by SDS PAGE (Fig. 4.4,
track 5). The pooled active fractions from this step were then
dialysed overnight in Tris buffer and the final purification step
was chromatography on a high performance, strong anion exchange
column (Mono Q). E3 was eluted free from other contaminating
polypeptides at a salt concentration of 225mM and showed a single
band of protein of M 31,000 on SDS PAGE (Fig. 4.4, track 6)..
r
Purified A. calcoaceticus E3 was stable for many months when stored
in 50mM-Tris/HCl buffer, pH 7.5 in the presence of 50% glycerol at 
o
-20 C.
The native molecular weight value obtained from f.p.l.c. gel 
filtration indicated that A^ calcoaceticus E3 is a monomeric protein 
like the E. coli enzyme (Chaudhuri & Coggins, 1985).
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4.9.2 Cross reaction with anti-E. coli~E3
Immunoprecipitation experiments on the purified 
A. calcoaceticus E3 were in agreement with those on crude 
preparations; only 50% of the enzyme activity was precipitated by 
anti-E. coli-E3 and protein A. This suggested that the two 
putative isoenzymes had the same molecular weight but somehow 
differed in the exposed amino acid sequences on the surface of the 
molecule. These differences affect the ability of the enzyme to 
interact with antibody; one isoenzyme must have epitopes in common 
with the JE^ coli enzyme and the other must lack the epitope, 
recognised by the anti-E. coli-E3 antibodies. To confirm the 
existence of isoenzymes antigen and antibody titration curves were 
determined and enzyme inhibition assays carried out. These 
experiments all provided evidence for the existence of. two 
isoenzymes. The strongest evidence for two isoenzymes came from 
the native gel electrophoresis; both activity staining and 
immunoblotting confirmed the existence of two enzyme species one of 
which bound to the anti-E. coli-E3 while the other did not. 
Unfortunately isoelectric focussing failed to.separate the two 
isoenzymes and although immunoaffinity chromatography resulted in 
some enrichment of the species which could be immunoprecipitated the 
yields were too low to be practically useful.
4.9.3 Specificity and role of the purified A. calcoaceticus E3 
The question whether quinate dehydrogenase and shikimate
i
dehydrogenase activities were associated with the same protein in
A. calcoaceticus has also been resolved by this study. The
purified A_^_ calcoaceticus shikimate dehydrogenase had no detectable
+ +
quinate dehydrogenase activity when NAD , NADP or DCPIP were 
used as electron acceptors at various pH's. The enzymic properties
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of the purified _?u_ calcoaceticus enzyme with regard to preference
for phosphorylated pyridine nucleotide and pH optimum were very
similar but not identical to those of the well characterised E_^_ coli
biosynthetic enzyme. The A_^ _ calcoaceticus enzyme has a specific 
+
activity with NAD , at pH 10.6, which is 22% of the specific
+
activity obtained with NADP while the coli enzyme has a
+
specific activity with NAD of only 10% of that found with
+ +
NADP . Although the specific activities with NADP at pH 7.5
for both the A. calcoaceticus enzyme and the E. coli enzyme are very 
similar the A. calcoaceticus enzyme shows a specific activity 6-fold 
higher than the E. coli enzyme- when DCPIP and PMS are used as 
electron acceptors. This relatively high level of dye-linked 
shikimate dehydrogenase activity found with the A. calcoaceticus 
enzyme distinguishes it from the E. coli enzyme.
Since it was impossible to separate completely the two
postulated A. calcoacetius isoenzymes it was not possible to
establish whether they differed in their specific activities.or
substrate binding properties. .
The very low levels of quinate dehydrogenase activity found
in crude extracts of A. calcoaceticus was at first surprising in the
light of the findings that other microbial species which, like A. .
calcoaceticus can utilise quinic acid, have quite high levels of 
+
NAD -dependent quinate dehydrogenase (Ahmed & Giles, 1969?
Ingledew & Tai, 1972); However the recent studies of van Kleef and
t
Duine (1988) provide an explanation. These authors have shown that
+
A. calcoaceticus has an NAD -independent, membrane associated
quinate dehydrogenase which utilises PQQ as a co-factor. This
*
enzyme which appears to be the dye-linked hydroaromatic. 
dehydrogenase originally reported by Tresguerres et al. (1970a,b) is
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the enzyme which enables A. calcoaceticus to utilise quinate. All 
the crude extracts of A^ _ calcoaceticus used in this study were high 
speed supernatants (samples centrifuged at 100,000g for 2 h) and 
this would have effectively sedimented all membrane-associated 
enzymes. This accounts for the very low levels of quinate 
dehydrogenase activity found in the extracts.
4.9.4 Separation of the isoenzymes
Although there was good immunochemical evidence for two 
isoenzymes of shikimate dehydrogenase in A. calcoaceticus their 
quantitative separation was not achieved. The two isoenzymes were 
not separated by ion exchange and dye columns, by gel filtration, by 
SDS PAGE and by isoelectric focusing. They were resolved by PAGE 
under native conditions but this is not a practical preparative 
method. Since the two isoenzymes were immunochemically distinct 
the best idea for their separation appeared to be immunoaffinity 
chromatography. Although this method gave some enrichment for the 
isoenzyme that bound to the anti-E. coli-E3 column the yields were 
very low and quantitative separation was not achieved.
The major difficulty with the immunoaffinity column was its 
very low affinity for the A. calcoaceticus enzyme. One possible 
reason for this is that specific A^ _ calcoaceticus enzyme binding 
antibody was only a minor fraction of the Ig on a column. The 
antibodies used were polyclonal and must have contained many 
different molecular species each with different specificities for 
the various epitopes of the structurally complex immunogen, E^ coli 
shikimate dehydrogenase. Comparison of the antibody titres between 
E. coli E3 and A. calcoaceticus E3 highlights the problem. For the 
E. coli enzyme the titre was 1:128 while for the A. calcoaceticus 
enzyme the titre was only 1:1 (see Fig. 3.18). This indicates that
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the IgG which is specific for the A_^  calcoaceticus enzyme is only a 
minor fraction of the mixture of IgG species present. The 
chemically coupling procedure required to attach the IgG molecules 
to the Sepharose column inevitably reduces the number of intact 
antigen binding sites and this is particularly damaging to column 
capacity when the number of sites available is already very small.
It is also likely that other factors such as low affinity 
and non-specific binding also contributed to the failure of the 
immunoaffinity chromatography. Better results might have been
achieved if a high affinity, polyclonal antibody preparation had 
been available.
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5. General discussion
The major objective of the work presented in this thesis was 
to prepare antibodies against the five 12. coli enzymes that catalyse 
the reactions at the centre of the shikimate pathway and to use 
these reagents to detect sequence and structural similarities 
between the enzymes of the pathway within and between species.
Polyclonal antibody preparations were obtained against all 
five enzymes and against the pentafunctional arom protein of N^ . 
crassa which has a single, five domain, polypeptide chain that 
catalyses the same five reactions.
With the antibodies for the 12. coli enzymes no cross 
reaction was detected between an antibody raised against any single 
enzyme of the pathway and any other enzymes of the pathway. This is 
consistent with sequence studies for the enzymes which initially 
revealed no homologies between the pathway enzymes (Duncan et al., 
1987). More recent work has revealed one short region of homology 
between dehydroquinate synthase (El) and dehydroquinase (E2) but the 
region showing homology represents only about 5% of the sequence (K. 
Kleanthous and J.R. Coggins, manuscript in preparation) and the 
chances of picking up such a short region of homology using antibody 
techniques are very low.
The antibodies raised against the 12. coli enzymes proved to 
be of limited use for detecting the appropriate shikimate pathway 
enzymes in other species. Some success was obtained with studies of 
extracts of gram negative bacteria. Antibodies raised against the 
12. coli shikimate dehydrogenase (E3) cross reacted well with 
extracts of f3. typhimurium and 12. caratovora which suggested that
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there was considerable conservation of the sequence of this enzyme 
between these species. There is very little comparative sequence 
data for bacterial shikimate pathway enzymes. In the case of EPSP 
synthase (E5) it is known that the sequences of the JE. coli and 55. 
typhimurium enzymes are 90% identical (Duncan et al., 1987); similar 
levels of homology have been reported for the dehydroquinases (E2) 
of E. coli and S^ . typhimurium (I.G. Charles, unpublished results) 
and the shikimate kinases (E4) of J2. coli and j2. caratovora (Minton 
ej: al., 1989). It seems very likely that there is a similar degree 
of homology between the shikimate dehydrogenases of these species.
The cross-reactions did not extend outside the gram negative 
species. Generally no cross reaction was found with gram positive 
bacterial extracts or with fungal or plant extracts. Again there is 
very limited comparative sequence information for the shikimate 
pathway enzymes in these species. For EPSP synthase it is known 
that the fungal and gram negative bacterial enzymes are only about 
30% identical (Duncan et al., 1987) while the plant and gram 
negative bacterial enzymes are approximately 50% identical (Kishore 
& Shah, 1988; S.P. Granger and J.R Coggins, unpublished results). 
Only one shikimate pathway enzyme has been sequenced from a gram 
positive organism and this enzyme, dehydroquinase from £[. 
coelicolor, is completely different from the corresponding J2. coli 
enzyme. Preliminary sequence information indicates that this enzyme 
resembles the inducible fungal dehydroquinases (P.J. White and J.R. 
Coggins, unpublished results).
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The cross reaction results confirm the value of antibodies 
for detecting enzymes from closely related species where the overall 
amino acid sequences are 90% or more identical. However where the 
species divide is wider so that the match of amino acid sequence 
falls to 50% or less antibodies are no longer useful for detecting 
homologous enzymes.
The most detailed studies reported in this thesis involved 
anti-E. coli shikimate dehydrogenase. Extracts of the gram negative 
soil bacteria A. calcoaceticus cross reacted weakly with the anti-E^ 
coli-E3 and revealed that A. calcoaceticus had two forms of 
shikimate dehydrogenase. This was interesting beacause of the 
central position played by shikimate dehydrogenase in the metabolism 
of this type of organism.
It is well known that some organisms, which normally grow on 
living or dead plants or in the soil, such as ttf. crassa and A. 
calcoaceticus, have both a shikimate biosynthetic pathway which 
allows them to synthesise essential aromatic compounds and a quinate 
catabolic pathway which allows them to use abundant plant 
metabolites, such as quinic acid, as carbon sources. The shikimate 
pathway enzymes have so far only been studied in detail in 13. coli 
and in the two filamentous fungi N. crassa and A. nidulans. The two 
fungi have both the biosynthetic shikimate and the catabolic quinate 
pathways. E2. coli, in contrast only has the shikimate biosynthetic 
pathway; it lacks the quinate pathway (Mitsuhashi & Davis, 1954).
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It was therefore of considerable interest to look at the comparative 
aspects of this pathway in a bacterial species, A_. calcoaceticus 
which has the quinate pathway enzymes.
The results presented in detail in chapter 4 showed clearly 
that A. calcoaceticus differs totally from N. crassa in the way its 
shikimate and quinate pathway enzymes are organised. The five 
central shikimate pathway enzymes are separable like the 
corresponding E. coli enzymes; there is no pentafunctional 
polypeptide as found in N. crassa. A. calcoaceticus has no 
bifunctional NAD(P)+-dependendent quinate (shikimate) 
dehydrogenase analogous to the inducible quinate pathway enzyme 
found in N. crassa. The purified shikimate dehydrogenase of A. 
calcoaceticus has no detectable quinate dehydrogenase activity. The 
quinate dehydrogenase of A. calcoaceticus appears to be a membrane 
associated, PQQ-dependent enzyme, which has been partially 
characterised by van Kleef & Duine (1988). Quinate dehydrogenase is 
therefore completely different in N. crassa and A. calcoaceticus.
While it is clear that A. calcoaceticus has both a 
biosynthetic shikimate pathway and the ability to utilise quinate 
the precise relationship between these two pathways remains 
unresolved. The enzymes required for the conversion of 
dehydroquinate to protocatechuate have not been fully 
characterised; it does appear that there are two dehydroquinases, 
as is found in tJ. crassa. The observation that there are two forms 
of shikimate dehydrogenase raises the possibility that* one of these 
may be the shikimate pathway biosynthetic enzyme., while the other 
may be part of the catabolic pathway, which would allow the organism 
to use shikimate and products that can be converted to shikimate
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as carbon sources.
Further work is undoubtedly necessary to complete the 
characterisation of both the shikimate and quinate pathway enzymes 
in A. calcoaceticus. This will be especially interesting because of 
the major differences reported in this thesis between the enzymes of
A. calcoaceticus and N. crassa.
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APPENDIX
Amino acid homologies between the E3. Cerevisi'ae arom multifunctional 
enzyme and the corresponding monofunctional EC. coli enzymes (taken 
from Duncan et_ al., 1987). The sequence give in this figure for EC. 
coli dehydroquinase (the aroD gene product) has recently been 
revised as shown on p. 184 (L.D. Graham, E. Borthwick and J.R. 
Coggins, unpublished results).
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Revised sequence for 12. coli dehydroquinase (L.D. Graham, E. 
Borthwick and J.R. Coggins, unpublished results).
1 MKTVTVKDLV IGTGAPKIIV SLMAKDIASV KSEALAYREA DFDILEWRVD
51 HYADLSNVES VMAAAKILRE TMPEKPLLFT FRSAKEGG.EQ AISTEAYIAL
101 NRAAIDSGLV DMIDLELFTG DDQVKETVAY AHAHDVKWM SNHDFHKTPE
151 AEEIIARLRK MQSFDADIPK IALMPQSTSD VLTLLAATLE MQEQYADRPI
201 ITMSMAKTGV ISRLAGEVFG SAATFGAVKK ASAPGQISVN DLRTVLTILH
251 QA
